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1. Summary 
Signaling by Bone Morphogenetic proteins (BMPs) plays a pivotal role during early 
dorsoventral (D-V) patterning of fish and frog embryos, determining both differential cell 
fates as well as the direction of cell movements along the D-V axis during gastrulation. 
Several forward genetics screens with ENU-mutagenised zebrafish have unravelled the 
indispensable function of several components of the BMP signaling pathway, including the 
BMP-ligands themselves, BMP receptors, the BMP-regulated transcription factor Smad5 and 
the extracellular BMP inhibitor Chordin. The BMP signaling pathway interacts with that of 
other signaling molecules, like Fibroblast Growth Factors or Wnts. However, there are still 
new genes to be discovered involved in early patterning processes; also the exact role of the 
BMP gradient in cell fate determination along the D-V axis of the gastrulating zebrafish 
embryo is not absolutely clarified. 
As starting point of my thesis work I participated in a reverse genetics screen based on 
antisense morpholino oligonucleotides for specific gene knock-downs in zebrafish. As part of 
a consortium of several labs, I designed and screened a collection of morpholinos for 
phenotypes in early patterning, pituitary development and skin development. A morpholino 
targeting the gene acyl-CoA Synthetase longchain family member 4a (acsl4a), whose product 
is involved in the metabolism of the longchain fatty acid arachidonic acid, caused defects in 
D-V patterning. 
In the first part of this thesis I characterise the phenotype of embryos after acsl4a knock-
down, pointing to an essential role of Acsl4a in maintaining the BMP signaling gradient 
during gastrulation. However, the phenotype could only be obtained by one of several tested 
morpholinos. Also, I failed to rescue the defects by concomitant forced expression of acsl4a 
that is not targeted by the morpholino. Furthermore, I tested other components of the 
arachidonic acid metabolism, none of which interfered with early patterning of the zebrafish 
embryo. In conclusion, the role of acsl4a, and its connection to BMP signaling during D-V 
patterning of the zebrafish embryo remains elusive. 
In the second part of the thesis I address the question of cell fate commitment, thus the timing 
of cell determination, along the D-V axis and its dependence on BMP signaling. According to 
the morphogen concept, the BMP gradient with from dorsal-to-ventral progressively 
increasing BMP signaling determines differential cell fates along the D-V axis. In the 
ectoderm, high BMP levels are thought to induce epidermal fates, while blocking neural 
development, so that ventral cells will give rise to skin, whereas neurons are formed from the 
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dorsal ectoderm, where BMP levels are lowest. In other instances, BMPs have been described 
as factors that maintain the pluripotency of stem cells, thus acting as a principle inhibitor of 
cell specification processes. Interestingly, the BMP gradient is highly dynamic over time, 
with a rather broad expression early, which becomes progressively restricted to the ventral 
side of the embryo during the course of gastrulation. Therefore, I wondered whether BMPs 
might keep the ventral ectoderm in a more pluripotent state, while dorsal cells become 
specified and committed to their final fate significantly earlier, consistent with the earlier loss 
of BMP expression. To test this notion, I carried out differential cell commitment studies by 
heterotopic and heterochronic transplantations of dorsal versus ventral ectodermal cells of the 
zebrafish embryo during different stages of gastrulation. Surprisingly, neither ventral nor 
dorsal cells were found to be committed to their initial fates, indicated by the loss of their 
respective marker genes expression upon transplantation into the ectopic environment. 
However, only ventral cells were able to adopt the fate of their new environment (dorsal), 
whereas dorsal cells in an ectopic ventral environment lacked both dorsal and ventral marker 
gene expression. This indicates that ventral ectodermal cells do indeed maintain their 
pluripotency longer than dorsal cells. Further experiments with mutant embryos have to show 
whether this effect requires BMP signaling. 
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1.2 Zusammenfassung 
Signale durch Bone Morphogenetic Proteins (BMPs) spielen im Zebrafish und Frosch 
Embryo eine entscheidende Rolle bei der Musterbildung entlang der dorsoventralen Achse, 
dabei bestimmen sie sowohl unterschiedliche Zellschicksale als auch die gerichtete 
Zellbewegung entlang der D/V-Achse während der Gastrulation. 
Mehrere soegannte „forward genetic“ Screens mit ENU-mutagenisierten Zebrafischen haben 
die unentbehrliche Funktion von mehreren Komponenten des BMP-Signal-Wegs aufgezeigt, 
darunter die BMP-Liganden selbst, die Rezeptoren von BMPs, der durch BMPs regulierte 
Transkriptionsfaktor Smad5 und der extrazelluläre BMP-Inhibitor Chordin. Der BMP-
Signalweg interagiert mit denen anderer Signalwege, wie Fibroblast Growth Factors oder 
Wnts. Jedoch gibt es immer noch neue Gene zu entdecken, die in Prozessen der frühen 
Musterbildung beteiligt sind; weiterhin ist die genaue Rolle des BMP Gradienten in der 
Festlegung von Zellschicksalen entlang der D-V Achse eines gastrulierenden Zebrafisch 
Embryos nicht vollkommen geklärt. 
Als Ausgangspunkt meiner Doktorarbeit habe ich an einem rückwärts gerichteten genetischen 
Screen, basierend auf Antisense Morpholino Oligonukleotiden für spezifischen Knock-Down 
von Genen im Zebrafisch, teilgenommen. Als Teil eines Konsortiums mehrerer 
Arbeitsgruppen habe ich eine Kollektion von Morpholinos erstellt und auf Phänotypen in der 
Frühentwicklung, Entwicklung der Hypophyse und der Haut untersucht. Ein Morpholino, 
gerichtet gegen das Gen acyl-CoA Synthetase longchain family member 4a (acsl4a), dessen 
Produkt im Metabolismus der langkettigen Fettsäure Arachidonsäure beteiligt ist, verursachte 
Defekte in der D-V Musterbildung. 
Im ersten Teil dieser Arbeit beschreibe ich den Phänotyp von Embryonen nach dem Knock-
down von acsl4a, der auf eine essentielle Rolle von Acsl4a in der Aufrechterhaltung des 
Gradienten des BMP Signals während der Gastrulation hindeutet. Jedoch konnte der Phänotyp 
nur mit einem von mehreren untersuchten Morpholinos erreicht werden. Ebenfalls ist es mir 
missglückt die Defekte durch gleichzeitige Überexpression von acsl4a, welches nicht von 
dem Morpholino erkannt wird, zu retten. Ausserdem habe ich weitere Komponenten des 
Archidonsäure Metabolismus untersucht, jedoch keine der getesteten Komponenten 
interferierte mit der Frühentwicklung des Zebrafisch Embryos. Zusammengefasst bleibt die 
Rolle von acsl4a und seine Verbindung zum BMP-Signalweg während der D-V 
Musterbildung des Zebrafisch Embryos ungeklärt. 
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Im zweiten Teil dieser Arbeit befasse ich mit der Frage der Festlegung von Zellschicksalen, 
genauer der zeitlichen Folge der zellulären Bestimmung, entlang der D-V Achse und ihrer 
Abhängigkeit von BMP Signalen. Entsprechen dem Konzept von Morphogenen bestimmt der 
stufenweise von dorsal nach ventral ansteigende BMP Gradient die verschiedenen 
Zellschicksale entlang der D-V Achse. Im Ektoderm wird angenommen, dass ein hoher Grad 
von BMP Signal epidermale Schicksale induziert, bei gleichzeitigem blockieren der neuralen 
Entwicklung, so dass ventrale Zellen zu Haut werden, während Neuronen sich aus dem 
dorsalen Ektoderm, wo der Grad der BMP Signale am niedrigsten ist, entstehen. In anderen 
Zusammenhängen wurden BMPs als Faktoren beschrieben die die Pluripotenz von 
Stammzellen aufrechterhalten, dabei arbeiten sie als prinzipieller Inhibitor von 
Zellspezifikationsprozessen. Interessanterweise ist der Gradient von BMPs sehr dynamisch 
über die Zeit, mit einer sehr breiten Expression zu einem frühen Zeitpunkt, die während der 
Gastrulation schrittweise auf die ventrale Seite des Embryos beschränkt wird. Deswegen habe 
ich mich gefragt, ob BMPs das ventrale Ektoderm in einem mehr pluripotenten Zustand 
halten, während dorsale Zellen zu einem wesentlich früheren Zeitpunkt spezifiziert und auf 
ihr endgültiges Zellschicksal festgelegt werden, passend zu dem früheren Verlust der 
Expression von BMPs. Um diesen Gedanken zu überprüfen habe ich Studien zur zellulären 
Festlegung mit heterotopischen und heterochronischen Transplantationen von dorsalen gegen 
ventralen ektodermalen Zellen des Zebrafisch Embryos während verschiedener Zeitpunkte der 
Gastrulation durchgeführt. Überraschenderweise, konnte ich weder für ventrale noch dorsale 
Zellen zeigen, dass sie auf ihr ursprüngliches Schicksal festgelegt sind, da sie die Expression 
ihrer entsprechenden Markergene nach der Transplantation in eine ektopische Umgebung 
verlieren. Jedoch, nur ventrale Zellen waren fähig das Schicksal ihrer neuen Umgebung 
(dorsal) anzunehmen, wobei dorsalen Zellen in einer ektopischen ventralen Umgebung 
sowohl die Expression dorsaler als auch ventraler Markergene fehlt. Dies zeigt, dass ventrale 
ektodermale Zellen tatsächlich ihre Pluripotenz länger als dorsale Zellen behalten. Weitere 
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2. General Introduction 
Higher animals develop from a fertilised egg to a three-dimensional, highly structured 
organismn consisting of multiple different cell types and tissues which - in the case of 
bilateria – are organized along at least two main body axes: the anterior-posterior (A-P) and 
the dorsal-ventral (D-V) axis. After fertilisation of the egg by a sperm cell, the first 
developmental process called cleavage is initiated, during which the zygote divides by several 
rounds of mitosis and (total or partial) cytokinesis into the so-called blastomeres. During these 
rapid cell divisions, the cell cycle just consists of an M- (mitosis) and an S- (DNA synthesis) 
phase, development is driven by maternally provided gene products, and cells become 
progressively smaller. However, once a certain ratio of DNA and cytoplasm is reached, G1 
and G2 phases are established, cell divisions slow down, and zygotic transcription starts (mid-
blastula-transition). After the blastula stages, the process of gastrulation starts, during which 
the three germlayers, ectoderm, mesoderm and endoderm, are formed. The ectoderm will later 
give rise to the epidermis, the nervous system and the neural crest, the mesoderm will form 
notochord, muscle, parts of the body skeleton, the blood, as well as vasculature and excretion 
tissues, and the endoderm will form the gastrointestinal system. In addition, the gastrulating 
embryo changes its overall shape and acquires a much more complex architecture, driven by 
the so-called morphogenetic cell movements during which mesoderm and endoderm become 
internalized. In addition, the body axes are set up and the general body plan is acquired. 
Gastrulation is followed by neurulation, during which the neural tube of the central nervous 
system is formed, and by organogenesis, during which the organs of the animal develop 
(Gilbert, 2003). 
All of these developmental processes are under the control of a complex system of signaling 
pathways and transcription factors. These factors act in a spatially and temporally strictly 
regulated and coordinated fashion. While some of them have redundant roles, others are 
absolutely indispensable, so that a single loss of their function would cause major changes in 
the embryonic body plan. 
 
2.1. Early zebrafish development 
In 1981, George Steisinger introduced the zebrafish (Danio rerio) as a genetic model system 
for vertebrate development (Streisinger et al., 1981). The large number of progeny, the 
transparency of embryos and larvae, and the extracorporal development makes the zebrafish 
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highly suitable for large scale forward genetics screens and embryological methods like cell 
transplantations, treatments with chemical compounds and microinjection to overexpress and 
knock-down specific genes (reverse genetics). In the following, I will give an introduction 
into the early patterning processes during gastrulation of zebrafish, focussing on the 
establishment of the dorsal-ventral axis.  
The anteriorposterior axis of the zebrafish embryo already become apparent shortly after 
fertilization, when the cytoplasm accumulates on one side of the zygote (the animal pole) and 
the yolk granules on the other (the vegetal pole). This animal-vegetal axis corresponds to the 
later anterior-posterior axis, with the head forming at the animal pole and the tailbud at the 
vegetal pole. The first cleavage of the zebrafish zygote occurs around 45 minutes after 
fertilisation, followed by meroblastic cleavages every 15 minutes until the 128-cell-stage. 
Between two hours and five hours post fertilisation (hpf), the blastula stages, the embryo, also 
called blastoderm, sits like a cap on the huge yolk cell, which does not cleave. At the 512-
cell-stage (2.75 hpf), the embryo enters mid-blastula-transition (MBT; see above) and the first 
two cell lineages segregate from each other, the deep cells, which will form the proper 
embryo, and the Yolk Syncitial Layer (YSL), which does not contribute to the later animal. 
During cleavage, the cytoplasm of the most marginal blastomere has remained in contact with 
the yolk cell and the YSL is formed when these blastomeres fuse to the yolk cell, thereby 
releasing their nuclei into the cytoplasma of the yolk cell, where they form a syncytial layer 
(Kimmel and Law, 1985b). Shortly after the MBT a third cell lineage is formed, the 
enveloping layer (EVL). It derives from superficial blastomeres that flatten out to form an 
embryonic skin, also called the periderm (Kimmel and Law, 1985c). It is currently unclear 
whether the periderm is maintained throughout the entire life of the fish, or eventuall shed off 
and replaced by derivatives of basal keratinocytes from the ventral ectoderm (see below). 
Gastrulation starts at approximately 4.5 hpf with the morphogenetic movement of epiboly, 
which leads to a progressive covering of the yolk cell by the blastoderm (Kimmel et al., 1995; 
Kimmel and Law, 1985a). Accordingly, gastrula stages are named in percentage of yolk 
coverage. The 30% epiboly stage is reached shortly after the onset of gastrulation, the 50% 
epiboly stage at 5.5 hpf, the 70% epiboly stage (mid-gastrulation) and the 100% epiboly stage 
(end of gastrulation) at 10 hpf. In addition to epiboly, two other main morphogenetic 
movements of gastrulation can be distinguished: emboly (by some authors also called 
involution) and convergence and extension (C&E), both of which start at the 50% epiboly 
stage (Warga et al., 1990; Solnica-Krezel, 2005). During emboly, the mesoderm and the 
endoderm, which are induced in marginal cells facing the yolk cell and by signals emanating 
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from the YSL (Schier and Talbot, 2005), are brought into the interior of the embryo, whereas 
cells of the ectoderm remains outside. During convergence (Myers et al., 2002), lateral cells 
of both the ectoderm and the mesendoderm move towards the dorsal side to form the body 
axis. The dorsal side thickens accordingly. This thickening becomes first apparent at 6 hpf as 
a structure called the embryonic shield, which marks the dorsal side and which for the first 
time allows to morphologically recognize the dorsovental axis. Within this shield, the dorsal 
organizer, also called the Spemann-Mangold organizer, is located (see below). Driven by 
extension movements, the dorsal tissue further extends along the animal-vegetal / anterior-
posterior axis of the embryo to form the body axis. 
 
2.2 The establishment of the dorsal-ventral axis in zebrafish 
Fate mapping experiments have shown that the future fate of an embryonic cell depends on its 
position within the late blastula and early blastula embryo (Kimmel et al., 1990). As outlined 
above, marginal cells facing the yolk will give rise to mesodermal and endodermal 
derivatives, while animal cells form to ectoderm. Of particular importance is also the position 
along the dorsoventral axis. Within the mesoderm, dorsal-most cells will form prechordal 
plate and notochord, dorsolateral cells somatic muscle, ventrolateral cells blood and ventral-
most cells kidney and anus. Similarly, within the ectoderm, dorsal cells give rise to the 
neuroectoderm, intermediate cells to neural crest and placodes, and ventral-most cells to the 
epidermis. Initially organized within one plane along the dorsoventral circumference of the 
embryo, all of these cells types will move dorsally, so that eventually, the neuroectoderm will 
also be internalized and covered by skin. Over the past ten to fifteen years, enourmous 
progress has been made in eludidating the genetic and molecular network regulating dorso-
ventral axis formation during early zebrafish development (Schier and Talbot, 2005). Two 
major steps can be distinguished; first, the formation of the Spemann-Mangold-organizer as 
the initial step of dorsoventral pattern formation (Nojima et al., 2004; Pelegri and Maischein, 
1998), and second, the function of the organizer to further pattern the dorsoventral axis 
(Hammerschmidt and Mullins, 2002). Similar to the effects obtained by Mangold and 
Spemann with amphibian embryos, transplantation of the shield of zebrafish embryos into 
ventral regions leads to secondary body axis formation by an inducing ectopic muscle and 
neural development in adjacent tissue, while the organizer itself gives rise to prechordal plate, 
notochord and some fore- and midbrain tissues (Saúde et al., 2000). On the molecular level, 
organizer formation can be first recognized by the presence of ß-catenin protein in the nuclei 
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of the dorsal marginal cells and the YSL (Schneider et al., 1996). ß-catenin is an intracellular 
transducer of canonical Wnt (named because of D.melanogaster Wingless and vertebrate 
Integrated) signaling. In the absence of Wnt signaling, ß-catenin is phosphorylated by a 
complex of APC, Axin and the kinase GSK3, and thereby targeted for proteasomal 
degradation. However, upon binding of Wnt ligands to their Frizzled transmembrane 
receptors and the co-receptor LRP, this destruction complex is inactivated by Dishevelled and 
GBP, and ß-catenin can accumulate in the cytoplasm and translocate into the nucleus, where it 
participates as a partner of LEF/TCF transcription factors in transcriptional regulation (Logan 
and Nusse, 2004). While the nature of the Wnt ligand remains elusive, zebrafish mutants in ß-
catenin-2 display compromised organizer formation and severe hyper-ventralization 
(Bellipanni et al., 2006). Among the first genes activated by ß-catenin is bozozok, a homeobox 
containing gene, which acts as repressor of ventralising genes like bmp2b , encoding a Bone 
morpogentic protein (BMP; see below) and vox/vent, encoding transcription factors mediating 
BMP signaling (Fekany et al., 1999; Imai et al., 2001; Leung et al., 2003; Shimizu et al., 
2002). Other targets of ß-catenin are Nodal-like factors expressed in the YSL, mainly 
involved in the induction of the mesendoderm, but also required for the formation of the 
dorsal organizer (Dougan et al., 2003; Feldman et al., 1998). A second wave of ß-catenin 
dependent gene activation results in the expression of Fibroblast Growth Factors (FGFs) 
(Maegawa et al., 2006).  
Fibroblast Growth Factors are involved in mesoderm formation, neural induction, 
dorsoventral and anterior-posterior patterning. FGFs signal via receptor-tyrosine kinases and 
the Ras/ MAPK pathway. During late blastula, fgf3, fgf8 and fgf24 expression is initiated in 
dorsal marginal cells, the precursors of the Spemann-Mangold organizer, where they promote 
expression of the BMP inhibitor Chordin (see also below), thereby restricting BMP activity 
and regulating dorsoventral patterning (Maegawa et al., 2006; Draper et al., 2003; Furthauer 
et al., 1999; Furthauer et al., 1997; Kiefer et al., 1996). Later in gastrulation, FGFs induce 
posterior neuroectodermal cell fates, but independent of the BMP signaling or organizer 
function (Rentzsch et al., 2004). 
Another gene activated by ß-catenin and Nodal signals is dickkopf (dkk), constituting a 
negative feedback and temporal restriction of active Wnt signaling in the organizer domain. 
dkk1 is expressed at the dorsal margin and later in the prechordal plate. Dkk protein binds the 
LRP subunit of the Wnt-receptor, thereby preventing the action of canonical Wnt signals and 
promoting the specification of anterior neural fates and axial mesendoderm, probably by 
blocking Wnt signals (Hashimoto et al., 2000; Shinya et al., 2000). Thus, while being 
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essential for early steps, canonical Wnt signaling needs to be actively blocked to allow later 
steps of dorsal development during mid- and late gastrulation. At the same time, active Wnt 
signaling, mainly via the ligands Wnt8 and Wnt3a, becomes indispensable for the 
specification of ventral and posterior cell fates (Erter et al., 2001; Lekven et al., 2001; 
Shimizu et al., 2005), This switch form an early pro-dorsal to a later pro-ventral and anti-
dorsal effect, while still quite puzzling, has also been observed for canonicalWnt signaling 
during amphibian development (Moon et al., 1997). Thus, it seems to be a more common 
phenomenon, which might point to a primary role of Wnt signaling in the timing of cell 
specification, rather than or in addition to cell fate determination per se (see also below). 
 
2.3. The role of Bone Morphogenetic Proteins during gastrulation 
Like the aforementioned Nodals, Bone Morphogenetic Proteins are members of the large 
family of TGFß signaling molecules. Zygotic expression of bmp2b and bmp7 in zebrafish 
starts right after mid-blastula transition. However, transcripts encoding Bmp4, Bmp7 and 
Radar, a homologue of the mammalian TGFß-family member Growth Differentiation Factor 6 
(GDF6), are also maternally provided (Goutel et al., 2000; Kramer et al., 2002; Sidi et al., 
2003). GDF6 is driving the expression of bmp2b and bmp7, thereby most likely acting via the 
BMP type I receptor Alk8 and the BMP-regulated transcription factor Smad5 (see also below) 
(Kramer et al., 2002; Sidi et al., 2003).. During late blastula and gastrula stages three bmps are 
prominently expressed, bmp2b, bmp7 and bmp4 , all of which are required for dorsoventral 
patterning and the establishment of ventrolateral fates (Dick et al., 2000; Kishimoto et al., 
1997; Nguyen et al., 1998; Schmid et al., 2000; Stickney et al., 2007). Thus, bmp2b and bmp7 
mutants are severely hyper-dorsalised, with an extension of muscle and neuroectodermal 
precursors into ventral most regions of the embryo, whereas ventral cell fates like epidermal, 
kidney or blood precursors are completely or largely absent. Compared to bmp2b and bmp7, 
however, the role of bmp4 during dorsoventral patterning is minor, whereas it is more 
important in specifing left-right asymmetry (Chen et al., 1997; Chocron et al., 2007; Hwang et 
al., 1997; Martinez-Barbera et al., 1997; Stickney et al., 2007) 
The Bmp-ligands act as dimers. During dorsoventral patterning, Bmp2b and Bmp7 most 
likely work as heterodimer (Schmid et al., 2000; Little and Mullins, 2009). They bind to type 
a complex of type I and type II transmembrane receptor Ser/Thr kinases. To date five type I 
receptors are identified in zebrafish, alk3a and alk3b (Nikaido et al., 1999; Little and Mullins, 
2009), alk6a and alk6b (Nikaido et al., 1999b; Little and Mullins, 2009) and alk8, which is 
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most similar to mammalian Alk2 (Bauer et al., 2001; Mintzer et al., 2001). The Bmp2b/7 
heterodimers signal through heteromeric type I receptors consisting of Alk8, which is 
indispensable, and either of the four Alk3/6 molecules, which can replace each other in a 
redundant manner (Little and Mullins, 2009). Similar to Bmp4, the zebrafish orthologues of 
the BMP type II receptors have been found to be largely involved mediating BMP signaling 
during in left-right patterning (Monteiro et al., 2008), whereas during dorsoventral patterning, 
ActRII, a type II receptor shared with TGFß-like Nodal and Activin factors, seems to be used 
to mediate BMP signaling (Nagaso et al., 1999). Upon ligand binding the receptor cross-
phosphorylate each other by their Ser/Thr kinase domain, followed by the phosphorylation of 
the receptor-regulated Smad (R-Smad) proteins (named after C.elegans Sma (Savage et al., 
1996)and D.melanogaster Mad (Sekelsky et al., 1995) via the type I receptors. Upon 
phosphorylation, R-Smad disaggregate from the cytoplasmic part of the BMP receptors and 
associate with so-called Co-Smad proteins, with which they are translocated into the nucleus 
where they work as transcriptional regulators (Massague, 1996; Massague and Weis-Garcia, 
1996; Raftery and Sutherland, 1999) (Fig.2-1). R-Smads specifically involved in BMP signal 
transduction are Smad1, Smad5 and Smad8, the most common Co-Smad shared by BMP and 
Nodal/Activin signaling is Smad4, while for zebrafish dorsoventral patterning, only Smad5 
could thus far be shown to play an indispensable role (Hild et al., 1999; Kramer et al., 2002; 
McReynolds et al., 2007). Several direct or indirect transcriptional target of Bmp/Smad target 
genes have been described, some of which in turn encode for regulators or components of the 
BMP signal transduction pathway, thereby constituting positive or negative feedback loops 
involved in the fine-tuning of BMP signaling. Examples are the bmp2b/4/7 genes themselves, 
constituting a positive feedback (Kishimoto et al., 1997), or the the smad7 gene, which 
encodes an inhibitory Smad protein, thereby constituting a negative feedback (Pogoda and 
Meyer, 2002). 
In blastula stages bmp2b and bmp7 are broadly expressed throughout the embryo, sparing just 
the dorsal-most regions of the future Spemann-Mangold organizer, where their expression is 
repressed by Boz (Fekany et al., 1999; Leung et al., 2003). In addition, BMP inhibitors start to 
be expressed on the dorsal side, attenuating the positive feedback of BMP signaling on 
bmp2b/7 gene expression, and thereby progressively restricting BMP activity and bmp 
expression to the ventral side of the embryo (Hammerschmidt and Mullins, 2002). 
The most relevant BMP inhibitor is the protein Chordin, which is secreted from organizer 
cells and has long-range signaling effects to attenuate BMP signaling in dorsolateral cells of 
both the ectoderm and the mesenderm (Schulte-Merker et al., 1997; Hammerschmidt et al., 
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1996). Accordingly, chordin mutants are hyper-ventralised, with a reduction in the number of 
neuroectodermal and muscle precursor cells, while derivatives of the ventral ectoderm and 
mesoderm are made in excess. The organizer and adjacent dorsal tissues also make generate 
other extracellular Bmp inhibitors such as Noggin-1 or Follistatin-like 2. Compared to 
Chordin, however, they are less important (Bauer et al., 1998; Dal-Pra et al., 2006; Fainsod et 
al., 1997; Furthauer et al., 1999; Zimmerman et al., 1996). The activity of Chordin itself is 
also under tight control. Thus, it is cleaved by metalloproteases Tolloid/Bmp1, which are 
most active on the ventral side of the embryo (Blader et al., 1997; Connors et al., 1999; 
Muraoka et al., 2006). Tolloid, in turn, is inactived upon binding to Sizzled, a secreted protein 
promoting Chordin activity, but in contrast to Chordin made on the ventral side in response to 
Bmp signaling (Muraoka et al., 2006; Yabe et al., 2003). Further secreted and BMP-binding 
factors like Twisted gastrulation (Little and Mullins, 2004; Ross et al., 2001; Xi and Fisher, 
2005) and Crossveinless-2 (Rentzsch et al., 2006; Zhang et al., 2008) can regulate BMP 
signaling in a context-dependent positive or negative manner. 
The BMP activity gradient is important for the establishment of the dorsal-ventral axis, as 
BMP play important roles in cell fate determination and differentiation. Among the target 
genes of BMP signaling is deltaNp63 that is directly activated by BMP/Smad5 signaling in 
the ventral ectoderm and involved in the development of basal keratinocytes of the epidermis 
(Lee and Kimelman, 2002; Rentzsch et al., 2003). Similarly, although no direct target genes 
have been identified via DNA binding and transactivation as yet, BMP signaling is supposed 
to activate the expression of blood or kidney-specifying genes in the ventral mesoderm. 
Furthermore, according to the morphogen concept, it should with lower thresholds activate 
ectodermal genes involved in the specification of neural crest and placodal ectoderm.  
In addition to cell fate specification along the dorsoventral axis, the BMP gradient has been 
shown to govern cell migrations along the dorsoventral axis during dorsal convergence 
movements, establishing a reverse gradient of cadherin-dependent cell-cell adhesivness (von 
der Hardt et al., 2007). 
An additional aspect of BMP signaling similar to that alluded to above for canoncial Wnt 
signaling could be concerned with the timing of cell specification, rather than or in addition to 
determining the exact fate specification cells will require. Such a role would be consistent 









Figure 2-1: The signaling pathway of Bone Morphogenetic Proteins (modified from Varga and 
Wrana, 2005) 
During dorsoventral patterning in zebrafish, the ligands Bmp2b and Bmp7 bind as heterodimer to a 
heteromeric complex of consisting of the type I receptors Alk8 and Alk3/6, and most likely the type II 
receptor ActRII. The intracellular signal transducers Smad1, 5, 8 become phosphorylated after receptor 
activation, associate with Smad4 and transloctate to the nucleus where they participate in transcriptional 
regulation. Inhibitors of BMP signaling like chordin and noggin bind to the ligands and prevent 
activation of the receptor. Among the target genes are the regulators and components of the BMP signal 
transducting pathway, thereby constituting positive and negative feedback loops. 
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2.4 The role of Bone Morphogenetic Proteins in stem cell biology 
Stem cells are undifferentiated cells that have the ability of renewal while remaining capable 
of differentiating into a specialised cell (Chambers and Smith, 2004). The differentiation 
potentials can vary, depending on the stem cell type. A fertilized egg is totipotent, and can 
give rise to any cell type including extraembryonic tissues. Pluripotent stem cell is the term 
used for embryonic stem cells that can differentiate into any cell type of the embryo proper. 
Multipotent stem cells are usually stem cells that are restricted to a tissue or cell lineage, for 
example hematopoietic stem cell, the progenitors of all blood cells. Even more restricted cells 
are often called oligopotent. And cells that are still self-renewing but only differentiate into 
one cell type by asynchronous cell division are called unipotent stem cell, for example the 
satellite cell of adult muscles (Scholer, 2004).  
Several intrinsic and extrinsic factors are known to regulate and maintain the fate of a stem 
cell and to prevent it from differentiating, like the POU-domain transcription factor Oct4 
(Nichols et al., 1998a), homeodomain protein Nanog (Chambers et al., 2003; Mitsui et al., 
2003), the cytokine Leukemia Inhibitory Factor (LIF) (Matsuda et al., 1999), the 
prostaglandin PGE2 (North et al., 2007), Wnts (Nusse, 2008; Sato et al., 2004), FGFs 
(Dvorak et al., 2006) and BMPs (Varga and Wrana, 2005; Ying et al., 2003; Zhang and Li, 
2005).  
The effects of BMPs on stem cells can vary up to being seemingly contrary, depending on the 
cell types and the context. Embryonic stem cells of mouse (mES) cultured on a stromal feeder 
layer and treated with serum differentiate into neurons unless treated with BMPs, which will 
drive them towards epidermal differentiation (Kawasaki et al., 2000), consistent with the 
aforementioned positive effects of BMP signaling on the developmental of ventral (skin) 
versus dorsal (neural) cell types in the ectoderm of the zebrafish embryo. However, when 
mES cells are incubated in a less complex medium (supplemented with LIF and FGF2), BMP 
will also exhibit their a neural-blocking effect. However, rather than promoting their 
epidermal differentation, they will keep the mES in an undifferentiated state, as for instance 
indicated by the expression of the stem cell-specific marker Oct4 (Munoz-Sanjuan and 
Brivanlou, 2002; Tropepe et al., 2001; (Ying et al., 2003). This effect is most likely achieved 
by interfering with LIF function and suppressing the transcription of differentiation genes via 
blocking MAPK pathways (Qi et al., 2004). Along these lines, it is tempting to speculate that 
the primary function of BMP signaling might be concerned with blocking neural 
development, consistent with the neural default model (Stern, 2005), while for epidermal 
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specification, additional factors are necessary. Similarly, neural specification most likely 
requires other factors in addition to BMP inhibitors. Thus, Chordin and Noggin fail to induce 
neural fate in the absence of FGF signaling (Launay et al., 1996; Sasai et al., 1996). In 
addition, Wnts have been shown to be required for neural induction (Baker et al., 1999). 
However, it remains a matter of debate to which extent FGFs and Wnts act as direct neural 
inducers, and to which extent by interfering with and blocking BMP signaling (Furthauer et 
al., 1997; Furthauer et al., 2004; Rentzsch et al., 2004). FGF signaling for instance can block 
BMP signal transduction via its downstream effector MAPK, which phosphoralytes Smad1 at 
a specific site of the linker region., thereby preventing its translocation into the nucleus (Pera 
et al., 2003). Similarly, Wnts can crosstalk to BMPs via phosphorylation of Smads through 
GSK3 (Fuentealba et al., 2007). In conclusion, the role of BMP signaling in stem cell biology 
has to be seen in relation to other signaling pathways. 
A specification-blocking effect as observed in mES cells would also be consistent with the 
reported roles of Bmp2, Bmp4 and Bmp8b and their Drosophila orthologue Decapentaplegic 
to maintain germ line stem cells in the mammalian testis and the fly ovary, respectively (Xie 
et al., 1998; (Funk et al., 2002). However, experiments with human embryonic stem cells 
(hES) indicate an opposite role for BMPs. Here, BMP-2 promotes the differentiation of hES, 
mainly into extraembryonic endoderm, accompanied by a loss of stem cell marker expression, 
whereas the BMP inhibitor Noggin blocks this differentiation (Pera et al., 2004).  
For dorsovental patterning of the zebrafish embryo, there are different data sets in line with a 
possible differentiation -blocking and/or stem cell-maintaining role of BMP signaling. One 
comes form the analysis of mutants in Pou2, the zebrafish orthologue of the stem cell 
maintenance factor Oct4 (Belting et al., 2001; Reim and Brand, 2002). Mutants lacking both 
maternal and zygotic pou2 gene products display loss of bmp expression and a hyper-
dorsalization similar to that of bmp mutants. Futhermore, the dorsalised phenotype of pou2 
mutants can be rescued by re-introduction of bmp transcripts (Reim and Brand, 2006), 
suggesting that Pou2 acts via BMPs, and that the dorsalised phenotype might result from 
precocious specification of ventral cells. Consistent with this notion, experiments with 
transgene-driven temporally controlled BMP inhibition revealed that compared to dorsal cell 
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2.5. Aim of the work 
The genetic network controlling dorsoventral patterning and axis formation of the vertebrate 
embryo, and the pivotal role of BMP signaling within this control system, are rather well 
understood. However, several questions remain open. To identify new genes involved in 
developmental processes I joined a consortium for a large-scale reverse genetic screen using 
antisense morpholino oligonucleotides (Pickart et al., 2006). During the screen I found acyl-
CoA synthetase longchain family member 4a (acsl4a) to be required for dorsal-ventral 
patterning of the zebrafish gastrula. Acsl4a catalyzes the synthesis of a range of 
arachachidonic acid derivates, such as prostaglandins. Interestingly, the prostaglandin PGE2 
has recently been shown to be required for the maintainence of hematopoietic stem cells of 
zebrafish larvae (North et al., 2007), raising the possibility that it might fulfil a similar 
function to allow proper ventral development during dorsoventral patterning of the early 
zebrafish embryo. This would be consistent with the stem cell maintaining roles of Pou2 and 
BMP signaling described above, and was subject of the first part of my thesis work.  
If BMPs and their partners do indeed pattern the dorsoventral axis by attenuating cell 
specification, ventral cells, which receive high and longer BMP signaling, should become 
specified later than dorsal cells, in which BMP signaling is weaker and less persistent. In the 
second part of my thesis, I tested this notion, carrying out cell commitment studies via 
heterotopic and heterochronic transplantations of ectodermal cells. 
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3. Material and Methods 
3.1. Zebrafish lines and husbandary  
Wild-type embryos were obtained from crosses of TL/EK or AB zebrafish. gsc::GFP 
transgenic embryos were obtained from outcross of heterozygous fish with wildtype strains. 
Embryos were raised and staged according to Kimmel et al. (1995). Dechorionation was 
performed with Watchmakers forceps, and embryos older than 15 hpf, which were to be 
manipulated were anaesthetized by addition of 0.2% v/v Tricaine to embryo medium. 
Dechorionated embryos were kept in petridishes coated with 1% agarose. 
 
3.2. Embryological methods 
Microinjection of zebrafish embryos 
Morpholino oligonucleotides (MOs) were either purchased from Gene Tools and a stock of 
1mM was prepared, or the screen consortium sent aliquots of 25µg/µl stocks. 
Synthetic mRNA, MOs, or linage tracers were diluted to working concentrations in Danieau-
buffered solution (Nasevicius and Ekker, 2000) containing 10% phenol red (Sigma). A 
volume of 2 nl was injected into the yolk cell of 1-2 cell stage embryos with a fine glas needle 
connected to a pressure-driven P420 picopump (World Precision Instruments) and an M3310 
manual micromanipulator (Science Products). 
For the injection of MOs and dyes into the yolk cell, embryos were dechorionated and 
injected through a very narrow glass capillary with a M3310 Manual micromanipulator at 
high stage (3-3,5hpf). 
The working concentrations are specified in the text; used RNA constructs and MO sequences 
are given below. 
 
Cell transplantation experiments 
Donor embryos were injected at 1-cell stage with fluorescent lineage tracers like fluorescein 
dextran (1mg/ml) or rhodamin dextran (1mg/ml). For the heterochronic transplantations the 
Host embryos were injected with in vitro synthesised RNA of truncated BMP receptor Ia or 
constitutive active alk8, three hours after the donor embryos were injected. Donor and Host 
embryos were manually dechorionated and placed into 1% methylcellulose on groove-slides. 
Depending on the experiments around 10 cells were transplanted with a glass capillary from 
the dorsal or ventral ectoderm embryo to the ventral or dorsal ectoderm, respectively, of the 
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host embryos in case of heterotopic transplantation; or into the animal pole of ventralised or 
dorsalised Host embryos in case of heterochronic transplantations; for a detailed describtion 
of the experiments performed see chapter 5. After the transplantation procedure the embryos 
were transferred into a coated petridish. 
 
Treatment of embryos with chemical compounds 
The chemical compounds were diluted in DMSO, MeOH or water to prepare stock solutions 
according to the instruction manuals. The working solutions were prepared just prior to use by 
the desired dilution of the stock solution in Embryo medium, in case of acidic solution an 
embryo medium with citrate-buffer was used. Embryos to be treated with agonist and 
antagonist of the arachidonic acid cascade were dechorionated and transferred into 20ml glass 
vials, maximum 20 embryos per vial and covered with 1-2ml Embryo medium, so that the 
embryos are just covered with water. The medium was replaced with working solutions; the 
control clutch was treated with embryo medium containing the appropriate solvent. Embryos 
were kept in the dark and slightly shaked during incubation. The working solutions were 
replaced by a fresh one every two hours until end of the treatment. 
 
in vitro transcription of sense RNA (RNA synthesis for micro-injection) 
For in vitro transcription of the different sense RNAs 10µg of the respective plasmids were 
linearized with 2µl restriction enzyme and 10µl Buffermix in a total volume of 100µl for 2h at 
appropiate temperature; followed by a Phenol/ Chloroform extraction. Linearised plasmids 
were checked on a 0,8% agarose gel and quantified by photometry. 
For in vitro transcription the mMessage mMachine Kit was used. 2 µg linearized plasmid 
DNA was mixed with 2 µL 10x transcription buffer, 2 µL NTP Mix, 2 µL enzyme mix in a 20 
µL reaction and incubated at 37°C for 2 hours. 1 µL DNase was added and the mixture was 
incubated at 37°C for another 20 minutes to remove the template DNA. The reaction was 
stopped and purified by addition of 15µl ammonium acetate, 115 µL water and 150µl of 
Phenol/ Chloroform Mixture (Roth), followed by centrifugation at 14000 rpm for 3 minutes. 
The liquid phase was transferred into a new microreaction tube and mixed with 150µl 
Isopropanol, incubated for 20 minutes at -20°C and followed by centrifugation at 14000 rpm 
at 4°C for 15 minutes. The pellet was resuspend in 90µl ddH2O, 10µl NH4Ac and 100µl 
Isopropanol, incubated for 20 minutes at -20°C and followed by centrifugation at 14000 rpm 
at 4°C for 15 minutes again. The pellet was rinsed in 500 µL 70% ethanol and resuspended in 
20 µL ddH2O. The RNA was checked on a 1% agarose gel and stored at -20°C. 
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Whole-mount in situ-hybridizations 
Synthesis of labeled anti-sense RNA (in situ probe synthesis) 
Linearisation and purification of Plasmid were done as described for sense RNA synthesis. 
For in vitro transcription 2 µg linearized plasmid DNA was mixed with 2 µL 10x transcription 
buffer, 2 µL Dig-RNA labeling Mix or FITC-RNA labeling Mix (Roche), 1 µL RNasin 
(Promega), 2 µL of the appropiate polymerase (T7, T3, Sp6) in a 20 µL reaction and 
incubated at 37°C for 2 hours. 2 µL of 10x transcription buffer, 17 µL ddH2O and 1 µL 
DNase (RNase free, Roche) were added and the mixture was incubated at 37°C for another 30 
minutes to remove the template DNA. Free nucleotides were removed by addition of 20 µL 
7.8 M ammonium acetate and 120 µL ethanol and incubation at room temperature for 50 
minutes, followed by centrifugation at 14000 rpm for 20 minutes. The pellet was rinsed in 
300 µL 70% ethanol and resuspended in 20 µL ddH2O. 20 µL formamide (Fluka) was added 
and RNA was stored at -20°C. 
Whole-mount in situ hybridization 
Embryos for in situ-hybridization were fixed in 4% PFA/PBS overnight at 4°C or 4 hours at 
room temperature, washed in PBST, dechorionated, transferred though a methanol series and 
stored in 100% methanol at -20°C. 
For in situ-hybridization embryos were transferred from MeOH to PBST and depending on 
their developmental stage digested with 1 mg/ml proteinase K (24 hpf: 8 minutes; 36 hpf: 10 
minutes; 48 hpf: 15 minutes; 72 hpf: 20 minutes) at room temperature and re-fixed in 4% 
PFA/PBS for 20 minutes. From PBST embryos were rinsed in Hyb- and incubated in Hyb+ at 
70°C for a minimum of 4 hours. RNA-probes were diluted in Hyb+ to working concentration 
and incubated with embryos at 70°C overnight. On the next day embryos were washed at 
70°C with the following buffers: 100% Hyb-, 25% 2xSSCT/ 75% Hyb-, 50% 2xSSCT/ 50% 
Hyb-, 75% 2xSSCT/25% Hyb-, 2x SSCT for 15 minutes each and 0.2x SSCT for 30 minutes 
two times. Then embryos were transferred into PBS buffered conditions at room temperature 
(75% 0.2xSSCT/ 25% PBST; 50% 0.2x SSCT/ 50% PBST; 25% 0.2x SSCT/ 75% PBST; 
PBST for 10 minutes each). Embryos were blocked against unspecific binding for at least 2 
hours in 2% sheep serum/ 2% BSA/ PBST. For probe detection embryos were incubated with 
alkaline phosphatase-coupled antibody overnight at 4°C. Embryos were intensively washed 
with PBST, transferred into staining buffer (5 minutes for three times) followed by detection 
of alkaline phosphatase activity by addition of 1:50 NBT/BCIP (blue) in staining buffer. For 
fluorescent in situs embryos were transferred into 0,1M Tris-HCl buffer adjusted to pH 8.0 
(three times for 5 minutes) followed by addition of 1 tablet/ ml of FastRed and Tris buffer 
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(Sigma). The color reaction was stopped by rinsing the embryos with PBST and fixing in 4% 
PFA/PBS overnight. Stained embryos were either transferred though a methanol series into 
benzylbezoat/benzylalcohol (2:1) for microscopy or transferred into 80% glycerol in PBS.  
PBST: PBS (D8662, Sigma), 0.1% Tween20 
20xSSC: 175.3 g NaCl, 88.2 g Sodiumcitrate dehydrate (C6H5Na3O7 x 2H2O), pH 7.0; adjust 
to 1 L with distilled water.  
Stain: 100 mM Tris (pH 9.5), 50 mM MgCl2, 100 mM NaCl, 0.1% Tween20 
 
Immunohistochemistry/ whole-mount antibody staining 
After fixation and reconstitution as described in 7.2.2, embryos were incubated for 1-2 hours 
at room temperature in antibody blocking solution. This was replaced by primary antibody in 
blocking solution and incubated overnight at 4°C. The following embryos were washed six 
times in PBST for 15 minutes, blocked for 1 hour before appropriate secondary antibody in 
blocking solution was added for 2 hours at room temperature or overnight at 4°C. The 
secondary antibody was discarded and embryos were washed six times in PBST.  
Fluorescently stained specimens were fixed in 4% PFA/PBS and transferred to 60% 
glycerol/40% PBS.  
For DAB staining, the signal was amplified using the Vectastain Elite ABC Kit (Vector 
Laboratories). This system consists of avidine and biotin-labeled horseradish peroxidase, the 
two of which form multi-molecule complexes of avidine. The peroxidase is recruited to the 
secondary antibody by free biotin-binding sites in the avidine molecules. After incubation in 
AB solution (<24 hpf for 45 minutes; 24 hpf for 1 hour; 2-3 dpf 3-4 hours; >3 dpf for 4 hours) 
embryos were rinsed and washed six times for 30 minutes in PBST and incubated 30 minutes 
in DAB solution. The detection reaction was started by addition of 1 µL 0.3% H2O2 per 1 ml 
DAB solution. Staining reactions were stopped by rinsing in PBST, followed by fixation in 
4% PFA/PBS. Stained embryos were transferred through a methanol series and stored and 
analyzed in benzylbenzoat/benzylalcohol (2:1).  
Blocking solution: 10% fetal calf serum; 1% DMSO; 0.1% Tween 20; in PBS 
DAB solution: 1 DAB tablet (3, 3-Diaminobenzidine tetrahydrochloride, Sigma, D5905) was 
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Microscopy 
Stained embryos were analysed in either benzylbenzoat/benzylalcohol (2:1) mixture or in 
80%Glycerol/20%PBS; live embryos were mounted in 1% methylcellulose or 1% low 
melting agarose. Documentation was done using a Zeiss AxioImager with an AxioCam MRc 
for light microscopy and a Zeiss LSM 510/ 710 for confocal microscopy.  
 
3.3. Molecular methods 
Bacterial growth and plasmid preparation 
Available bacterial clones were ordered from Imagenes. 
Glycerol stocks or agar stabs of bacterial cell stocks were propagated by streaking on LB-agar 
plates containing 50 µg/mL ampicillin or 25 µg/mL kanamycin, and incubated overnight at 
37°C. After inoculation with single colonies, bacterial cultures were grown in LB-medium 
supplemented with appropriate selective antibiotics in a shaking 37°C-incubator. 
Small yield plasmid preparations from 3 mL bactertial cultures (Mini-preparations) were done 
with the QIAprepSpin Miniprep Kit (Qiagen 27106) as per manufacturer instructions, to 
obtain high quality DNA for subsequent sequencing and cloning procedures.  
Medium yield plasmid preparations from 50 mL cultures (Midi-preparations) were made with 
the QIAfilter plasmid Midi Kit (Qiagen 12243), for cloning and preparing stocks of plasmid 
DNA. 
 
Isolation of total RNA from embryos 
50 embryos were mixed with 500 µL E3-medium and 1.5 mL Trizol LS Reagent (Gibco, 
BRL) and homogenized using a seringe. 400 µL chloroform was added after 5 minutes 
incubation, followed by vortexing and 10 minutes incubation at room temperature. 
Afterwards the cell debris was spun down at 13000 rpm and the supernatant, containing DNA 
and RNA, transferred into a fresh tube. For the precipitation 1mL isopropanol was added. 
After centrifugation at 14000 rpm at 4°C the pellet was washed with 70% ethanol, dried and 
taken up in RNAse-free ddH2O. 
Genomic DNA was removed by a DNase (Boehringer) treatment, followed by a 
phenol/chloroform (Roth) extraction. The concentration of the purified RNA was measured at 
540nm using Standard photometer. 
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cDNA synthesis 
In a 10.6 µL reaction, 2 µg of total RNA together with 1 µL oligo (dT)15 (100pmol, Roche) 
was denatured at 70°C for 5 minutes then stored on ice. Reverse transcriptase buffer, 2 mM 
DTT, 10 mM dNTP and 200 U SuperScript II reverse transcriptase (Gibco, BRL) were added 
to give a final volume of 20 µL. After incubation at 42°C for 1.5 hours 20µl Tricine EDTA 
buffer (Clontech RACE) was added and the cDNA stored at -80°C. 
 
Restriction digests 
Digestion of DNA by restriction enzymes was performed using the conditions recommended 
by the manual (New England Biollabs). 
 
Electrophoretic separation of DNA 
Size fractionation of DNA fragments was performed by electrophoresis on 0.8-2% (w/v) 
agarose (Roth) gels in 1xTAE containing 100 ng/mL ethidium bromide, submerged in 1xTAE 
running buffer. Samples were mixed with loading buffer and run at 100-150 V. The DNA was 
visualized and photographed under UV light (λ=312 nm). 
50x TAE (1L): 242 g Tris base, 57.1 mL glacial acetic acid, 100 mL 0.5 M EDTA (pH 8.0) 
 
Purification of DNA fragments  
For recovery of DNA from agarose gels, bands of specific sizes were cut from the gel on a 
transilluminator and purified with the QIAquick SpinColumn Gel Elution as per manufacturer 
instructions. 
DNA concentration was determined by UV spectrophotometry at a wavelength of 260 nm. 
 
Polymerase Chain Reaction (PCR) 
PCR reactions were usually carried out at a final volume of 25 µL, containing 1xPCR-buffer, 
0.2 mM dNTP (PeqLab), 1 µM forward and reverse primers (MWG or Sigma), 2.5 U Taq 
DNA polymerase (Genaxxon), or proof reading polymerase Pfu or advantage Taq (Roche), 
and template DNA.  
Amplification was done in DNAengine Thermocycler (Applied Biosystems), using programs 
with 35-40 cycles of denaturation, annealing and elongation. 
For temporal expression profiling, RT-PCR was performed using 1 µL cDNA (described in 
7.1.5) in above described PCR mixtures. cDNA samples were adjusted to equivalent relative 
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mRNA amounts via control PCR reactions with primers specific for the house-keeping gene 
ef1α (Nordnes et al., 1994). 
 
Sequencing 
DNA sequencing was done using the chain termination method, which uses fluorophore 
labeled didesoxynucleotide phosphate to terminate strand elongation. Sequencing reactions 
were performed using 400-600 ng plasmid-DNA or 10-50 ng PCR product purified with the 
appropriate Qiagen Kits mentioned above. The DNA, 3 pmol primer and 1 µL 
BigDyeTerminator Mix (Applied Biosystems) were mixed to a 12 µL reaction. The 
amplification program for plasmid sequencing started with an initial template denaturation at 
96°C for 2 minutes, followed by 25 cycles consisting of denaturation at 96°C for 10 seconds, 
primer annealing at 53°C (unless otherwise required with gene specific primers) for 5 seconds 
and extension at 60°C for 4 minutes. After addition of 8 µL ddH20, samples were purified and 
column chromatography was performed at the in-house sequencing facility with an ABI DNA 
sequencer module. 
 
Cloning of DNA fragments 
For cloning of coding sequences from cDNA, PCR products were amplified using 
proofreading polymerases (Pfu, Fermentas). For further subcloning, primers with restrictions 
sites at the 5’end were designed; the restriction enzymes have be non-cutters in the cloned 
sequence. After purification, PCR products were cloned by non-directional cloning into 
pGem-T Easy vector (Promega) or pCRII Topo vector (Invitrogen) following manufators 
instructions.  
To clone the DNA fragments into the destination vector, pGem-T easy or Topo vector 
containing the correct insert, proven by sequencing, were completely digested with the 
choosen restriction enzymes. After complete DNA restriction und purification of the insert 
DNA, ligations were performed using 50-100 ng vector DNA and a three molar excess of 
insert DNA, catalysed by 10 U T4-DNA-ligase in a 10 µL reaction. When required, 
dephosphorylation of DNA ends prior to ligation was achieved by addition of 1 U Shrimp 
Alkaline Phosphatase in 10 µL, incubation at 37°C for 30 minutes and inactivation of the 
phosphatase at 65°C for 15 minutes. Ligations were incubated at 16°C overnight or at room 
temperature for 2 hours.  
Plasmids were transformed into chemo-competent E. coli strains (DH5α or TOP10) via heat-
shock at 42°C for 45 seconds, followed by 2 minutes cooling on ice. 
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3.4. Materials 
General laboratory chemicals were of analytical research grade and were purchased mainly 
from the following manufacturers: Aldrich; Baker Chemicals; Boehringer-Ingelheim; 
Bethesda Research Laboratories (BRL); Cayman Chemicals; Difco Laboratories; Fluka; 
Hoechst AG; Invitrogen; Merck; Pharmacia; Roth; Serva; Sigma. 
Enzymes and kits were obtained from the following suppliers:  Ambion; Boehringer-
Ingelheim; Fermentas; Invitrogen; New England Biolabs; Promega; Gibco Life Technologies; 
Qiagen; Roche GmbH; Stratagene. 
 
Morpholinos 
MOs referenced with MODB were distributed via the screen consortium and are designed as 
transcriptional blocker; further informations can be found in the Morpholino Database 
(MODB; http://secretomes.biocompute.umn.edu/MODB/index.php) (Knowlton et al., 2008). 
 
Morpholino sequence Reference 
SP3005a TCTGCTGAGAAGCTGGAGGGGACTG MODB 
SP3005b GCACTGAGGTCCATGTTCAGACGCA MODB  
Acsl4_splice GGTTTCTTAAATAAAAGCTCACCTT this work 
Acsl4C GCCTTGGGTCAAAGTTCAAAAAGAT this work  
Acsl4D CTCCAAAATGTGCAACCGGCTTTTA this work 
zcPLA2 GGCAGCCAGCAGTTTGGAGGTCAGG MODB 
bmp7 GCACTGGAAACATTTTTAGAGTCAT (Lele et al., 2001) 
Alox5a TCACCGTGTAGCTGGGCATTTTCAA MODB 
Alox5b TGCAGCTCTTGATGACGCCTCTGAT MODB 
5-LO TGTACGTGAACATTCTGCTGAAATG MODB 
Alox12 CTCTGTGGTGTGGTGGTGAAAATCT MODB 
12-LO GGCCACTGTCACTTTGTACTCCATC MODB 
BR0001 GAACTGTCTTCACAATCCGAGAGTG MODB 
BR0002 TTGAAGTCGAACCCATCTCTGACGT MODB 
BR0003 TTTGACGCCATCCTCCAGCTTATGT MODB 
BR0004 CTGTAACTCATCCATCATCAAGCCT MODB 
BR0005 CCAGTTGGACACCACAGATGCGTAA MODB 
BR0006 CCAATTTCCAGTCCCATCGACATTT MODB 
BR0007 CTCACGCATCAGCCACGAAAGAATC MODB 
BR0008 TGGGCTCCAGTGTTTATTTCTTCCG MODB 
BR0009 TGCCCAAATCCACAAGTGACATCTC MODB 
BR0010 CAGTCCTTTATGTGCCATCTTCTCA MODB 
BR0011 GGCCTGGACAGCCACGAGACATCTC MODB 
BR0012 TTTAGGTCCCACGCTGCCATTCTGC MODB 
BR0013 TCCAGATCAGTCCGTGCGCCATTAC MODB 
BR0014 AACAAGGTCTTTGGGCTGATGAACA MODB 
BR0015 CTGACCTCCATACTGCTGTAACAGA MODB 
BR0016 GCACCAAGCAAACCAACCTCATAAT MODB 
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BR0017 TTTTTGAGCTTCGGATTGTCCTGCT MODB 
BR0018 AGAATACATTGATCTCCATTATGCA MODB 
BR0019 ACTCATCCATCTTTGTGTTGGTCTG MODB 
BR0020 TTCAGTGTCCGCCATCTTCACCACA MODB 
BR0021 TTTGTTGCTACTGTTGACTATCCCG MODB 
BR0022 GTTTGTCAGTCCTATCTGTTGTCAG MODB 
BR0023 CGCCTGTAAAAACAACTCGTAAGTC MODB 
BR0024 TCCACGAAGTCCCCGTAATAATATC MODB 
BR0025 CTTCCATAGTCTCGTATCCTCTGCG MODB 
BR0026 CCGCTCCCTTCTGTCTGCTAAATAA MODB 
BR0027 TTTCCGGTGAAAGACATGGTTTACG MODB 
SP3001 GGCATCTTCCCCTCTGCTGGGCGTC MODB 
SP3002 CTTCATCTTGAGAGCAGCGCTGGGT MODB 
SP3003 CATTCTGACCTGAGCGATTTCCAAA MODB 
SP3004 CAGAACAAAGGAATGAGGCAGGAAC MODB 
SP3006 AGTCTACTGCTCGCTTCCTCCTACG MODB 
SP3007 CACATCACCATACCTTCTCAGTGGA MODB 
SP3008 TCATTCTCACTGATGGATCTATTCA MODB 
SP3009 GAAGACGGTGGTCCTGGATGAAGTA MODB 
SP3010 TCACTCTTAAGTCTCACTTGGAAAG MODB 
SP3011 GCATTTCGACTCTCAATTTCTCGAG MODB 
SP3012 ATTTCCAATCCTCTGCTGCTCCTGT MODB 
SP3013 CATGGTGTTATCCAAAAAATTGTTA MODB 
SP3014 AAAGCAACTCGATCCATCATGACCA MODB 
SP3015 CATTCTGCTGTCCGACACAAACTAA MODB 
SP3017 ATGGTTTAAAACAAATCCTCTTGAA MODB 
SP3019 TAATATCTCCACAAAGAGTCGCCCA MODB 
SP3020 TGTCCGGCAGAATGAGGTTCTCTGT MODB 
SP3021 CCATGTTTGAGTCTGAGTGCTGACG MODB 
SP3022 GCTCCATTAGAAACGCAGTCGAACC MODB 
SP3023 TGAACGCCATAATGGGTCAACTATC MODB 
SP3024 ATGGTTTCTGCTCTTCTCCTTCTTC MODB 
SP3026 TTGATGGACAGACAAGAACACCTGA MODB 
SP3054 GAAAAATGTCTTTCGCCGGGAATCC MODB 
BB0002 GACCTGAGATGAAATGGCAAAGTAA MODB 
BB0006 ATCTCTGAAAAGACAATCTAGCCTA MODB 
boc AACGTGCAGTAGTTTGGAGTTGAAT MODB 
cndp2 ACAGTGACAATCCCTCAGTGACAGA MODB 
elmo1 TTTCTTCACACCGTTTACTCTGCAA MODB 
mcts1 GTCGTATTCGGTCACTGTATTCCTC MODB 
npc2 CATGGTTCAAATGAATGTAGGTTCT MODB 
nxph1 TCCCTTCTCTCAAACTTCCACTAAT MODB 
ppt1 CAATCTCAATCCTTTAATTTTCTGT MODB 
rfng GCATTCTTCCAGTGCTGAACGCCAG MODB 
 
Probes  
Name Vector Cut. enzyme Polymerase Reference 
otx2 pBSSKII   EcoRI  T7 (Li et al., 1994) 
pax2a pBSSK XbaI T7 (Schulte-Merker et al., 1994a) 
eve1 pBSSK HindIII T3 (Joly et al., 1993) 
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tbx24 pBSSK SalI T3 (Nikaido et al., 2002) 
ntl pBSSK XhoI T7 (Schulte-Merker et al., 1992) 
sox19a pBSSK NotI T7 (Okuda et al., 2006) 
bmp4 pCR2.1 BamHI T7 (Nikaido et al., 1997) 
bmp7 pCRII SpeI T7 (Hild et al., 1999) 
bmp2b pBSSK NotI T7 (Martinez-Barbera et al., 1997) 
acsl4a short pGemT SacII Sp6 this work 
acsl4a pME18S-Fl PCR amplified T3 this work 
 
RNA constructs for microinjection 
Name Vector Restr. enzyme Polymerase Reference 
zfacsl4a full length pCS2+ NotI Sp6 this work 
Mouse acsl4 pCS2+ NotI Sp6 this work 
zfAcsl4a-gfp full length Xlt.GFPCS2+ NotI Sp6 this work 
zfacsl4a-5’UTR-gfp Xlt.GFPCS2+ NotI Sp6 this work 
alk8CA pCS2+ NotI Sp6 (Bauer et al., 2001) 
XtBRIa pCS2+ NotI Sp6 (Graff et al., 1994) 
 
Primers 
acsl4_as_XbaI  GTT TCT AGA GTC CTA CTT CTG GCC ATA CAT 
acsl4_asmut_XbaI  GTT TCT AGA GTC CAA CTT CTG GCC ATA CAT 
acsl4_forBamHI TGC GGA TCC AAC ATG GAC CTC AGT GCC GTT 
mmacsl4 rev XbaI GCT CTA GAT TAT TTG CCC CCA TAC ATT C 
mmacsl4 rev BamHI AGG GAT CCA CCA TGA ACC TTA AGC TAA ATG T 
acsl4_RTfor_1286  GCA GCG TAC TGA AAC CTT CC 
acsl4 RTfor  TGC CTT CTG ATT GGT CAC TG 
acsl4_RTrev_1627 TGA TAG TGC CTG CTC CAC AG 
acsl4 RTrev  ACG CAA ACA CTT GAC TGC TG 
acsl4_896 TGA ACA CAG CAG GAT TTC CA 
acsl4 splice_for TGG TCA CCT TTT ATG CGA CTC 
acsl4 splice_rev CAC AGC ATG CAC TCA GTT GA 
 
primary antibodies 
anti-fluorescein rabbit IgG Molecular Probes 
anti-p63 (4A4) mouse IgG Santa Cruz 
anti-phospho Smad 1/5/8 rabbit IgG Cell Signaling 
 
secondary antibodies 
Anti-mouse AlexaFluor647 goat IgG Invitrogen 
Anti-rabbit AlexaFluor488 goat IgG Molecular Probes 
Anti-rabbit biotinylated goat IgG Vector Labs 
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4. The role of acyl-coA-synthetase longchain family member 4 in 
dorsoventral patterning during zebrafish gastrulation 
4.1. Introduction 
4.1.1 The arachidonic acid pathway 
The first project of my PhD thesis is concerned with the characterisation of acyl-CoA 
synthetase long-chain family member 4a, an enzyme-encoding gene that I found essential for 
dorsoventral patterning of the zebrafish embryo in an antisense morpholino oligonucleotide 
(MO)-based screen conducted as part of a research consortium funded by the National Insitute 
of Heatlh (USA). ACSL4a’s major catalytic substrate is arachidonic acid (AA) (Cao et al., 
1998), a polyunsaturated omega-6-fatty acid that is also named 5,8,11,14-eicosatetraenoic 
acid. It consists of a chain of 20 carbon atoms with four cis-double bonds (C20:4:n-6). The 
common name arachidonic acid is deduced from the saturated arachidic acid initially 
described from peanuts (Arachis hypogaea). AA is one of the essential fatty acids of animal 
diet. It is either taken up directly in the intestine, or it is synthesised from linoelic acid, a C18 
acid with 2 double bonds, in the liver. Within the body, it is transported via the blood stream 
by lipidproteins or albumin (Zhou and Nilsson, 2001). The uptake by the cell most likely 
occurs via transport proteins like fatty-acid binding proteins on the plasmamembrane (Brash, 
2001). Upon uptake esterified arachidonic acid is incorporated into and stored within 
plasmamembranes, in particular the outer nuclear membrane, the endoplasmatic reticulum and 
the Golgi apparatus. Accordingly, most of the enzyme machinery involved in AA metabolism 
is thought to be located close to or within the nucleus (Capriotti et al., 1988; Luo et al., 2006). 
In the first step the carboxy-group of arachidonic acid has to be activated by forming an 
energy-rich thio-ester bond with the thiol group of coenzyme A (Fatty acid + CoA + ATP 
<=> Acyl-CoA + AMP + PPi). This step is facilitated through Acyl-CoA Synthetase 
Longchain family member 4 (Cao et al., 1998), the enzyme that is subject of the studies 
presented here. In the second step Arachidonyl-CoA is integrated into the sn2-position of 
phospholipids by the action of acyltransferases, thus via phospholipid remodelling rather than 
phospholipid de novo synthesis. This step requires a deacylation of phospholipids by a 
Phospholipase, followed by reacylation of membrane phospholipids with arachidonyl-CoA by 
a long-chain fatty acyl-CoA acyl transferase. These steps are followed by further remodelling 
steps mediated by CoA-independent transacylases (Balsinde et al., 1997; Balsinde et al., 
1995; Leslie, 2004a; Yamashita et al., 1997). Intracellularly, AA is stored conjugated to such 
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phospholipids, usually phosphatidylethanolamine, until it is released from them by the 
catalytic action of Phospholipase A2s (PLA2). Up to now 15 genes encoding PLA2s have 
been identified in mammals and they are subgrouped in three types, the intracellular calcium-
independent PLA2s (iPLA2s), the secrected PLA2s (sPLA2s) and the cytosolic PLA2s 
(cPLA2s) (Leslie, 2004b). Among the Phospholipase A2s, cPLA2-alpha has shown 
specificity for arachidonic acid (de Carvalho et al., 1995; Leslie et al., 1988). It is regulated 
by intracellular Ca2+ and phosphorylation through MAPKs (Evans et al., 2001; Lin et al., 
1993), which is a critical step in the regulation the avaibility of free intracellular AA. In an 
alternative pathway arachidonyl-CoA can be directly hydrolysed to free AA by an acyl-CoA 
hydrolase (Farooqui et al., 2000; Sakuma et al., 1999). Free AA in turn serves as substrate for  
eicosanoid synthesis (see below) (Brock and Peters-Golden, 2007). Thus, free intracellular 
AA for eicosanoid production can be either supplied directly, via the hydrolysation of 
arachidonyl-CoA that most likely derives from freshly uptaken AA, or in a more indirect 
fashion from stored AA that is conjugated to phospolipids, integrated into membrane 
integration and released from them by Phospholipase A2. 
 
 
4.1.2 The cyclooxygenase pathway of prostanoid production 
Arachidonic acid serves as precursor molecule for eicosanoid synthesis (see Figure 4-1 for an 
overview). Eicosanoid (from the Greek word for twenty, eicosa) are a very large family of 
lipid mediators that fall into two major groups, the leukotrienes and the prostanoids, which 
can be further subdivided into prostaglandins, prostacyclins and thromboxanes. They extert a 
range of diverse, hormone-like biological functions (Brock and Peters-Golden, 2007). 
However in contrast to the endocrine nature of classical hormones, eicosanoids are formed in 
almost all tissues, rather than in specialized glands, are not stored in tissues to any appreciable 
extent, and act locally in an autocrine or paracrine fashion on the secreting cells themselves or 
cells in their neighborhood, rather than circulating to distant sites of actions. All of them are 
synthesised from free AA in a multistep reaction (Evans et al., 2001). In the first step of 
prostanoid synthesis, the intermediate Prostaglandin H2 (PGH2) is formed from AA by 
Prostaglandin H2 -Synthase (PGHS). The two isoforms of PGHS are also called 
Cyclooxygenase 1 and 2 (COX-1, COX-2). COX-1 is usually responsible for the constitutive 
prostaglandin synthesis, whereas COX-2 is important for induced synthesis of prostaglandins 
(Smith et al., 2000). In a tissue-specific manner, PGH2 is further metabolised to 
thromboxanes, prostacyclins or prostaglandins. Thromboxanes are found in blood platelets 
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and promote platelet aggregation, whereas prostacyclins seem to inhibit blood clotting. 
Among the large group of Prostaglandins (PGs), PGE2, PGF2 and PGD2 are the most active 
ones; PGE2 is for example responsible for the induction or enhancement of inflammation and 
fever, vasodilatation and bone formation. By interfering with the canonical Wnt-signaling 
pathway and via PPARgamma signaling, PGE2 can also promote colon cancer (Castellone et 
al., 2005; Wang and DuBois, 2007). PGF2 can for instance induce contractions of the uterus, 
while PGD2 is thought to be a bronchoconstrictor (Karlson et al., 2005). Prostanoids are 
released from cells by facilitated transport (Schuster, 2002). Signaling in target cells occurs 
via specific receptors that belong to the G-Protein-coupled receptor (GPCR) superfamily of 
seven transmembrane spanning proteins (Narumiya and FitzGerald, 2001). For PGE2, four 
receptors are known (called EP1-4). Various downstream signaling pathways can be activated 
upon ligand binding, including G-Protein signaling via Phosphoinositide-3-Kinase (PI3K), 
Protein Kinase B (Akt), and / or cAMP/ Protein Kinase A (PKA) signaling, as well as 
signaling via Glycogen Synthase Kinase 3 and ß-catenin, thereby interfereing with the 
canonical Wnt transduction pathway (Dey et al., 2006; Sugimoto and Narumiya, 2007). 
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Figure 4-1: Overview of the most prominent pathways of eicosanoids 
Arachidonic acid is released from phospholipids by the action of cPLA2, which is activated by 
extracellular or intracellular signals (cell activation). (Upper panel) Prostanoids are synthesised via 
Cyclooxygenase 1 and 2 (COX-1, -2), which form Prostaglandin H2 (PGH2). NSAIDs are blocking the 
cyclooxygenases. PGH2 is the precursor for further prostaglandins, thromboxanes and prostacyclins 
synthesis. Upon release they act as autocrine or paracrine signaling molecules, via binding to receptors 
of the GPCR class or to PPAR nuclear receptors, in a huge variety of tissues and contexts, as indicated 
in the panel.  
(Lower panel) after cell activation and release of AA the second major class of eicosanoids, the 
leukotrienes, are synthesised by the action of lipoxygensaes and FLAP. They act as autocrine or 
paracrine factors via PPAR or GPCR receptors, too, in a variety of tissues. Schemes from Funk, 2001. 
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4.1.3 The leukotriene and other pathway 
A second major pathway of AA oxygenation is the leukotriene pathway, which leads to the 
formation of leukotrienes and the hydroperoxy and hydroxy eicosatetraenoic acids 
(abbreviated HPETEs and HETEs, respectively) (for leukotrienes, see lower panel of Figure 
4-1). As for prostanoids the release of AA through cPLA2 is required, followed by the 
enzymatic reaction of 5-lipoxygenase (5-LO) and 5-lipoxygenase-activating protein (FLAP) 
(Peters-Golden and Brock, 2001; Peters-Golden and Brock, 2003). Leukotrienes signal 
through GPCRs, too, and play an important in the immune system, especially in leukocytes 
and mast cells, but also promote bronchoconstriction. Further HETEs as well as Lipoxins are 
produced by other Lipoxygenase (12-LO, 15-LO) (Karlson et al., 2005). In Hydra spec. 
HETEs have shown to be involved in head development (Di Marzo et al., 1993; Hassel et al., 
1996; Muller et al., 1998). More common roles of them are in pulmonary function regulation 
and in vascular tone and inflammatory responses (Moreno, 2009). Lipoxins are anti-
inflammatory mediators found in leukocytes (Chiang et al., 2005; Serhan et al., 1984). 
In a further pathway, enzymes of the family of Cytochrome P450 oxidases can catalyse a 
reaction of arachidonic acid with O2 to form epoxytrienoic acids (EET) that are described as 
vasodilators (Spector et al., 2004). 
Beside its conversion by oxygenases, free AA has bioactive functions itself. It can stimulate 
Peroxisome Proliferator-Activated Receptors (PPARs), a group of nuclear hormone receptors 
that require binding to fatty acids for nuclear translocation and transcriptional regulation. 
Furthermore, AA regulates certain ion channels (Brash, 2001), induces apoptosis (Cao et al., 




4.1.4 The enzyme acyl-coA-synthetase longchain family member 4 (ACSL4) 
Acyl-CoA synthetases in general are required to form the thioester bond between CoenzymA 
and the carboxy group of fatty acids. The enzymes are subdivided into several subgroups, 
based on their specificity for particular fatty acids. The longchain family members are specific 
for C12-C20 fatty acids like palmitic acid, linoelic acid, oleic acid and arachidonic acid. Five 
ACSLs have been identified in mammals (Soupene and Kuypers, 2008); in zebrafish three 
members have been annotated (ZFIN Data). Mammalian ACSL4 is expressed in a wide range 
of tissues, including heart, brain, liver, adipose tissue, adrenal gland, epididymis and ovaries 
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(de Jong et al., 2007; Kang et al., 1997). Immunohistochemistry has further localisized 
mammalian ACSL4 protein at the membrane of peroxisomes and the ER of liver cells (Lewin 
et al., 2001; Lewin et al., 2002).  
Patients sufferings from Alport-Syndrome and non-specific X-linked mental retardation 
(MRX) showed chromosomal deletion including the human ASCL4 (Meloni et al., 2002; 
Piccini et al., 1998). However, it remains contentious whether it is the loss of ASCL4 or 
neighboring genes that is responsible for MRX (Verot et al., 2003). 
In a mice model with disrupted gene acsl4, female heterozygous mice became pregnant less 
frequently and produced smaller litters, due to increased in utero death rates of heterozygous 
embryos from stage E12 onwards. This might be due to combined zygotic and maternal 
effects. Mothers suffered from enlarged uteri containing cysts and higher levels of 
prostaglandin. In was speculated that the abnormal accumulation of uterine prostaglandins 
might impair female fertility. Male hemizygous mice did not show a phenotype, homozygous 
animals are not described, so far (Cho et al., 2001). In vitro studies of steroidogenesis have 
further revealed that ACSL4 is involved in a pathway of trophic hormone-stimulated 
steroidogenesis. The release of AA is required for the expression of StAR protein 
(steroidogenic acute regulatory protein), a critical regulator of steroid biosynthesis. Thereby 
an isoform of ACSL4 is involved in a PLA2-independent pathway to release free AA (Cho et 
al., 2000; Maloberti et al., 2005; Stocco et al., 2001). Further in vitro studies have shown that 
the expression of ACSL4 isoforms is upregulated in human hepatocellular carcinoma cells. 
Here, ACSL4 regulates AA-dependent cell growth and AA-induced apoptosis (Hu et al., 
2008; Liang et al., 2005). 
 
 
4.1.5 Aim of the project 
As a starting point of this part of my PhD work I screened a collection of morpholino 
antisense oligonucleotides in collaboration with the laboratories of Stephen C. Ekker 
(University of Minnesota) and Steve A. Farber (Carnegie Institution, Baltimore). One of the 
first morpholinos I screened, named SP3005, caused dorsalisation of zebrafish embryos. This 
morpholino targets the 5’UTR of zebrafish acyl-coA-synthetase longchain family member 4a 
(acsl4a). In zebrafish, the arachidonic acid and eicosanoids networks have been little 
investigated thus far. Only the prostaglandin PGE2 and the cyclooxygenases Cox1 and Cox2, 
the crucial enzymes of prostaglandin synthesis, have been described to be important for 
zebrafish development. Thus, PGE2 is required for proper cell migration during gastrulation 
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(Cha et al., 2006a) as well as for vascular tube formation and maintenance of haematopoietic 
stem cell (Cha et al., 2005; North et al., 2007). However, there were no reports on a function 
of arachidonic acid metabolism and eicosanoids during embryonic patterning processes. 
Because of the long-standing interest of the Hammerschmidt laboratory in dorsal-ventral 
patterning, I decided to further characterise the phenotype caused by the morpholino targeting 
zebrafish acsl4a, and the correlation between Ascl4a and BMP signaling, a central pathway 
regulating dorsal-ventral patterning of the zebrafish embryo (see General Introduction). In 
addition, I investigated whether ascl4a is required for gastrulation movements, comparable to 
reported roles of Cox enzymes their product and AA derivative PGE2. Finally, in 
collaboration with the laboratory of Steven A. Farber, an expert in lipid metabolim and its 
role during zebrafish development (Ghiselli and Farber, 2005; Ho et al., 2004), I knocked 
down other putative components of AA metabolism, such as a cPL2A phospholipase and 
different lipoxygenases, and treated embryos with chemical AA antagonists and agonists. 
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4.2. Results 
4.2.1. Knock-down with morpholino SP3005a causes dorsalisation of the 
zebrafish embryo 
The zebrafish acsl4a gene is located on chromosome 14 and encodes a protein of 706 amino 
acid residues with 74% identify to the human and mouse ACSL4 proteins. As part of the 
aforementioned large-scale antisense morpholino oligonucleotide (MO) screen, MO SP3005a 
was designed that targets the 5’UTR at position -38 of acsl4a (see Materials and Methods). 
For a first characterisation of the morphant phenotype, I examined the morphology of 
embryos injected with different amounts of the MO (Fig. 4-2). Dorsoventral patterning and 
the establishment of the dorsal body axis take place during gastrulation. Defects during these 
patterning processes lead to a gain of dorsal tissues, like neuroectoderm and presomitic 
mesoderm, and concomitant loss of ventral tissues like epidermis and somatic mesoderm in 
the case of dorsalisation, and contrary shifts in the case of ventralisation. During gastrula and 
early segmentation stages (5-12 hours post fertilisation; hpf), these shifts can be best 
visualised with appropriate dorsal and ventral markers, such as genes that display a specific 
dorsoventral expression pattern. However, morphologically, the strength of dorsalisation or 
ventralisation of embryos can be best determined much later (24 hpf), when the respective 
derivatives of dorsal and ventral tissues have been formed and cell types have fully 
differentiated. For classification of dorsalisation strenghts into C1 (weakest) to C5 (strongest) 
(Fig. 4-2 K), I used criteria as previously described (Kishimoto et al., 1997).  
After the injection of MO at a concentration of 0,125 mM, 74% (n=52/70) of the embryos had 
died before 24 hpf, most likely as a result of strongest dorsalization, which leads to an 
“explosion” of embryos due to somite constriction during early segmentation stages (Mullins 
et al., 1996), while 25% (n=17/70) showed strong dorsalisation (C4 or C5). Injection of 0,1 
mM to 0,05 mM caused the whole spectrum of dorsalisation classes. Injection of 0,1 mM 
MO, caused 4% (n=4/100) lethality, 49% (n=49/100) C4/5 dorsalisation and 47% (n=47/100) 
moderate and mild dorsalisation (C3-C1), while 4% (n=4/100) had wild-type morphology. 
Embryos injected with 0.075 mM and 0.05 mM MO showed no lethality, reduced numbers of 
strong dorsalization, and correspondingly higher proportions of moderate and mild 
dorsalisation classes (C1-C3; 68% (n=35/51) for 0.075 mM; 72% (n=64/87) for 0.05 mM). 
Injection of 0.25 mM caused only mild phenotypes (0% C4/C5; 61% C1-C3, n=33/54), while 
upon injection of 0.0125 mM, embryos predominately appeared unaffected (91%, n=90/99) 
(Fig 4-1 I, K). In conclusion, injection of SP3005a MO caused dorsalization in a dose-
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dependent fashion, possible reflecting the range of phenotypes obtained upon partial to 
complete knock-down of gene function. Importantly, complete knock-down appears to cause 
strongest dorsalization, as also obtained upon complete loss of BMP signaling (see also 
General Introduction and below). 
I performed an analysis using whole mount in situ-hybridisations to confirm the observed 
dorsalisation. Injected and uninjected embryos were stained at mid gastrula stages (80% 
epiboly; 8 hpf) with previously described markers for dorsal-ventral patterning (Fig. 4-1). The 
gene orthodenticle homolog 2 (otx2) encodes a homeodomain-containing transcription factor 
and is expressed in fore- and midbrain precursor cells of the anterior neuroecoderm, thereby 
serving as a marker for dorsal ectoderm (Li et al., 1994). In SP3005a morphant embryos (0,1 
mM MO) the expression domain of this dorsal ectodermal marker was expanded into 
ventrolateral regions of the embryo (Fig. 4-1 A, B). Respectively, expression of tbx24, which 
encodes a T-Box transcription factor made in the paraxial mesoderm (Nikaido et al., 2002), 
was also ventrally expanded in acls4 morphants (Fig. 4-1 E, F). In reverse, as expected for a 
dorsalised embryo, the expression of gata 2, a marker for ventral ectoderm (Detrich et al., 
1995), was reduced and restricted to the most-ventral region of the embryo (Fig. 4-1 C, D). 
Similarly, the marker for ventral mesoderm, eve1 (Joly et al., 1993), was expressed in a much 
smaller domain in ventral-most regions only (Fig. 4-1 G, H). Based on these results, I 
characterise the phenotype of SP3005a morphants as dorsalisation, pointing to an 
indispensable role of Acsl4a for the specification of ventral cell fates during dorsoventral 
patterning of the zebrafish embryo. However, I should also point out that according to the 
marker gene expression data, the dorsalization of the SP3005a morphants was weaker than 
that obtained upon complete inactivation of BMP signaling, which for instance leads to a 
complete loss of gata2 and eve1 expression (Mullins et al., 1996).  
To determine the efficacy of acsl4a knock-down by the SP3005a MO, I generated an N-
terminal fusion construct of Green Fluorescent Protein (GFP) and the morpholino binding 
site. For this purpose, I cloned parts of the acsl4a cDNA containing the 5’UTR target site of 
the morpholino and the translation initiation site, in front of and in frame with the coding 
region of gfp. The plasmid was used for in vitro synthesis of mRNA, which was injected into 
zebrafish embryos. Injection of the mRNA alone led to ubiquitous GFP expression, whereas 
GFP was completely suppressed when I coinjected the mRNA with SP3005a MO (Fig. 4-1 L, 
M). Thus, SP3005a MO efficiently blocks the translation of mRNAs containing the acsl4a 
target sequence. 
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Figure 4-2:  Knockdown of Acyl-CoA-Synthetase longchain family member 4a with morpholino 
SP3005a causes dorsalisation. 
Whole-mount in situ-hybridisation with markers previously described in DV patterning, otx2 (A, B) as 
marker for dorsal ectoderm, gata2 (C, D) for ventral ectoderm, tbx24 (E, F) for paraxial mesoderm and eve1 
(G, H) for ventral mesoderm; at 80% epiboly in uninjected embryos (A, C, E, G) and embryos injected with 
0,1 mM MO SP3005a (B, D, F, H).  
(I) Graphical illustration of obtained strengths of dorsalisation upon injection of SP3005a MO at 
concentrations ranging from 0.125 mM to 0.0125 mM. Dorsalisation strengths were classified at 24 hpf, 
using morphological criteria as described in Mullins et al. (1996) and as shown in panel (K). 
(L, M) GFP expression after injection of acsl4a-UTR-gfp fusion mRNA (L); GFP expression is lost after 
injection of the mRNA together MO SP3005a (M). 
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4.2.2. ACSL4a seems to be required for the maintenance of BMP signaling 
Several signaling molecules are involved in dorsal-ventral patterning; some of the most 
prominent are the BMPs (Bone Morphogenetic Proteins) (Hammerschmidt and Mullins, 
2002). Because the knockdown of acyl-CoA-Synthetase longchain family member 4a with 
morpholino SP3005a cause dorsalisation, as observed after loss of BMP signaling (Bauer et 
al., 2001; Kishimoto et al., 1997), I investigated to which extent BMP signaling is affected in 
acsl4a morphants. 
First, I studied the expression patterns and intensities of bmp2b, bmp4 and bmp7 by whole-
mount in situ-hybridisation at the onset of gastrulation and at mid- to late-gastrula stages. At 
the onset of gastrlation (shield stage; 6 hpf), I could not see any differences in the expression 
of any of the three bmps in the injected embryos compared to the uninjected control (Fig. 4-3 
A -M). But the expression domains and levels were strongly reduced in the acsl4a morphants 
at the 80% epiboly stage (8 hpf; Fig. 4-3). To further confirm the loss of active BMP 
signaling in the morphants, I performed whole mount immunostainings against 
phosphorylated SMAD1/5/8 proteins. These are the receptor-SMADs expressed during early 
zebrafish development, which become phosphorylated through active BMP-signaling. 
Knockdown of acsl4a caused a dramatic reduction of SMAD protein phosphorylation at 80% 
epiboly (Fig. 4-3 N, O), indicating the loss of active signaling. Because the expression of 
bmps is normal at shield stage, the initiation of the BMP gradient along the dorsal-ventral axis 
seems to be unaffected by Acsl4a knock-down. But later during gastrulation the knockdown 
of acsl4a seems to affect the maintenance of bmp2/4/7 expression, possibly by promoting the 
aforementioned positive feedback of BMP signaling on bmp gene expression (see General 
Introduction).  
To investigate whether acsl4a and bmps might indeed regulate dorsoventral patterning by 
acting together in one linear pathway, or independent of each in parallel pathways, I 
performed genetic interaction and epistasis experiments. For the test of genetic interaction, I 
carried out synergistic enhancement studies, co-injecting MO SP3005a and bmp7 MO at 
suboptimal concentrations and classified the embryos at 24 hpf by their morphology. Upon 
coinjection of MO SP3005a at 0.025 mM and bmp7 MO at 0.02 mM, I obtained 44% 
(n=47/106) dorsalised embryos, with phenotypes ranging from C1 to C5. In contrast, in the 
single injections, I observed only 3% (n=3/90) C1 for bmp7 MO and 9% (n=9/99) phenotypes 
ranging from C1 to C3 upon acsl4a knock-down (Fig. 4-3 P). Thus, the dorsalisation obtained 
upon concomitant partial inactivation of acsl4a and bmp7 is stronger than the sum of the two 
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single effects, pointing to a synergistic enhancement, rather than an additive effect, and a 
genetic interaction of the two genes during dorsoventral patterning.  
As a first step to address the epistasis between acsl4a and bmp genes, I combined loss of 
acsl4a with gain of bmp2b, injecting acsl4a MO at a concentration of 0.1 mM into embryos 
from a cross between a wild-type fish and a transgenic fish carrying the transgene 
hsp70::bmp2b. This transgenic line had been generated in the Hammerschmidt laboratory by a 
former postdoctoral fellow, Fabian Rentzsch (Rentzsch et al., 2006). In the transgene, bmp2b 
is under the control of the temperature-sensitive hsp70 promoter, leading to ubiquitous bmp2b 
expression in transgenic embryos within 30 minutes after the application of a heatshock 
(incubation of embryos at 39°C instead of the regular 28°C). Upon heatshock at shield stage 
the ectopic transcript was stable for several hours and caused strong ventralisation of the 
whole embryo. In the control clutches 50% (n=31/63) of the embryos showed V3 
ventralsation at 24 hpf (Kishimoto et al., 1997), the other 50% (n=32/63) had wild-typic 
morphology. Without heatshock, all embryos were wild type. This indicates that, as expected, 
half of the embryos from the cross carried the transgene, and that the transgene was 
functional. Injection of acsl4a MO without subsequent heatshock led to the expected 
dorsalisation (wildtype 8/37, C1 6/37, C2 9/37, C3 11/37, C4 2/37, C5 1/37). When the 
embryos injected with acsl4a MO were heatshocked at shield stage, 50% (n=26/52) of the 
embryos showed V3 phenotypes as in the control clutches without MO injection. The rest of 
the clutch showed dorsalised phenotypes in a similar ratio as the injected controls without 
heatshock (wildtype 3/26, C1 4/26, C2 8/26, C3 10/26, C4 1/26). Thus, the forced expression 
of bmp2b during gastrula stages overcomes the dorsalising effects of acsl4a knock-down. 
This indicates that BMPs do not require and do not act via Ascl4a to fulfil their essential 
ventralising role during dorsoventral patterning of the zebrafish embryo. In reverse, this mean 
that Ascl4a might either act upstream of bmps in a linear pathway, or independent of BMPs in 
a parallel pathway. To distinguish between these two possibilities, it would be necessary to 
combine gain of Acsl4a function with loss of BMP function (but see below). 
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4.2.3. During gastrulation, acsl4a is mainly expressed and required in the Yolk 
Syncytial Layer  
I performed whole mount in situ-hybridisations and reverse transcriptase-PCR (RT-PCR) to 
unveil the temporal and spatial expression pattern of acsl4a, obtaining the same results with 
two independent antisense riboprobes and PCR primer pairs, respectively. 
Whole-mount in situ-hybridisations revealed prominent acsl4a expression in the Yolk 
Syncytial Layer (YSL) of gastrulating embryos (80% epiboly; 8 hpf), whereas expression in 
blastoderm was much weaker (Fig. 4-4 A, B). The YSL is an extraembryonic structure that is 
required for proper mesoderm and endoderm formation (Chen and Kimelman, 2000). 
Expression of acsl4a in the YSL also persisted during somitogenesis. At these later stages, 
additional acsl4a expression could be detected in the brain and the eyes (Fig. 4-4 C-E). 
I also performed RT-PCR analyses for different developmental stages during the first 24 hpf. 
By RT-PCR I could obtain a strong signal in fertilized eggs, which declined during blastula 
and early gastrula stages and increased again from mid gastrula stages onwards (Fig. 4-4 H). 
This points to the presence of maternally provided acsl4a transcripts during early stages of 
zebrafish development, whereas zygotic expression is first initiated after the onset of 
gastrulation. Consistently, I could not find significant expression of acsl4a via whole mount 
in situ-hybridization at 50% epiboly and shield stage (5 – 6 hpf), indicating that at late 
blastula and early gastrula stages, when BMP signaling is actively patterning the dorsoventral 
axis (Pyati et al., 2005), acsl4a mRNA levels are minor. 
Figure 4-3 (above): acsl4a may act upstream or in parallel to BMP-signaling during mid-gastrulation. 
(A –M) Expression pattern of bmp2b /4 /7 by whole-mount in situ-hybridisation. No difference in 
expression domains and intensities were detected at shield stage between uninjected (A, E, I) and with 
0.1mM MO SP3005a injected embryos (B, F, K), but a strong reduction in the morphants at 80% epiboly 
(D, H, M) compared to the wild-type situation (C, G, L).  Active BMP-signaling, indicated by anti-Phospho-
Smad stainings at 80% epiboly is strongly reduced in SP3005a morphants (O), (P) uninjected control. 
(P) Test for synergistic enhancement between bmp7 and acsl4a; phenotypic classification was done after 24 
hpf. Partial bmp7 and acsl4a inactivation by suboptimal MO concentrations result only in a small amount of 
dorsalised embryos in the single MO injections (lane 1 and 2), but in stronger dorsalisation upon co-
injection (lane 3) of the two MOs. 
(Q) Epistatic analysis, combining MO-mediated loss of Ascl4a function with gain of Bmp2b function in 
hsp70::bmp2b transgenic embryos; phenotypic characterisation was done at 24hpf; (lane 1) hsp70::bmp2b 
embryos without heatshock shows no phenotype, (lane 2) MO SP3005a injected in hsp70::bmp2b embryos 
without heatshock resulted in dorsalisation, (lane 3) hsp70::bmp2b embryos with heatshock at shield stage 
resulted in strong ventralisation in 50% of the embryos, (lane 4) MO SP3005a injected in hsp70::bmp2b 
embryos with heatshock at shield stage resulted in strong ventralisation in 50% of the embryos and 
dorsalisation in the other 50%. 
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Because the most prominent expression of acsl4a during gastrulation is in the YSL, I 
wondered whether the phenotype of morpholino SP3005a is due to knockdown of ACSL4a in 
the YSL. To address this question I injected 0.8 mM of acsl4a MO into the yolk cell of high 
stage embryos (3-3.5 hpf). Since MOs cannot cross cell membranes, MOs delivered this way 
will only target mRNAs present in the YSL. To indirectly visualise the confinement to the 
yolk cell and the success of the injection, the MO was co-injected with rhodamin-dextran 
(Fig. 4-4 F, G). Injection of SP3005a into the yolk cell successfully blocked the translation of 
co-injected Acsl4a-GFP (not shown). However, only a comparably low number of 
successfully injected embryos successfully injected with SP3005a MO and rhodamin-dextran 
(n=5/37, data from three different experiments) showed mild to moderate dorsalisation 
phenotypes, while all embryos injected with rhodamin-dextran alone had wild-type 
morphology (Fig. 4-4 F, G). This indicates that Acsl4a is indeed required in the YSL, where it 
displays its strongest expression. I can only speculate about the reasons for the rather low 
penetrance and strength of dorsalisation obtained by mid blastula yolk injections compared to 
injections at the 1-cell stage. They could point to an additional requirement of low level 
Acsl4a in the YSL during earlier (blastula) stages, and/or to an additional requirement of low 
level Acsl4a in the blastoderm.  
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Figure 4-4: acsl4a is expressed and required in the yolk synticial layer during gastrulation stages 
(A –E) Whole-mount in situ-hybridisations of wildtype embryos, with a probe against acsl4a (stages are 
indicated in the lower left corner); (A) during gastrula acsl4a is expressed in the YSL, (B) shows a 
transversal section of (A), (C-E) from somitogenesis onwards expression is detected in brain tissues, too, the 
YSL expression persists. 
(G) Live image of a 24hpf embryo, injected into the yolk cell at high stage with 0.8 mM MO SP3005a 
/RhodamineDextran, shows dorsalisation phenotype, (F) control embryo injected with solely Rhodamine 
Dextran. 
(H) RT-PCR for acsl4a at different developmental stages (2-cell stage, sphere, 30% epiboly, shield, 80% 
epiboly, tailbud, 24 hpf) detects a strong expression of acsl4a in fertilised eggs, a declining expression in 
blastula stages, no expression at shield stage and increased expression from mid-gastrula onwards. ef1a as 
control PCR. 
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4.2.4. Further morpholinos targeting acsl4a do not lead to dorsalisation 
To confirm the phenotype caused by morpholino SP3005a I designed further morpholinos 
targeting acsl4a (for sequences, see Materials and Methods). Injected embryos were analysed 
for dorsalisation at 24 hpf (Fig. 4-5). Each morpholino was injected at least three times with a 
concentration of 0.5 mM, and into two different wild-type strains, Tl/Ek and AB. One 
morpholino, named SP3005b, targets the region around the translational start site (AUG) site 
of the acsl4a mRNA. Upon coinjection with the same GFP-construct that I used for the 
efficacy check of SP3005a, SP3005b MO abolished GFP expression, indicating that it is 
functional (Fig. 4-5 G, H). However, in contrast SP3005a, SP3005b did not cause any 
dorsalisation of injected embryos (Fig. 4-5 C). Another morpholino named “splice site MO” 
targets the splice donor site of exon 4 of the acsl4a pre-mRNA. The functionality of this MO 
was tested by RT-PCR, revealing almost complete absence of the wild-type acsl4a transcript, 
whereas I could amplify a new transcript with an intron-specific primer (not shown). Like 
SP3005b, the splice site MO failed to yield any sign of dorsalisation. Instead, embryos 
displayed a rather subtle upward bending of the tail (Fig. 4-5 F).  Also, a coinjection of 
SP3005b and the splice site morpholino did not cause dorsalisation. Finally, I tested two 
additional morpholinos, named acsl4C and acsl4D, which target the 5’UTR of the acsl4 
mRNA further upstream of SP3005a, at the positions -107 and -154, respectively of the 
transcript sequence. These two morpholinos did not cause any morphological defects, even 
when I coinjected them (Fig. 4-5 D, E). In sum, of a total of five sequence-independent MOs 
targeting acsl4a, only the orginal one, SP3005a, caused dorsalisation, although two of the 
remaining four were shown to be functional. This strongly suggests that the dorsalisation 
obtained by SP3005a may be an off-target effect. 
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4.2.5. Injection of acsl4a RNA does not lead to a rescue of the dorsalisation caused 
by morpholino SP3005a 
As a second approach to investigate the specificity of the phenotype caused by morpholino 
SP3005a, I tried to rescue the dorsalisation of morphants by re-applying acsl4a mRNA. For 
this purpose, I amplified the zebrafish acsl4a coding region via PCR from cDNA of 80% 
epiboly embryos (for primer sequences and cloning see Material and Methods), and cloned it 
into the pCS2+ expression vector (Rupp et al., 1994). Also I constructed a corresponding 
mouse Acsl4 expression construct in pCS2+.  
Upon injection of zebrafish acsl4a RNA into wild-type embryos various phenotypes could be 
observed at 24 hpf (Tab. 4-1). Most frequently, embryos displayed a small head and small 
eyes, always in combination with blood pooling in the ventral fin. In some cases, these defects 
were combined with the loss of an eye on one side of the embryo. Approximately 50% of the 
Figure 4-5: Knockdown of Acyl-CoA-Synthetase longchain family member 4a with several 
morpholinos did not phenocopy the phenotype of MO SP3005a. 
Examination of injected embryos at 24 hpf for morphological changes, (A) uninjected control, (B) MO 
SP3005a show dorsalisation, (C) MO SP3005b, (D) MO acsl4C and (E) MO acsl4D do not show any 
morphological defects, (F) the splice site MO show no dorsalisation, but a slight bend up tail. 
Coinjection of acsl4a-5’UTR-GFP construct with MO SP3005b diminished GFP expression (H) in 
comparison to the control without MO. 
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embryos showed these phenotypes. Interestingly, single embryos showed a fusion of the eyes 
(Fig. 4-6 A-C), mostly combined with a shortened axis and malformations or absence of the 
notochord. Embryos injected with RNA in a concentration below 0.125µg/µl did not show 
any phenotype and grew up as normal wildtypes. The injection of the mouse Acsl4 construct 
did not lead to any discernible phenotypes at any concentration. 
In several zebrafish mutants, fusion of the eyes results from the absence of the prechordal 
plate, the anterior-most part of the dorsal mesoderm which is the source of signaling 
molecules inducing the separation of the eye field during early segmentation stages (Schier 
and Talbot, 2005). Therefore, I carried out in situ-hybridisations of injected embryos for the 
prechordal plate marker gene goosecoid (gsc) (Schulte-Merker et al., 1994a). During normal 
development, prechordal precursors ingress in marginal regions of the early gastrula embryos, 
and migrate towards the animal pole during further gastrulation. In contrast, in many of the 
acsl4a RNA-injected embryos, the gsc-expressing cells cells remained close to the margin 
(Fig. 4-6 D-L; n=15/ 23), indicating defects in prechordal plate formation or migration. This 
disturbed development of the prechordal plate visualised by gsc expression at mid gastrula 
stages was obtained more frequently than the corresponding fusion of the eyes, suggesting 
that defects could partially heal during further development. However, even for the gsc in 
situ-hybridisations, the strength and penetrance of prechordal plate defects varied from 
























0.125µg/µl 65 3 7 77 29 15 




For SP3005a MO specificity controls, I co-injected the morpholino with acsl4a RNA (which 
does not contain the endogenous 5’UTR and should therefore not be targeted by the MO). The 
coinjected embryos were compared with single injected embryos after 24hpf, applying 
morphological criteria to classify the strength of dorsalisation. In addition, I carried out in 
situ-hybridisations with dorsoventral marker genes at mid-gastrulation. I tested various 
combinations of concentrations of morpholino SP3005a and the zebrafish acsl4a RNA. 
Tabelle 4-1: Morphological phenotypes observed after 24hpf upon overexpression of acsl4a 
(absolute numbers of obtained embryos) 
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Morpholino concentrations ranged from 0.05mM to 0.2 mM for the morpholino, thus doses 
that cause only mild phenotypes up to doses that were nearly toxic. The RNA was injected 
from 0.02 µg/µl, a concentration that in single injected embryos never yielded any phenotype, 
to 0.2 µg/µl, the concentration resulting in the range of defects described above. However, in 
a total of 26 independent co-injection experiments, I never obtained a significant alleviation 
of dorsalisation strength compared to the controls injected with SP3005a MO alone. 
Similarly, no sign of rescue was obtained in three additional experiments, in which I co-
injected SP3005a MO and mouse Acsl4 mRNA.  
Consistent results were obtained via in situ-hybridisation at mid gastrulation, for instance with 
a bmp4 probe, which marks both ventral cell types and prechordal plate precursors (Fig. 4-6 
H). Embryos co-injected with MO and RNA displayed a marginal shift of the prechordal plate 
domain, indicative of the aforementioned effects of forced acsl4a expression on prechordal 
plate precursor cell migration (Fig. 4-6 L). In addition, they displayed a reduction of the 
ventral bmp4 domain, indicative of dorsalisation, that was indistinguishable from the 
phenotype of control embryos injected with the MO alone (compare Fig. 4-6 L with Fig. 4-6 
I). This indicates that the RNA failed to rescue the defects caused by the MO.  
As further controls of these crucial experiments, I tested the stability and functionality of the 
injected mRNA. Thus, I carried out agarose gel electrophoresis of the injection solution after 
its recovery from the injection needle, and obtained normal sized RNA bands, ruling out RNA 
degradation. Furthermore, I cloned the zebrafish acsl4a in-frame into the N-terminus of the 
gfp coding region of the vector Xlt.GFPltCS2+, a derivative of pCS2+ containing gfp (Miller 
et al., 1999). Upon injection of in vitro-synthesized RNA of the acsl4a-gfp fusion contruct, I 
could not see GFP expression, which is worrisome. However, the sequences of the acsl4a nd 
acsl4a-GFP expression constructs did not reveal major mutations, except for a suboptimal 
kozak consensus sequence. Furthermore, I could detect transient expression of GFP in 
embryos injected with linearised pCS2-acsl4a-GFP plasmid-DNA, which should be 
transcribed in vivo driven by the CMV promoter of the plasmid  (Fig. 4-6 M, N). I conclude 
that the construct itself is functional, but that the injected RNA might not be stable enough to 
express GFP. Further overexpression studies will be necessary to obtain more conclusive 
results. However, for the time being, I do not have any positive results on a rescue of the 
SP3005a morphant phenotype and thereby for the specificity of the MO effect. Together with 
the aforementioned failure of phenocopy with other MOs, it seems likely that the dorsalisation 
caused by the SP3005a MO is an unspecific off-target effect, rather than pointing to an 
essential ventralising role of acsl4a during dorsoventral patterning of the zebrafish embryo. 
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Figure 4-6: Overexpression of acsl4a cause defects in the prechordal plate formation, but cannot 
rescue the phenotype of MO SP3005s 
(A-C) live pictures of 24hpf embryos injected with acsl4a RNA in a concentration of 0.2µg/ µl.  
(D-E) whole-mount in situ-hybridisations embryos at 80% epiboly, with a gsc probe to mark prechordal 
plate cells. Prechordal plate cells stay close to the margin in embryos injected with acsl4a RNA (F dorsal 
view, G lateral view) n comparison to the uninjected control (D dorsal view, E lateral view). 
(H-L) whole-mount in situ-hybridisations using bmp4 at 80% epiboly in an approach to rescue the 
dorsalisation phenotype of MO SP3005a by a forced acsl4a expression. (H) Uninjected embryos, (I) 
embryos injected with MO SP3005a show loss of ventral bmp4 expression, (K) embryos injected with 
acsl4a RNA show a marginal shift of prechordal plate cells, (L) embryos co-injected with of RNA and MO 
show no restoration of the ventral bmp4 domain, but still the marginal shift of prechordal plate cells. 
(M, N) embroys injected with linearised plasmid of full-length acsl4a GFP-fusion construct show transient 
GFP expression. 
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4.2.6. Knockdown of acsl4a shows no specific defects during gastrulation 
comparable to loss of PGE2 signaling 
It was shown by Cha et al. that prostaglandin E2 (PGE2) plays a role during gastrulation for 
proper convergence and extension (C&E) and epiboly movements (see General Introduction). 
Because ACSL4a is supposed to be specifically involved in arachidonic acid metabolism and 
arachidonic acid is a precursor molecule for prostaglandin synthesis, I compared acsl4a 
morphants to embryos with blocked PGE2 synthesis by ntl (Schulte-Merker et al., 1994b) 
whole mount in situ-hybridisations at the end of gastrulation. ntl marks the notochord anlage, 
which during gastrulation becomes longer and narrower, driven by C&E movements. Thus, 
the shape of the ntl expression domain reflects possible defects during C&E.  
As control for disturbed PGE2 synthesis I treated embryos with 50µM Indomethacin, which is 
a nonselective inhibitor of cyclooxygenases 1 and 2 (Cha et al., 2005). In addition, I injected 
the morpholino targeting prostaglandin E2 synthetase (ptges) as described previously (Cha et 
al., 2006a). The embryos injected with SP3005b, acsl4a MO C or acsl4a MO D (each at a 
concentration of 0.5 mM) showed no difference in ntl expression compared to the wild-type 
control (Fig. 4-7 C-E). The SP3005a morphants displayed a moderately shorter and broader 
ntl expression domain, pointing to slightly compromised C&E movements (Fig. 4-7 B). But  
defects were much weaker than in Indomethacin-treated and ptges MO-injected embryos (Fig. 
4-7 H, L). However, C&E defects of a comparable strength as in Indomethacin and ptges MO 
controls were obtained by injection of the acsl4a splice site MO (n=33/58 embryos) (Fig. 4-7 
F).  
To test whether the C&E defects of the acsl4a splice site morphants are due to insufficient 
prostaglandin E2 synthesis, I tried to rescue the gastrulation phenotype by incubating 
morphants with PGE2. Treatment with 10µM PGE2 (from Sigma-Aldrich) led to a reduction 
of the phenotypic strength of Indomethacin-treated and ptges-MO injected controls, indicated 
by a narrowing of the ntl expression (compare Figs. 4-7 I, L with Figs. 4-7 H,K). In contrast, 
parallel treatment of acsl4a splice site morphants with PGE2 failed to alleviate the defects in 
the shape of the ntl expression domain (compare Fig. 4-7 G with Fig. 4-7 F). In sum, I failed 
to obtain conclusive results for an essential role of Acsl4a during prostaglandin synthesis in 
gastrulating zebrafish embryos. 
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4.2.7. Morpholinos targeting genes downstream of acsl4a show no phenotype 
during early development 
Arachidonic acid is the precursor molecule for eicosanoids, which are subdivided into four 
families, the prostaglandins, the prostacyclins, the thromboxanes and the leukotrienes.  
Apart from the prostaglandin PGE2, very limited data exist about the roles of the different 
eicosanoids during animal development, whereas their roles in cancer and inflammation are 
well investigated (Moreno, 2009; Patel et al., 2008; Wang and DuBois, 2008).  
In collaboration with Steven A. Farber (Carnegie Institution, Baltimore) I searched the 
zebrafish genome for potential genes involved in the arachidonic acid pathway and eicosanoid 
production, to be included as potential targets in our large-scale morpholino screen. 
Figure 4-7: Test for epiboly defects of acls4a morphants in comparison with inhibition of PGE2 
synthesis. 
Whole-mount in situ-staining using ntl, a marker for the notochord anlage to show compromised 
C&E movements, in late gastrulation stage embryos. (A) Uninjected control, embryos injected with 
(B) MO SP3005a, (C) MO SP3005b, (D) MO acsl4C, (E) MO acsl4D, (F) splice site MO, (G) splice 
site MO and treated with PGE2. Embryos with affected C&E movements show a shorter but 
expanded (indicated by bars) expression of ntl. 
As control embryos were treated with Indomethacin (H, I) or injected with ptges MO (K, L), and 
respective rescue experiment with PGE2 (I, L) were done as previously described.  
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The cytosolic Phospholipase A2 (zcPLA2) is an intracellular Phospholipase required for the 
release of arachidonic acid from phospholipid membranes, the initial step of eicosanoids 
production from stored arachidonic acid sources. I investigated the effect obtained by 
injection of zcPLA2 MO via whole mount in situ-hybridisations with probes for different 
dorsoventral marker genes. No difference between control and morphant embryos could be 
seen during mid gastrula stages in the expression domains of otx2, a marker for dorsal 
ectoderm (see above) and tbx6, a marker for ventrolateral mesoderm (Hug et al., 1997). 
Furthermore, no difference in the expression of in pax2.1 (Krauss et al., 1991) in the central 
nervous system, spinal chord or the pronephric duct, a derivative of the ventral mesoderm, 
was visible at mid segmentation stages (Fig. 4-8 A-D). Therefore zcPLA2 seems to have no 
role during early patterning. 
My collaborator Steven A. Farber provided me with some evidence from mass-spectrometry 
analysis of acsl4a morphants, according to which levels of 5(S)-Hydroxyeicosatetraenoic 
Acid (HETE) are altered. Hydroxyeicosatetraenoic acids, which are made from arachidonic 
acid by lipoxygeneases (see above), were already described to regulate head formation and 
regeneration in Hydra spec. (Hassel et al., 1996; Muller et al., 1998). Therefore morpholinos 
against ESTs encoding lipoxygenases were included in the screen. Three different 
morpholinos targeting potential 5-lipoxygenases (lox5), two designed by myself, and two 
morpholinos targeting 12-lipoxygenase (lox12), one designed by myself, did not show any 
phenotype when injected in wild-type embryos. Furthermore, co-injection of one of these 
morpholinos with MO SP3005a did not change the strength of dorsalisation (not shown). In 
sum, by screening morpholinos, no further member of the arachidonic acid and eicosanoid 
pathway could be identified to play a role during early developmental stages of zebrafish. 
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4.2.8. Treatments with agonist and antagonist of the arachidonic acid pathway 
In addition to the morpholino-based approach, I started an analysis of known agonist and 
antagonist of the arachidonic acid and eicosanoids pathways. One of the best-known 
antagonists of prostaglandin synthesis is Acetylsalicylsäure (ASS, also known as Aspirin). 
Embryos incubated during gastrulation stages with 1 mg/ml ASS solution showed delayed or 
stopped gastrulation (Fig. 4-8 F). The effectiveness differed, depending on the supplying 
company of ASS, the time point of administration and also the used wild-type strain. Thus, 
embryos from the AB line could tolerate double as much ASS as embryos of the Tl/Ek line. 
Furthermore, when ASS was administered after the shield stage (6 hpf; early gastrulation), the 
survival rate was much higher and phenotypes weaker than upon treatments starting before 
Figure 4-8: Only components that directly interfere with prostaglandin synthesis show defects in 
early embryonic development  
whole-mount in situ-hybridisations of uninjected (A, B) and with zcPLA2 MO injected (C, D) embryos. 
(A, C) Markers for DV patterning otx2 for dorsal ectoderm and tbx6 for ventrolateral mesoderm in a 
combined approach at 80% epiboly. (B, D) pax2.1 as marker for the central nervous system, spinal chord 
or the pronephric duct during somitogenesis. 
(E, F) live images of embroys treated with acetylsaliacylacid (ASS) show delayed or stopped gastrulation 
(F) compared to the untreated control (E). 
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the onset of gastrulation (data not shown). Since ASS inhibits the Cyclooxgenases COX-1 and 
COX-2, these results are in accordance to previous results obtained with cox morpholinos 
(Cha et al., 2006a; Cha et al., 2005). In the following, I used ASS as a positve control for 
experiments testing further compounds. All of these compounds were tested in at least two 
independent experiments with freshly prepared solutions. Incubation of embryos with 
arachidonic acid (Calbiochem), tested in dilution series from 2.5 µg/ml to 2.5 mg/ml, caused 
no specific developmental defects, but displayed general cellular toxicity leading to 
embryonic death when applied above 1 mg/ml concentrations. At these higher concentrations, 
the embryos became necrotic soon after the AA-solution was added, however, no specific 
developmental defects, e.g. during gastrulation, were observed. Similar results were obtained 
using arachidonic acid from Sigma-Aldrich, except that this solution was toxic from 25 µg/ml 
upwards. Finally, treating SP3005a morphants as well as zebrafish acsl4a RNA injected 
embryos with sub-lethal concentrations of AA did not lead to any shifts in the strength or 
penetrance of their defects.  
Because of the mass-spectrometry data supplied by Steven A. Farber indicating higher r5(S)-
HETE levels in SP3005a morphants, I also incubated wild type, SP3005a MO-injected and 
acsl4a mRNA-injected embryos in solutions of 5(S)-HETE, as well as the related 12(S)-
HETE, ranging from 3 nM to 150 µM concentrations. These concentrations cover all thus far 
described biological active concentrations. But in six independent experiments, I never 
obtained an effect of one of the HETEs on early zebrafish development, including 
dorsoventral patterning. 
Furthermore, I tested inhibitors of phospholipases. The sPLA2-IIA Inhibitor I (Church et al., 
2001) has reported working solution from 100 nM to 10 µM. However, incubation of 
embryos in a solution concentrated up to 35µM did not harm the development in any way, 
indicating that the function of secreted phospholipase is dispensable during early 
development. Next I tested AACOCF3 (Arachidonyltrifluoromethyl Ketone), an analogue of 
arachidonic acid that selectively binds and inhibits cytosolic Phospholipase A2 (Street et al., 
1993). The treatment with 20 µM AACOCF3 slowed down gastrulation, but the embryos 
recovered during further development, and did not unveil any morphological differences 
compared to the control at 24 hpf. Also it did not alter the strength of the SP3005a morphant 
phenotype.  
Finally, I treated embryos with a bunch of antagonists of leukotriene and hydroxy-eicosa-
tetraenoic acid production. The benzoquinone dervivate AA-861 is a competive inhibitor of 5-
Lipoxygenase (Ashida et al., 1983; Wang et al., 2000). In a series with highly concentrated 
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compound (3 mM to 30 mM), I found that embryos incubated in a 6 mM solution showed 
slight developmental retardation at 24 hpf, but no morphological malformations. Also, AA-
861 did not rescue SP3005a morphants, although one would expect this, if the dorsalisation of 
was due to the observed increase in 5-(S)-HETE levels in morphant embryos. Another 
inhibitor of 5-lipoxygenase is MK-886, which binds FLAP (5-lipoxygenase activating 
protein) (Ford-Hutchinson, 1991). MK-886 was tested up to concentrations of 5 µM, five 
times higher than the reported working solutions, but did not give a phenotype. Caffeic acid 
(3,4-Dihydroxycinnamic Acid) is a natural anti-oxidant in plants and has been reported to be a 
potent 5-lipoxygenase inhibitor (Koshihara et al., 1984). At a concentration of 5 mM, it 
caused slowed down gastrulation and caused developmental retardation at 24hpf. Lower 
concentrated solutions (2.5mM) led to the formation of smaller heads and smaller eyes. 
However, they did not lead to a reduction of dorsalisation in SP3005a morphants. Instead, 
embryonic lethality was increased, indicating an enhanced toxicity. A selective inhibitor of 
12-lipoxygenase, named Baicalein (Sekiya and Okuda, 1982), was tested from 40 to 400µM 
without any effect. 
In summary, none of the tested chemical compounds interfered with early patterning in a 
specific manner like MO SP3005a. Therefore, I was not able to further unveil the role of 
arachidonic acid pathways during axis specification of zebrafish. 
The Role of acsl4a in D-V patterning 
 - 58 - 
4.3. Discussion 
4.3.1. Knockdown of acsl4a create a new role for arachidonic acid metabolism 
during early embryonic development  
While I was screening for morpholinos causing phenotypes during early development I found 
a morpholino that led to a loss of dorsal structures similar to phenotypes described in mutants 
with compromised or absent BMP signaling (Hammerschmidt and Mullins, 2002). This 
morpholino, named SP3005a, targets the 5’UTR of the mRNA of acyl-CoA synthetase 
longchain family member 4a (acls4a). Zebrafish Acsl4 genes and proteins had not been 
described so far, but some information was available from their mammalian orthologues. 
I characterised the phenotype of SP3005a morphants as a general dorsalisation of the embryo, 
as evidenced by the shifts of the expression domains of dorsal and ventral ectodermal and 
mesodermal markers at mid-gastrula stages and by morphological criteria at 24 hours post 
fertilisation (Fig. 4-2). Consistent alterations were observed in the expression of the three bmp 
genes that are essential for dorsoventral patterning of the zebrafish embryo, bmp2b, bmp4 and 
bmp7 (Fig. 4-3). Because the BMP signaling gradient depends on its own positive feedback 
loop, these data did not allow to distinguish whether the SP3005a MO interfered with 
dorsoventral patterning upstream or downstream of BMP signaling. For this purpose I had to 
perform epistatic analyses, combining the two opposite effects obtained by gain of function of 
one gene and loss of function of the other. In one combination, with constitutive BMP 
signaling (ventralisation) combined with loss of Acsl4a activity (dorsalisation), I could show 
that Acsl4a does not act downstream of the BMP signaling pathway (Fig. 4-3). To distinguish 
whether it acts upstream of BMP signaling or in a parallel pathway, it would have been 
necessary to combine opposite effects obtained by gain of Acsl4a function and loss of BMP 
signaling. However, unfortunately, overexpression of acsl4a did not cause a ventralised 
phenotype. So, two scenarios are possible. In the first, Acsl4a acts upstream of and via BMP-
signaling. Acsl4a may mediate the production of certain metabolites of the arachidonic acid 
cascade that either directly promote the transcription of bmp genes or components of the 
transduction pathway or that affect their gene products at the post-translational level. 
Recently, the canonical Wnt signaling and prostaglandin signaling pathways were linked, 
where prostaglandin can activate ß-catenin-dependent transcription via Axin (Castellone et 
al., 2005). A similar mode of action might be true for the BMP pathway, for example on the 
level of phosphorylation of SMADs. I showed that the initiation of bmp expression is 
unaffected and the expression is progressively lost during gastrulation. A possible scenario 
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would be that expression of bmps is initiated in an Acsl4a-independent fashion, but an 
arachidonic acid-derived signaling pathway interferes with SMAD-dependent signal 
transduction and thereby the maintenance of bmp expression. Interestingly, a similar 
connection between ACSL4 and BMP might also exist in the fruit fly Drosophila, 
melanogaster. Thus, according to a recent report (Zhang et al., 2009), Drosophila mutants in 
the fly ACSL4 homologue display reduced production of the Dpp, the fly BMP2/4 
homologue, and corresponding defects in the development of glial cells and neuronal wiring 
in the larval brain. However, the exact mechanism underlying this connection between Ascl4 
and Dpp/BMP remained elusive. Eicosanoids are known to act mainly via G-Protein coupled 
receptors that opens wide field of downstream signaling mechanism (Dey et al., 2006). One of 
the possible mediators, MAPK, has been shown recently to inhibit SMAD signal transduction 
(Pera et al., 2003). 
Cooperative functions of BMPs and eicosanoids are also known from other examples. 
Various Prostaglandins, the major eicosanoid subgroup, have been shown to cause an 
augementation of bone mass and induction of osteoblastic differentiation. In vitro studies 
describe an upregulation of BMP levels upon prostaglandin treatment (Arikawa et al., 2004; 
Damrongsri et al., 2006a; Damrongsri et al., 2006b; Li et al., 2007; Paralkar et al., 2003; 
Toyoda et al., 2005). It is likely that similar pathways are functional during early embryonic 
development. The exact mechanisms by which the eicosanoid and BMP pathways interact 
with each other are still unknown. Cha et al. (2005) have indirectly excluded BMPs as 
potential downstream targets of the Prostaglandin E2 pathway, showing that PGE2 regulates 
cell migration processes, rather than dorsoventral patterning of the zebrafish gastrula.  
In a second scenario, acsl4a and its downstream effectors could affect dorsoventral patterning 
independently of and in parallel to the BMP pathway. Because the expression of bmps 
depends on a feedbackloop, the down-regulation of bmp expression would in this case just be 
a secondary consequence of the dorsalisation. Eicosanoids can bind and activate Peroxisomal 
proliferator-activated receptors (PPARs) (Forman et al., 1995; Gupta and Dubois, 2002; 
Kliewer et al., 1995; Wahli et al., 1999). PPARs are nuclear receptor that function as 
transcription factor, usually working together with coactivators or corepresosors, upon 
binding to free fatty acid or eicosanoids (Berger and Moller, 2002; Feige et al., 2006; 
Schroeder et al., 2008). PPARs have diverse biological functions, e.g. they are known to be 
involved in adipocyte development (Moldes et al., 2003; Park et al., 2008). No investigations 
have been performed on the role of PPARs during early development, keeping this option 
speculative.  
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The knockdown of acl4a by morpholino SP3005a shows a possible new role for acyl-coA 
Synthetase longchain family member 4 and its derivates in patterning the dorsal-ventral axis 
during gastrulation. Dorsalised embryos, as for instance obtained by loss of BMP signaling, in 
addition to dorsoventral patterning also display defects during convergence, one of the 
morphogenetic movements of gastrulation (Myers et al., 2002; von der Hardt et al., 2007). 
Thus, the dorsalisation of SP3005a morphants includes some, but not all of the phenotypic 
traits caused by loss of PGE2 function (compromised convergence, extension and epiboly; 
Cha et al., 2005). In this light, it remains unclear why the loss of an arachidonic acid 
derivative can cause additional defects that are not obtained upon loss of its upstream 
substrate. Also, it remains unclear via which eicosanoid arachidonic acid affects dorsoventral 
patterning (in case the effect of the SP3005a MO is specific; see below). 
 
 
4.3.2 acsl4a is expressed in the yolk syncytial layer of the gastrulating embryo, 
from where it might regulate dorsoventral patterning of the blastoderm 
Zebrafish acsl4a is predominantly expressed in the yolk syncytial layer (YSL) during 
gastrulation stages. The YSL origantes from marginal blastomeres that do not form a 
membrane towards the yolk cell during cleavage stages, and release their nuclei into the yolk 
during blastula stges, so that a yolk syncytial layer consisting of multiple nuclei is formed 
beneath the deep cells. The YSL plays an important role in establishing the dorsoventral axis, 
since the accumulation of ß-catenin in some nuclei determines the future dorsal side (Nojima 
et al., 2004; Pelegri and Maischein, 1998). But obviously the initiation of the dorsal side in 
SP3005a morphants is not affected, because the gradient of BMP-expression is normal until 
the onset of gastrulation. Thus, acsl4a seems to be largely required for later steps of BMP 
gradient modification and maintenance during gastrulation, conistent with the time course of 
zygotic acsl4a expression, which is initiated at the shield stage and strongest throughout 
gastrulation (Fig. 4-4.). By RT-PCR I also found maternally supplied acsl4a transcript, 
however, there is no functional indication that acsl4a might play a role before the onset of 
gastrulation. During later development, acsl4a transcripts became apparent in the embryonic 
brain, which is along with of the reported expression of mammalian and Drosophila ACSLs 
(Soupene and Kuypers, 2008; Zhang et al., 2009). 
It is not known, where and it which form arachidionic acid is stored in the zebrafish embryo. 
From the acsl4a expression pattern, it seems very likely that a major source and storage 
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compartment is the yolk. The yolk cell provides the embryo with all necessary nutritions and 
is its energy source until the larva starts eating at day five of development (Poupard et al., 
2000). I tested if expression of acsl4a in the YSL is necessary for dorsoventral patterning of 
the blastoderm by injection of MO SP3005a solely into the yolk cell of blastula stage 
embryos. Using this approach of spatially restricted MO application, I obtained embryonic 
dorsalisation as upon MO application into the entire embryo, suggesting that Acsl4a protein is 
necessary in the YSL for dorsoventral patterning. However, the penetrance of the phenocopy 
was very low. This could have technical reasons. But it also cannot be ruled out that Ascl4a 
acts in both the YSL and the blastoderm.  
How could Ascl4a function in the YSL affect bmp gene expression and dorsoventral 
patterning in the blastoderm? ACSL4 proteins do not seem to possess specific membrane tags 
or transmembrane domains; however, based on in vitro data, they appear to act in the 
cytoplasm close to nuclear membranes. Thus, Ascl4a present in the YSL of zebrafish embryos 
could regulate the availability of arachidonic acid (AA) by might promoting its storage as 
integral parts of phospholipids within the outer membrane of YSL nuclei, in close 
neighborhood of the blastoderm. Upon phospholipase-dependent release from the nuclear 
membranes, free AA or its derivatives could diffuse or be brought to the blastoderm to fulfil 
their signaling function. It is unclear which of AA’s derivatives mediates its effect on 
dorsoventral patterning, and whether it is directly generated in the YSL or in the blastoderm. 
Cyclooxygenases, which are crucial for prostaglandin synthesis from AA, seem to be 
exclusively expressed in the blastoderm. At least no specific expression in the YSL is 
mentioned in the corresponding publication (Cha et al., 2005). So, either the blastoderm cells 
have an intracellular level of arachidonic acid that is sufficient for prostaglandin production or 
free arachidonic acid from the yolk cell is provided to the blastoderm by an unknown 
mechanism. However, things could be different for other AA derivatives, which might be 
generated in the YSL itself. Attractive candidates mediating AA and Ascl4 effects 
downstream of eicosanoids of the lipoxygenase pathway are the steroids. Thus, release of AA 
in a cPLA2-independent pathway is required for the expression of StAR protein 
(steroidogenic acute regulatory protein), a critical regulator of steroid biosynthesis (Cho et al., 
2000;Wang et al., 2000; Maloberti et al., 2005; Stocco et al., 2001). Future studies have to 
reveal whether zebrafish star genes are expressed during gastrulation, and, if so, whether 
expression is confined to the YSL or the blastoderm. 
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4.3.3 The phenotype of SP3005a morphants might be caused by off-target effects 
Dorsalisation is usually a very specific phenotype that has not been obtained as an artifact in 
any of the over 300 antisense MOs used in the Hammerschmidt laboratories. Nevertheless, 
there are substantial doubts about the specificity of the phenotype of SP3005a morphants, In 
attempts to confirm that the dorsalisation by the SP3005a MO is indeed due to the loss of 
Acsl4a function, I tested further acsl4a MOs and tried to rescue the phenotype of SP3005a 
morphants by co-injecting the MO with in vitro synthesized full-length ascl4a mRNA that 
cannot be targeted by the MO. However, none of four other acsl4a MOs generated dorsalised 
phenotypes, even when injected together to compensate for possible problems in the efficacy 
of Acsl4a knock-down. Two of these other MOs were even found to efficiently knock down 
acsl4a via scoring of GFP suppression or RT-PCR analysis, respectively. In sum, only one 
out of three MOs with acsl4a confirmed targeting acsl4a mRNA caused a dorsalisation 
phenotype, whereas the other two and two further, uncharacterized MOs did not..  
For rescue and overexpression studies, I cloned the coding region of the acsl4a cDNA into an 
expression vector that can be used for in vitro mRNA synthesis. The SP3005a MO sequence 
is complementary to nucleotides -38 to -13 in the 5’ UTR of the acsl4a mRNA. Since this 
sequence is absent from the acsl4a expression constructs, the injected in vitro synthesized 
mRNA will not be targeted by the MO. Injection of acsl4a mRNA into wild-type embryos 
caused in few cases defects in the prechordal plate migration, as revealed by in situ-
hybridisation for the prechordal plate marker gene goosecoid during midgastrulation stages. 
Since the PGE2 pathway interferes with PI3Kinase activity (Cha et al., 2006a) and PI3Kinase 
is involved in the transduction of chemotatic signals in migrating cells at the anterior edge of 
the prechordal plate (Montero et al., 2003), it is tempting to speculate that acsl4a 
overexpression might cause the prechordal plate defects by interfering with PI3Kinase 
activity. Thus, forced expression of acls4a could lead to ectopic generation of arachinoic acid 
derivatives and ectopic PI3Kinase activation in more posterior prechordal plate cells, thereby 
confusing chemotaxis and directed cell migration. However, this phenotype was obtained at 
rather low frequencies, and it is unclear whether it is specific (see also below).  
When coinjected at variable concentrations together with the SP3005a MO, acsl4a mRNA 
never caused a significant alleviation of the dorsalisation, providing further support for the 
suspision that the dorsalisation might be caused by an off-target effect of the MO. On the 
other hand, I have to admit that the failed rescue experiment is not fully conclusive, because 
the used mRNA might not be fully functional. To test its functionality, I had modified the 
used acsl4a expression construct by fusing the GFP coding region in frame to the 3’ end of 
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the acsl4a coding region. However, mRNA from this fusion construct failed to give GFP 
fluorescence in mid gastrula stage zebrafish embryos after injection at the 1-cell stage. In 
addition, sequencing revealed a missense mutation in the Kozak sequence directly adjacent to 
the ascl4a start codon. Therefore, it is possible that the injected acsl4a mRNA is not properly 
translated, which would explain the failed rescue of the morphant phenotype, and the low 
frequencies with which specific defects were obtained upon acsl4a overexpression in wild-
type embryos. Similar experiments with acsl4a mRNA after repair of the Kozak site mutation 
have to be carried out (see also below; outlook and perspectives). 
 
 
4.3.4 Further components of the arachidonic acid cascade can most likely be 
excluded as regulators of dorsoventral patterning 
Beside their role in inflammation, where they were initially described, eicosanoids are known 
to be involved in many developmental processes. Two of the best studied developmental 
processes regulated by eicosanoids are ovulation and implantation of mammalian blastocysts 
(Dey et al., 2004; Wang and Dey, 2005). The specific role of prostaglandins during oocyte 
maturation and ovulation is evolutionary conserved and has been found in many organisms, 
including non-mammalian species, like Xenopus (Sena and Liu, 2008) and several teleosts 
including zebrafish (Lister and Van Der Kraak, 2008; Sorbera et al., 2001), and even 
invertebrates like the fruitfly Drosophila melanogaster (Tootle and Spradling, 2008). The 
major prostaglandins involved are PGE2 and PGF2, which act via their G-Protein coupled 
receptors (GPCR) on several signal transduction pathway members like PI3K-Akt, PKA,  
JNK-NFkappaB or MAP kinases (Takahashi et al., 2006). The regulation of steroidgenesis by 
eicosanoids is a very important mechanism. In this context, a direct role of ACSL4 has been 
described, which together with the mitochondrial acyl-CoA thioesterase 1 (MTE-1, also 
called AA-related thioesterase involved in steroidogenesis ARTISt) was shown to be crucially 
involved in the regulation of steroid production (Stocco et al., 2005). Consistently, Acsl4 
knock-out in mice causes reproductive defects in heterozygous females, while the phenotype 
of homozygous mutants has not been reported as yet. However, hemizyous Ascl4-/Y males, 
which also should be Ascl4 nulls, appear normal (Cho et al., 2001). Homozygocity for 
amorphic mutations in Drosophila causes lethality during larval stages, and mutants are 
characterized by glial and neuronal wiring defects in the brain (Zhang et al., 2009), in line 
with the non-syndromic X-linked mental retardation (MRX) associated with ACSL4 
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mutations in human. 
The Drosophila work also points to a role of Ascl4 in the regulation of Dpp/BMP production 
in some, but not all Dpp expression sites (Zhang et al., 2009). Since mutants make it through 
embryogenesis, it is likely that early Dpp required for embryonic D-V patterning is normally 
expressed. In sum, there is no explicit linkage of ACSL proteins to axis and body plan 
formation described in any organism thus far.  
In zebrafish, little is known about the arachidonic acid cascade and the eicosanoid signaling 
pathways in general. Only the cyclooxygenase and prostaglandin pathway has been 
investigated so far (Cha et al., 2006b; Grosser et al., 2002; Lister and Van Der Kraak, 2008; 
North et al., 2007; Pini et al., 2005; Teraoka et al., 2009; Yeh and Wang, 2006). The most 
prominent prostaglandin in the zebrafish embryo is PGE2, whereas other prostaglandins are 
not or only weakly expressed (Cha et al., 2006a; Yeh and Wang, 2006).  
Mass-spectrometry data from my collaborating laboratory of Steven A. Farber showed 
increased levels of 5-S- hydroxy-eicosa-tetraenoic acid (HETE), a product of the 5-
lipoxygenase pathway, during somitogenesis (Steven A. Farber, personal communication). 
Studies in the past showed patterning effects of HETEs in Hydra spec. These studies, mainly 
done by Werner Müller in Heidelberg, revealed a role of the arachidonic acid cascade in 
pattern formation along the body axis of hydrozoans. Arachidonic acid and Diacylglycerol 
were shown to induce ectopic head formation with supernumerious tentacles, via 
Proteinkinase C as key regulator. In Hydra, arachidonic acid seems to work as morphogen, 
which appears to act at least partly via its main hydrozoan metabolites, the hydroxy-eicosa-
tetraenoic acid (HETE) lipoxygenase products, predominately 12-S-HETE (Hassel et al., 
1996; Muller et al., 1998). More recent studies also revealed the presence of an active BMP 
gradient along the head to foot axis of Hydra, with the head constituting an organizer-like 
structure that expresses a chordin ortholgue (Rentzsch et al., 2007). A link or cooperative role 
of the arachidonic acid cascade and BMP signaling even in such an evolutionary ancient 
phyla, would be perspicuous, but has not been shown.  
Based on these findings, HETEs and further lipoxygenase products were excellent candidates 
as the effective mediators of arachidonic acid and Acsl4a during zebrafish D-V patterning. 
Therefore, I performed an exhaustive test series, trying to phenocopy or rescue the 
dorsalisation of SP3005 morphants with 5(S)-HETE or a range of different lipoxygenase 
antagonists. As positive controls, I used the previously described cyclooxygenase drugs 
Indomethacin and Acetylsaliacyl acid. However, none of the lipoxygenease products or 
inhibitors yielded positive results. I also identified putative zebrafish 5-lipoxygenase and 12-
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lipoxygenase genes, and designed MOs against them. But neither injections into wild-type nor 
into SP3005a morphant embryos had any effect. A further detailed examination of 
lipoxygenases in zebrafish is necessary, since it is possible that there are further 
lipoxygenases that could be redundant to the two I have identified and knocked down.  
However, the results obtained with both the chemical drugs and the MOs suggest that 
hydroxy-eicosa-tetraenoic acids are dispensable for early zebrafish patterning. Because the 
targeted lipoxygenases are also required for the synthesis of leukotrienes, leukotrienes can be 
ruled out as potential effectors as well. 
Finally, to get more functional data for the requirement of arachidonic acid itself, I targeted 
phospholipases with chemical antagonists and MOs. The phospholipases, mainly the 
Cytosolic Phospholipase A2 (cPLA2) are the key enzymes in releasing arachidonic acid from 
phospholipids and making it available for eicosanoid synthesis. The laboratory of Steve 
Farber identified the Zebrafish homologue of zcPLA2 and designed a specific MO. However, 
in none of the approaches, I obtained dorsoventral or gastrulation defects, or an alleviation of 
the dorsalization of SP3005a morphants, as would be expected if zcPLA2 or related 
phospholipases played an essential role during early zebrafish development. 
As in the case of the lipoxygenases described above, one reason for the lack of phenotype of 
the morphant could be the existence of paralogues with redundant functions. To circumvent 
this problem, I also used antagonists that should target all enzymes of one class. However, 
they were ineffective as well. This approach might have suffered from technical problems, 
since the embryos had to be treated for at least five hours at 28°C in aqueous solution, which 
might have affected the stability of the compounds, decreasing the effectivity and maybe 
producing toxic by-products. The same might be true for the treatment with the metabolites 
like the HETEs themselves. I tried to prevent such problems by using titration series and by 
regular exchange of the solutions. Also, the treatments with the cyclooxgenase inhibitors 
interfering with prostaglandin signaling did work, leading to the same defects as in cox 
morphants, suggesting that technical problems might only play a minor role. Nevertheless, 
they cannot be completely ruled out, which means that my negative results are not fully 
conclusive. 
In summary, I could not obtain any positive results pointing to a role of arachidonic acid 
metabolits during early patterning of the zebrafish embryo, which would be consistent with 
the dorsalised phenotype of SP3005a morphants. 
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4.3.5 Outlook and perspectives 
There is a bunch of data suggesting that the dorsalisation caused by the SP3005a MO might 
be an off-target effect. On the other hand, dorsalisation is a very clean phenotype, which 
usually is not obtained by unspecific effects. Thus, and in light of the reported roles of BMP-
eicosanoid cooperations in multiple other instances, it remains possible that Acsl4 enzymes 
do play an essential role during dorsoventral patterning of the zebrafish embryo. One 
explanation for the failed rescue of SP3005a morphants with acsl4a mRNA could be 
problems with the translation rates of the exogeneous mRNA (see above). An explanation of 
the failed phenocopy by four other ascl4a MOs could be functional redundany between 
ascl4a and its paralogue. Indeed, a second ascl4 gene has been identified in zebrafish and is 
annotated in the Zebrafish Model Organism Database Zfin as acsl4l. Like acsl4a, acsl4l is 
strongly expressed in the YSL of gastrulating zebrafish embryos (http://zfin.org). 
Unfortunately, the 5’ region of the acsl4l cDNA has not been identified as yet, making it 
impossible to design acsl4l-specific ATG or 5’ UTR MOs. Also, I could not look up whether 
the SP3005a MO, but not SP3005b and the other ascl4a MOs, might target both acsl4 
paralogues. My initial experiments with an MO targeting an acsl4l splice site (generous gift 
of Steven A. Farber) indicate that ascl4l is dispensable for early zebrafish development. 
However, considering a redundant function of the two Acyl-CoA synthetase longchain family 
member 4 enzymes, it will be important to knock down both concomitantly in co-injection 
experiments. 
To identify the relevant arachidonic acid metabolites, more systematic approaches might be 
more fruitful. First, a more thorough investigation of the lipids present in the early embryo 
during blastula and gastrula stages should be carried out. The obtained profile should give 
hints about the pathways of lipid signaling active in the early embryo. This profiling has to be 
done by mass-spectrometrie. Second, a more detailed analysis of enzymes and receptors 
present in the early embryo has to be performed. Via the expression patterns one could nail 
down the site of signal production and the sites of action. Also the identification of possible 
paralogues will be helpful for later knock-down experiments. Finally, large-scale chemical 
compound screens similar to the one that led to the identification of PGE2 as regulator of 
hematopoetic stem cell homeostasis (North et al., 2007), could be carried out as an unbiased 
approach to identify lipid regulators of early zebrafish development. Results obtained in 
zebrafish will most likely also be relevant for other species. Clearly, the patterning and 
regeneration phenotypes observed in Hydra spec. strongly suggest that lipid signaling might 
be an evolutionary conserved patterning mechanism. 
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5. Studies for cell commitment during early gastrulation stages 
5.1. Introduction 
5.1.1. During gastrulation cells are specified towards their final fate in a region-
and time-dependent manner 
During development, a multi-cellular organism consisting of a whole range of different cell 
types is formed from a single cell, the fertilized oocyte, also called zygote. Thus, the zygote 
and its direct progenitors, the germ cells, are omnipotent, and can give rise to any cell of the 
later body. The same is usually true for most cells of the early embryo, which for instance 
revealed by the plasticity of “embryonic stem cells” derived from early stage mouse embryos. 
However, during the course of early development, most embryonic cells become 
progressively specified and less plastic, until they eventually undergo terminal differentiation, 
with their characteristic function, shape and gene expression. Important specification steps 
take place shortly before and during gastrulation, such as induction of mesodermal and 
endodermal cell fates, and determination of differential dorsal-ventral fates. Different 
approaches have been undertaken to determine the future fate and specification status of the 
cells of pre-gastrula embryos. Results on future cell fates are summarised in so-called “fate 
maps”. Such fate maps are generated by cell lineage analyses, as done for example in the 
nematode Caenorhabditis elegans by directly following the development of cells in vivo via 
time-lapse microscopy (Sulston et al., 1983), or by comparing subsequent developmental 
stages, as for example done in the fruitfly Drosophila (Hartenstein and Campos-Ortega, 
1985). A second method is to ablate cells and to analyse the structural defiencies caused by 
this, as already done in the late 1970s in Drosophila (Lohs-Schardin et al., 1979). A third 
method is the lineage tracing with dye-labelled cells, a method that was intially used in the 
clawed frog Xenopus laevis (Heasman et al., 1984), but later also in zebrafish (Kimmel and 
Law, 1985a; Kimmel and Law, 1985b; Kimmel and Law, 1985c).  
Full zebrafish fate maps have been generated for late blastula stages, revealing crucial spatial 
differences both along the animal-vegetal and the dorsal-ventral axis (see below). However, 
similar experimental approaches have also revealed particular differences during earlier stages 
of development, such as the establishment of dorsal-ventral polarity, which is already obvious 
during early cleavage stages (Abdelilah et al., 1994; Helde et al., 1994), and the segregation 
of the Yolk Syncitial Layer (YSL) and Enveloping Layer (EVL), which occurs during early 
blastula stages (Kimmel and Law, 1985b,c). Compared to Xenopus, specification steps in 
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zebrafish occur rather later. Thus, the D-V axis of Xenopus embryos is determined by cortical 
rotation of the fertilised egg, before the first cell cleavage (Moon and Kimelman, 1998). Also, 
the different cell fate domains of the zebrafish late blastula embryo are broader and more 
overlapping, with comparably many cells that can still give rise to more than one cell type 
(Fig. 5-1). The cells located closer to the animal pole will give rise to the ectoderm. Cells on 
the ventral side of the ectoderm will contribute to the epidermis, whereas cells on the dorsal 
side form the neuroectoderm. The anterior-posterior axis in the neuroectoderm is established 
according to the animal-vegetal axis. Cells are directed towards forebrain fates when they are 
closer to the animal pole, and cells further marginal will become mid- and hindbrain. 
Precursors of the spinal cord and neural crest can be also found on the ventral half, but in 
more marginal zones than the epidermal precursors. The region close to the margin gives rise 
to the mesodermal derivates. Here, dorsal-most cells will form prechordal plate and 
notochord, which are later positioned in the midline of the body axis. Muscles of the head 
derives from dorsal-lateral positions, while somite-derived muscles of trunk and tail stems 
from more lateral and ventral positions, respectively. The heart comes from lateral zones, 
while blood and pronephros derive from the ventral mesoderm. The presumptive endoderm is 
intermingled with mesodermal progenitors in most marginal positions. The pharynx is the 
most dorsal endodermal derivate, stomach, intestine and liver are derived from more lateral 
and ventral zones (Kimmel and Law, 1985a; Kimmel and Law, 1985b; Kimmel and Law, 
1985c; Kimmel and Warga, 1986; Kimmel et al., 1990; Shih and Fraser, 1995; Warga and 
Nusslein-Volhard, 1999; Woo and Fraser, 1995; Woo et al., 1995). 
However, fate maps do not necessarily say much about the actual specification status of 
investigated cells. They just describe to which cell types they, or better to say their progeny, 
will develop when left at their normal position and in their normal environment. However, 
crucial cell fate-determining processes, driven by both intrinsic and extrinsic factors, might 
occur after the time point of cell labelling. To address the specification status at a particular 
developmental stage, other approaches have to be used. For Xenopus, specification maps have 
been generated by cutting out small tissue pieces and culturing them in minimal medium. 
Compared to the blastula fate map, the blastula specification map shows some crucial 
differences. For example, dorsal ectoderm, which according to the fate map will give rise to 
neural tissue, forms epidermis according to the specification map. 
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This indicates that at blastula stages, neural fates have NOT been determined in the dorsal 
ectoderm as yet, and that neural development requires some neural-inducing extrinsic factors 
that normally reach the dorsal ectoderm after the investigated blastula stage. If these signals 
Figure 5-1: Fate maps of zebrafish 
(Upper panel) Fate map at 50% epiboly. At the animal pole the ectoderm is forming, whereas at the margin 
mesodermal and endodermal precursors are found. Dorsal ectoderm gives rise to neural tissue, thereby the 
forebrain develops close to the animal pole and the hindbrain closer to the margin, resembling the A/P axis. 
Ventral ectoderm forms the epidermis. The dorsal mesoderm will form notochord and prechordal plate, more 
lateral and ventral mesoderm gives rise to trunk and tail somites and blood derivates. (adapted from Schier 
and Talbot, 2005) 
(Lower panel) schematic view at a shield stage embryo from animal. Indicated are the different fates of 
ectodermal cells; (red) telencephalon (including the olfactory placode), (black) diencephalon (excluding the 
retina), (green) retina; (orange) midbrain, (dark blue) hindbrain, (light blue) spinal cord, (purple) somite, 
(yellow) neural crest, ear placodes and epidermis. (adapted from Woo and Fraser 1995) 
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are absent, as in the tissue explants, cells specify according to their intrinsic program. On the 
other hand, for the same reasons, the specification revealed by such transplantation 
experiments does not necessarily correspond to the actual final fate, and does therefore not 
give any information as to whether the final fate of a cell has already been determined or not. 
To address this question, so-called cell commitment studies have to be carried out. In case of 
ectoderm explants, for instance, treatment with factors like the BMP inhibitor Noggin and/or 
FGFs would make them acquire neural, rather than epidermal fates, indicating that at the time 
point of explantation, ectodermal cells had not been committed to their intrinsically 
programmed, epidermal fate as yet. In zebrafish, similar explantation experiments have 
suggested that at the onset of gastrulation, forebrain fates in the anterior dorsal ectoderm have 
already been specified, because the tissue will express forebrain-specific markers like opl 
even after explantation and cultivation in minimal medium in vitro (Grinblat et al., 1998). 
However, again, this does not necessarily mean that at the onset of gastrulation, cells are 
already irreversibly committed to their forebrain fate. Indeed, beads of BMPs, which can 
block neural induction, prevented the maintenance of forebrain marker expression even when 
implanted into the anterior neuroectoderm after the onset of gastrulation (Grinblat et al., 
1998).  
Another way to test for cell commitment is via heterotopic transplantation of cells into an 
ectopic embryonic environment. Woo and Fraser addressed the question of hindbrain 
specification by whole tissue grafting experiments (Woo and Fraser, 1998). Prospective 
hindbrain tissue was microsurgically dissected and transplanted from dorsal into ventral 
regions. Transplanted presumptive hindbrain tissue from shield stage embryos (early gastrula) 
was still able to differentiate into epidermal cells of the tail and fins as well as somitic tail 
muscle, indicating at this developmental stage, hindbrain progenitors were not committed to 
their fate. In contrast, transplanted hindbrain tissue from mid gastrula embryos maintained its 
fate, leading to the formation of ectopic hindbrain structures and demonstrating that at this 
stage, the tissue was committed (Woo and Fraser, 1998). However, also in this case, 
conclusions about the irreversible determination of final cell fates have to be taken with 
caution, as cells were transplated as entire and intact tissues. This could lead to some kind of 
community effect, via which cells protect each other from inductive, cell fate-modifying 
signals coming from the ectopic environment (for a review on community effects, see Gurdon 
et al., 1993). To circumvent this problem, individual cells have to be transplanted with a 
polished glass capillary. Using this technique, Ho and Kimmel (1993) investigated the timing 
of mesoderm induction, showing that at 5 hpf (onset of gastrulation), marginal cells 
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transplanted into ectopic animal positions could still adopt ectodermal fates according to their 
new environment and were not committed to their mesodermal fate as yet, whereas they did 
become committed during the further course of gastrulation. Furthermore, transplanted 
presumptive mesodermal and endodermal cells directly ingressed from their ectopic 
superficial positions into deeper cell layers, where the endogenous mesoderm and endoderm 
are located, revealing an intrinsic “homing” effect (David and Rosa, 2001; Aoki et al., 2002).  
The differential timing of fore- versus hindbrain specification, although revealed via different 
and not fully conclusive techniques (Grinblat et al., 1998; Woo and Fraser, 1998; see above) 
is consistent with recently obtained data with heat-shock inducable, temporally controlled 
overexpression of the BMP inhibitor Chordin, demonstating that dorsoventral patterning of 
the animal ectoderm (from which the forebrain derives) occurs earlier than dorsoventral 
patterning of the more marginal ectoderm (from which the hindbrain is formed) (Tucker et al., 
2008). This points to differential timing of cell fate specification along the animal-vegetal 
(anterior-posterior axis), with vegetal/posterior cells becoming specified later, possibly due to 
a specification-delaying effect of FGFs from the marginal mesoderm. However, the timing of 
cell specification and commitment along the dorsoventral (D-V) axis of zebrafish embryos 
had not been investigated as yet.  
 
 
5.1.2. Aim of the project 
One of the main interests of the Hammerschmidt Lab is to unveil the different functions of 
BMPs during development. A D-V BMP signaling gradient is established during early 
embryonic development. This gradient is mainly responsible for D-V patterning, which means 
the establishment of differential cell fates along the D-V axis of the gastrulating embryo. 
Taking into account that BMPs also work as stem cell factors (see General Introduction), I 
hypothesized that similar to the proposed effect of FGFs along the animal-vegetal axis (see 
above), BMPs might regulate the timing of cell specification along the D-V axis, so that 
ventral cells that are exposed to high levels of BMPs are kept in a pluripotent and 
uncommitted state longer than cells in dorsal positions with low or absent BMP activity. Such 
a scenario would be consistent with results obtained for Drosophila embryos, in which ventral 
cells (low Dpp/BMP) transplanted into the dorsal side (high Dpp/BMP) maintained their 
ventral fate, whereas ventrally transplanted dorsal cells did not (Technau, 1987).  
To test whether such differential and possibly BMP-dependent timing of cell commitment 
also occurs in zebrafish embryos, I carried out heterotopic and – for technical reasons -  
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heterochronic cell transplantations of ventral versus dorsal ectodermal cells from early to mid 
gastrula embryos, followed by the analysis of cell fates several hours after the tranplantation, 
using whole mount in situ -hybridisations with cell type-specific probes. 
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5.2. Results 
5.2.1. Dorsal and ventral cells do not show significant commitment differences 
after heterotopic transplantations at shield stage 
To address the question of cell commitment along the D-V axis, I started with heterotopic cell 
transplantations at the shield stage (early gastrula). Thereby I compared the behaviour of 
dorsal ectodermal cells (presumptive neuroectoderm) after transplantation into the ventral 
ectoderm (will give rise to epidermis) (Fig. 5-2 A) with the behavior of transplanted ventral 
ectodermal cells on the ectopic dorsal side (Fig. 5-2 F). 
For transplantations, donor embryos were injected at one- to two-cell stages with a fluorescent 
cell marker (fluorescein or rhodamin dextran (1mg/ml)) to be able to trace the transplanted 
cells or their descendants. Cell transpantations were done as previously described (see 
Materials and Methods), and mosaic embryos were fixed at the 20-25 somite stage, a time 
point when the neural and epidermal tissue are specified and clearly distinguishable by 
specific marker gene expression.  
At shield stage, when the transplantations were performed, the dorsal side can be readily 
recognized by a local thickening, the shield, where the future dorsal mesoderm is localized 
(the General Introduction). Thus, pending on proper orientation of the embryos, one can carry 
out the transplantations in a spatially controlled manner. However, since according to the fate 
map (see Fig. 5-1), incorrect embryonic orientation by just a few degrees can mean that cells 
are transplanted from or into a region with a different fate, I carried out some of my 
transplantations with transgenic donors and hosts expressing GFP under the control of the 
goosecoid (gsc) promoter. gsc is expressed in the presumptive prechordal plate cells of the 
dorsal mesoderm, thereby marking the shield and the dorsal midline (Schulte-Merker et al., 
1994a). In my dorsal-to-ventral transplantations, I tried to hit animal positions on the opposite 
side, approximately 180° from the gsc expression domain (Fig. 5-2 B). As expected from the 
fate map (Fig. 5-1), these cells later usually ended up in the epidermis covering the the yolk 
sac, the ventral trunk, or the tail (Fig. 5-2 C; and data not shown). In the reverse, ventral-to-
dorsal transplantations, I transplanted cells into positions slightly animal and lateral (up to 
30°) of the gsc domain (Fig. 5-2 G), with cells later ending up in the telencephalon, 
diencephalon, the retinas of the eyes or, in some cases, in the midbrain (Fig. 5-2 H; and data 
not shown), consistent with the fate map (Woo and Fraser, 1995) (see also Fig. 5-1). I 
conclude that I was transplanting cells into the correct positions. 
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For the identification of neural cell fates in mosaic embryos at the 20-25 somite stage, I 
carried out fluorescent whole mount in situ-hybridisations for sox19a or otx2. The panneural 
marker sox19a is broadly expressed in the neuroectoderm from early gastrula stages onwards 
and the expression persists in neural tissues during further embryogenesis (Okuda et al., 2006; 
Vriz et al., 1996). otx2 is a more specific marker for fore- and midbain cells, which also starts 
to be expressed at early gastrula stages. For the identification of epidermal cells, I used an 
antibody against DeltaNp63, which stains the nuclei of basal keratinocytes, the most abundant 
cell type in the larval fish epidermis (Lee and Kimelman, 2002). Furthermore, transplanted 
cells were visualised via anti-Fluorescein immunostaining. Stainings were analysed by 
confocal microscopy with a Zeiss LSM 510/ 710, searched for transplanted cell, and scanning 
them in single optic planes for colocalisation with the selected fate markers.   
Of the cells transplanted form the dorsal ectoderm (sox19a-positive) into the ventral ectoderm 
(DeltaNp63-positive), 72% (n=119/ 166) displayed expression of DeltaNp63, the epidermal 
marker of their new environment (Fig. 5-2 D and Tab. 5-2). The remaining, DeltaNp63-
negative cells (n=47/ 166 cells) were not integrated into the epidermis, and displayed either 
weak sox19a expression (n=34/ 166 cells) (Fig. 5-2 E), or were sox19a-negative, thus lacking 
both ventral and dorsal marker gene expression (n=13/ 166 cells) (Fig. 5-2 D, arrow indicates 
a p63 negative cells).  
After the reverse transplantation of ventral cells into the dorsal ectoderm, 79% of transplanted 
cells (n=126/ 160 cells) displayed expression of sox19a or otx2, the neuroectodermal markers 
of their new environment (Fig. 5-2I). In the otx2 stained embryos some cells were observed 
that did not express otx2 (n=34/ 160 cells). These cells were located in or close to the brain, 
but outside the endogenous otx2 domain (Fig. 5-2 K). Thus, they might represent more 
posterior cell fates, which would have been positive in sox19a in situ-hybridisations. Clearly, 
none of these otx2-negative cells showed expression of DeltaN63 (Tab. 5-2). 
In sum, my results indicate that at the onset of gastrulation, ventral ectodermal cells are not 
committed to their epidermal fate as yet, but can adopt neural fates when placed into the 
neuroectoderm. This was according to my working hypothesis and the concept of BMP 
signaling blocking cell specification / commitment. However, in contrast to my working 
hypothesis, I obtained similar results for the reverse transplantations, indicating that the 
majority of dorsal ectodermal cells are also not committed to their neural fate as yet, but able 
to respond to BMP signaling and to switch on DeltaNp63 expression. On the other hand, at 
least some of the dorsal cells remained positive for neural markers in ectopic ventral 
positions, whereas no cell at all maintained epidermal marker gene expression in ectopic 
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dorsal positions, suggesting at least some subtle differences in the commitment status between 
dorsal and ventral cells. 
Also, I noticed that in my dorsal-to-ventral transplants, the absolute number of embryos 
carrying transplanted cells at the 20-25 somite stage was rather low., This raised the 
possibility that statistics might have been distorted by the death of possibly neurally specified 
cells in ectopic epidermal environments. To look closer into this possibility, I quantified the 
survival rate of the transplantated cells by comparing the number of successful transplanted 
embryos right after the transplantation (6 hpf) with the number of embryos with transplanted 
cells at 24 hpf (Tab. 5-1). For the heterotopic transplantations from dorsal ectoderm to ventral 
ectoderm, the survival rate was 43% (23 out of 54 embryos with labelled cells at 6 hpf still 
contained labelled cells at 24 hpf). As a control to show that this is not due to a general 
insuitablility of dorsal cells for transplantations, I performed homotopic transplantations from 
dorsal to dorsal, yielding a survival rate of 76% (22/29). Interestingly, in the reverse 
heterotopic transplantation of ventral ectodermal cells into the dorsal ectoderm, the survial 
rate was 95% (36/38) (Fig. 5-2 G, H), thus, significantly higher than for the dorsal-to-ventral 
transplants, while in the homotopic ventral-to-ventral controls, it was 90% (n=27/ 30 
embryos). 
It has been described that in cell culture systems, committed neural cells undergo apotosis 
when challenged with BMP (Gambaro et al., 2006). To test whether this is also true for the 
majority of my ventrally transplanted dorsal cells, I selected embryos that had contained 
labelled cells at the shield, but lacked labelled cells at the 20-25 somite stage, and performed 
TUNEL stainings for apoptotic cells. However, I could not detect striking differences in the 
pattern of TUNEL-positive cells between experimental and control embryos, suggesting that 
apoptosis of transplanted cells, if at all, must have occurred during earlier stages after the 
transplantation. To determine this time point, I decided to track some of the heterotopic 
transplanted cells via time-lapse recording, mounting mosaic embryos directly after the 
transplantation and monitoring labelled cells with a Zeiss Axioimmager microscope for 18 
hours. However, in 4/4 examined embryos, I could track transplanted cells and their 
movements until the end of the recording time (24 hpf) without noticing the loss of any of the 
cells. Since not all of the cells were nicely separated from each other, I cannot rule out that 
some of them might have died during the recording. But if so, I have missed it, and could not 
determine the proper time point for further apoptosis. Therefore, it remains unclear whether or 
whether not dorsal cells undergo apoptosis in an ecoptic ventral environment (but also see 
below).  
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Figure 5-2: Heterotopic transplantation with embryos at shield stage do not unveil a difference between 
ventral and dorsal cells 
Cells were transplanted from donor embryos injected with fluorescein or rhodamine dextran from the dorsal 
ectoderm to the ventral ectoderm of shield stage embryos as shown in the scheme (A) and the revesre,experiment 
(F); modified from Kimelman et al., 1990. 
(B, C) show a successfully transplanted host embryo, transplanted cells are marked with rhodamine dextran (red 
arrow), (B) shows the dorsal cells on the ventral side of the embryo one hour after transplantation, the expression 
of GFP in gsc::GFP transgenic embryos (asterisk) marks the dorsal side; (C) shows the same embryos at the 25-
somite stage, with transplanted red cells now in the epidermis covering the yolk sac. (G, H) show the reverse 
experiment, wth vetral cells on the dorsal side (G) hat eded up n the brain (H). 
(D, E and I, K) show whole-mount fluorescent in situ-hydrisation against sox19a (red), followed by 
immunhistochemistry using antibodies against fluorescein dextran (green) and DeltaNp63 (blue); embryos were 
analysed by confocal microscopy. (D) shows transplanted cells expressing DeltaNp63; (E) shows dorsal cells 
weakly stained for sox19a. (I) show ventral cells integrated into the sox19a domain; (K) shows ventral cells in an 
otx2 staining with only partial coexpression (arrow). 
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In summary, at the onset of gastrulation (shield stage), dorsal as well as ventral ectodermal 
cells seem to be able to transfate upon transplantation into an ectopic environment, and are 
thus not committed to their normal fates, although for the dorsal ectodermal cells, at least a 
small fraction (approximately 20%) might have been committed to their neural fate, indicated 
by persistent sox19a expression. Also, I cannot rule out that the percentage of neurally 
committed dorsal cells was even higher, but that most of them had undergone apoptosis at an 
unknown time point between the transplantation and the investigated late somitogenesis stage.  
 
 
Transplantation embryos containing 
labelled cells shortly 
after transplantation 
embryos containing 
labelled cells at 24 hpf 
Heterotopic   
Dorsal to Ventral   
 at shield stage 54 23 
 at 60%epiboly 31 22 
 
  
Ventral to Dorsal   
at shield stage 38 36 
at 60% epiboly 25 14 
 
  
Homotopic   
Dorsal to Dorsal 30 27 
Ventral to Ventral 29 22 
 
  
Heterochronic    
Dorsal to alk8CA   
at 60% epiboly 34 34 
at 80% epiboly 10 10 
 
  
Ventral to tBRIa   
at 60% epiboly 28 18 
at 80%epiboly 9 6 
 
Table 5-1: Survival rate of transplanted cells; embryos with successfully transplanted cells 
were raised until next morning and then examined for existence of labelled (transplanted) 
cells; absolute numbers of counted embryos. 
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5.2.2. Dorsal and ventral cells do not show significant commitment differences 
after heterotopic transplantations at the 60-70% epiboly stage 
To investigate whether the subtle differences in the commitment of dorsal versus ventral cells 
described above become more obvious during the further course of gastrulation, I carried out 
similar heterotopic dorsal-to-ventral and ventral-to-dorsal transplantation experiments at a 
slightly later developmental stage (60-70% epiboly, 30-90 minutes after the shield stage 
analysed above).  
Transplantations at these later stages are technically more difficult, since the mesendoderm 
becomes internalized at the margin of the embryo and starts to progressively move underneath 
the ectoderm. Thus, to avoid mixed transplants of ectodermal and mesodermal cells, one has 
to stay in animal regions and/or outer cell layers of the embryo. Furthermore, lateral cells 
move towards the dorsal midline (convergence and extension), leading to a progressive 
thinnening of the ventral side (Solnica-Krezel, 2006), which got accordingly more difficult to 
penetrate with the transplantation capillary. Therefore, the absolute number of investigated 
mosaic embryos after transplantation at the 60-70% epiboly stage was lower than the number 
at shield stage. However, I also carried out control transplantations with gsc::GFP transgenic 
donors and hosts, as described above, revealing that cells with proper fate were transplanted 
into, and ended up in, proper positions (Fig. 5-3 B,C, G, H). In addition, I determined survival 
rates of transplanted cells. For dorsal-to-ventral transplantations, it was 71% (22/31), higher 
than the rate obtained at shield stage (43%), and for ventral-to-dorsal transplantations, it was 
56% (14/25), lower than at shield stage (95%). Finally, I selected a few of the mosaic 
embryos after dorsal-to-ventral transplantations for time-lapse analysis, as described above. 
Again, in 3/3 recordings, I could follow the transplanted cells over night without observing 
any loss of cells.  
Analysis of marker gene expression at the 20-25 somite stage revealed that 62% of cells (n= 
81/130) transplanted from the dorsal into the ventral ectoderm expressed DeltaNp63, 
indicating that these cells had obtained the epidermal fate according to their new environment. 
The other part of transplanted cells (n= 49/ 130 cells) either diplayed weak expression of the 
neural marker sox19a or lacked both DeltaNp63 and sox19a expression (Fig. 5-3 D, E), very 
similar to the behavior of cells upon transplantation at the shield stage. 
After transplantation of ventral ectodermal cells into the dorsal ectoderm, only 36% (n= 22/ 
60) of the cells expressed the neural marker, whereas 53% (n= 32/ 60 cells) lacked sox19a or 
otx2 expression, although they were located close to neural tissues (Fig. 5-3 I). Strikingly, a 
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minority of cells (n= 6/ 60 cells) were found in the epidermis of the head region expressing 
DeltaNp63 (Fig. 5-3 K). This could be interpreted as a sign of commitment of cells to an 
epidermal fate. However, as pointed out above, transplantations had to be carried out in rather 
animal positions to avoid mixing with mesoendodermal fates. In regions close to the animal 
pole, forebrain cells are located in close proximity to placodal and head epidermal cells (see 
Fig. 5-1). Thus, the obtained DeltaNp63-positive cells after ventral-to-dorsal transplantations 
could result from slightly mispositioned animal transplants.  
In conclusion, the heterotopic transplantation experiments at 60-70% epiboly stage (early to 
mid gastrulation) did not reveal any clearer differences in the commitment of dorsal versus 
ventral cells than the studies carried out at the onset of gastrulation. If at all, results were more 
inconsistent, which could be due to the aforementioned larger difficulties of the applied 
transplatation techniques at these later stages. Therefore, in the following experiments, I 
applied a different technique, transplanting cells from 60-80% epiboly stage host embryos 








Figure 5-3: Heterotopic transplantation with embryos of the 60% to 70% epiboly do not unveil 
striking differences between ventral and dorsal cells 
Panels (B to E) show mosaic embryos after transplantation of dorsal cells from 60-70% epiboly stage 
embryos donors into the ventral ectoderm of hosts, as illustrated in (A); panels (F to K) show the 
corresponding reverse ventral-to-dorsal transplantations. 
(B,C) and (H,I) show two successfully transplanted host embryos directly after transplantation (B,H) and at 
the 20-25 somite stage (C,I); transplanted cells are marked with rhodamine dextran (red arrow), the dorsal 
side in B and H is marked by the expression of GFP in gsc::GFP transgenic host embryos (asteriks). (B) 
shows transplanted cells on the ventral side of the embryo, which later are located in the skin covering the 
yolk cell (C). (G) shows transplanted cells on the dorsal side, which  ended up within brain tissues (H; green 
shows again gcs::GFP transgene expression. 
(D, E,  and K, L) show whole-mount fluorescent in situ-hydrisation against sox19a (red), followed by 
immunhistochemistry using antibodies against fluorescein dextran (green) and DeltaNp63 (blue), as noted of 
the dorsal to ventral (D-F) and ventral to dorsal (K, L) transplantation; (D) shows dorsal cells expressing  
p63, (E) shows dorsal cells  close to the sox19a expression domain. (I) shows ventral cells close to and in 
the otx2 domain (arrow), and (K) shows a single ventral cell positive for DeltaNp63.   
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5.2.3. Heterochronic transplantations of dorsal ectodermal cells from 60% 
epiboly stage donors into ventralised blastula stage embryos 
Because of the low efficiency of the late heterotopic transplantations, I started heterochronic 
transplantations that are technically easier to handle. I transplanted cells of donor embryos at 
60% epiboly (7 hpf) into the animal pole of sphere stage (4 hpf) embryos. Epiboly has not 
started yet in embyos at sphere stage, and the deep cells form a compact, but rather loose 
tissue; for this reason it is easy to integrate ectopic cells. Indeed, survival rates of cells 
transplanted this way was 100% (n=34/ 34 embryos) (Tab. 5-1), and cells ended up properly 
integrated into host tissue. However, at this pregastrula stage, the dorsoventral axis is not 
morphologically visible as yet, which makes it impossible to transplant cells in a spatially 
controlled fashion into dorsal or ventral regions of the embryo. To circumvent this problem, 
host embryos were injected at the one to two-cell stage with mRNA encoding either 
constitutively active or dominant negative BMP receptors (Bauer et al., 2001; Graff et al., 
1994). This leads to a broad hyper-ventralisation or hyper-dorsalisation of the entire embryo, 
respectively.  
When examined at 24 hpf by morphological criteria, embryos injected with caAlk8 mRNA 
(Bauer et al., 2001) showed ventralisation of the V3 classification. This means that from late 
blastula stages onwards most, although not all, of the embryonic cells are ventrally specified. 
Transplanted dorsal cells will therefore be surrounded by ventral cell types and challenged by 
BMP signals emanating from them. . 
After heterochronic transplantation of dorsal ectodermal cells from 60% epiboly donors into 
ventralised sphere stage hosts, mosaic embryos were raised until 24 hpf, when uninjected 
control siblings had reached the 20-25 somite stage, and were analysed via confocal 
microscopy after whole mount in situ-hybridisations and immunostainings, as described 
above for the heterotopic transplantations.  
56% (161/287) of the transplanted dorsal cells were negative for both the neural marker 
sox19a and the epidermal marker DeltaNp63 (Fig. 5-4 C, D), while 41% (119/287) expressed 
the neural marker sox19a. In the ventralised host embryo the endogenous expression domain 
of sox19a was strongly reduced due to the reduction of the neuroectoderm. However, a small 
sox19a domain remained. Nearly all transplanted cells that expressed sox19a were found 
within this domain, and might therefore not have been properly challenged by environmental 
BMP signals (Fig. 5-4 E, F). Only in two embryos I found clusters of transplanted cells that 
were completely surrounded by host epidermal cells. These clusters contained sox19a-
positive cells in the middle of the clusters, whereas cells at the periphery lacked both sox19a 
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and DeltaNp63 expression (Fig. 5-4 G). In very few cases (7/ 287 cells), I also found 
DeltaNp63-positive transplanted cells (Tab. 5-2). 
In conclusion, these results indicate that dorsal ectodermal cells directly exposed to BMPs 
from host cells could not maintain their neural fate, whereas cells in a distance of two- to 
three cell diameters could. Strikingly, however, almost all transplanted cells failed to acquire 
an epidermal fate, indicating that they had lost their trans-fating capacity. 
Next, I wanted to find out at which time point the dorsal cells loose their initial fate. To 
address this, I fixed and analysed embryos at different time points after the transplantation. 
One hour after transplantation, when the host embryos had reached 50% epiboly, only 25% 
(18/71) of transplanted cells were sox19a positive. Six hours after transplantation, when the 
host embryos were around tailbud stage, 44% (80/180) of the transplanted cells expressed 
sox19a. They were usually organised in clusters surrounded by or directly attached to the 
remaining endogenous sox19a expression domain of the host, whereas again most of the 
transplanted cells (56%) lacked sox19a transcripts (Fig. 5-4 E). This is a similar percentage as 
obtained at 20-25 somites or later (44% sox19a-positive at tailbud stage, 41% at 20-25 somite 
stage or later). It remains unclear why the fraction of sox19a positive cells was lower directly 
after the transplantation (25%). Higher proliferation rates of neural versus non-neural 
ectodermal cells could be one explantation. 
I conclude that most dorsal ectoderm cells of 60% epiboly stage embryos, when challenged in 
a ventral, BMP-expressing environment, loose their initial neural marker expression within 
one hour after transplantation. Unlike in the heterotopic transplantations, however, they do 
not become epidermis, but remain in the embryo in an unspecified or thus far unresolved 
state. My results also show that maintenance of neural fate requires some kind of community 
effect (see Introduction; 5.1.1), and shielding/insulating of transplated cells from direct 
contact with the BMP-expressing environment in large clones (Fig. 5-4 G).  
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5.2.4. 
Heterochronic transplantations of ventral ectodermal cells from 60% epiboly 
stage donors into dorsalised blastula stage embryos  
Next, I carried out the reverse experiment to test the behaviour of ventral cells in a dorsal 
environment, transplanting ventral ectodermal cells from of 60% epiboly stage embryos into 
the animal pole of dorsalised sphere stage embryos that had been injected at the 1 to 2-cell 
stage with mRNA encoding dominant negative, truncated version of the Xenopus BMP 
receptor 1a (Graff et al., 1994). At 18 hpf, injected host embryos displayed strong 
dorsalisation of C4/C5 strength, with many of them lysing during mid somitogenesis. 
stage (C,D,F,G), after whole mount fluorescent in situ-hybridisation against sox19a (red), and 
immunostainings of fluorescein dextran, the used lineage tracer (green), and DeltaNp63 (blue). For (E, F, 
G) embryos were not stained for DeltaNp63. 
(C, D) dorsal cells were surrounded by DeltaNp63 positive cells, but itself they were negative for 
DeltaNp63 as well as sox19a. (E, F) dorsal cells found in the sox19a domain partially coexpressed the 
neural marker. (G) dorsal cells found in an ectopic position, only the cells in the middle of the cluster are 
sox19a positive. 
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Therefore, mosaic embryos were raised at low temperature and fixed when controls had 
reached the 15-somite stage.  
Whole mount in situ-hybridisation and immunostaining revealed that within the host tissue, 
the neural markers  sox19a or otx2 were strongly upregulated, displaying a radialised 
expression domain throughout the entire embryos, whereas DeltaNp63 was absent. This 
indicates that endogenous epidermal tissue was completely lost.  
Similarly, all of the heterochronically transplanted ventral cells (228/228) lacked DeltaNp63, 
indicating that they were unable to maintain their initial fate. Of those, 61% (138/228) showed 
expression of one of the neural markers tested, indicating that they had adopted fates 
according to their new environment (sox19a: 57%, n=86/151; otx2: 68%, n=52/77) (Fig. 5-5 
C -E). However, the remaining 39% (90/228) of transplanted cells of ventral ectodermal 
origin did not express any of the tested epidermal and neural markers (sox19a 43%, n=65/ 151 
cells; for otx2 32%, n=25/ 77 cells), leaving their fate unsolved (Fig. 5-5 F). 
The survival rate of heterochronically transplanted ventral cells was around 64% (n=18/ 28 
embryos). I assume this might be due to technical difficulties, because the ventral ectodermal 
side becomes progressively thinner during gastrulation, which means that it becomes more 
difficult to get intact cells out of the embryo.  
In sum, my results indicate that ventral cells are not committed to epidermal fate, since I 
never detected ectopic expression of p63 with the counterstain. Also, the majority of cells can 
adopt the neural fate of the new environment. Thus, they are still multipotent. This is in 
striking difference to the results obtained for dorsal cells described above (5.2.2). 
Nevertheless, also a significant number of transplanted ventral cells lacked expression of both 
epidermal and neural markers. Future experiments have to show whether they are unspecified, 
or whether they might have acquired a different fate (see Discussion).  
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Figure 5-5: Heterochronic transplantation of ventral  cells from 60% epiboly stage embryos into 
dorsalised hosts  
(A) illustrates the transplantation procedure: ventral ectodermal cells from labeled donor of the 60% to 
70% epiboly stage are transplanted into late blastula (sphere) stage embryo that has been dorsalised by 
injection of constitutive dominant negative, truncated BMP receptor RNA. (B) shows a successfully 
transplanted dorsalised host embryo at the 15-somite stage; transplanted cells are marked with 
fluorescein dextran and located in brain (green arrows).  
(C to F) show confocal microscopy images of mosaic embryos at the 15 somite stage, after  whole 
mount fluorescent in situ-hybridisation against sox19a (red), and immunostainings of fluorescein 
dextran, the used lineage tracer (green), and DeltaNp63 (blue). 
(C, D, E) show ventral cells integrated into the sox19a domain and they did adopt the neural fate. (F) 
shows ventral cells integraed n the sox19a domain, but did not stain for the marker. 
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5.2.4 Heterochronic transplantations of dorsal and ventral ectodermal cells of 
80% epiboly stage embryos 
The results described above show that at the 60% epiboly stage, dorsal ectodermal cells are 
less plastic than ventral cells. However, both cell types are not committed to their intrinsic 
fate as yet, indicated by the loss of initial marker gene expression when integrated into ectopic 
tissues. This suggests that cell fate commitment must occur later. Therefore, I next carried out 
heterochronic transplantations as described above with dorsal or ventral ectodermal cells from  
embryos of the 80% epiboly stage (mid gastrulation; 8.5 hpf).  
However, also at this later stage, both dorsal and ventral cells appeared uncommitted. 93% 
(37/40) of the dorsal cells transplanted into ventralised hosts neither expressed sox19a nor 
DeltaNp63 (Fig. 5-6 A, B), while only 7% (3/40) of the transplanted cells maintained the 
expression of sox19a. This indicates that as at early gastrula stages, neuroectodermal cells of 
mid gastrula embryos are still not committed to their neural fate, while they have lost their 
capacity to become epidermal. Of the ventral ectodermal cells transplanted into dorsalised 
embryos, 86% (31/36) were negative for both the epidermal and neural markers (Fig. 5-6 C, 
D), while 6% (2/36) showed expression of sox19a, the marker of the new environment. This 
indicated that in contrast to dorsal cells, at least some of the ventral cells could transfate and 
specify according to their new environment. However, compared to the 60% epiboly stage, 
the fraction of such multipotent cells has dropped from 61% to 6%, pointing to some 
advances in cell fate specification. Along the same lines, it remains puzzling, however, why 
the fraction of uncommitted neuroectodermal cells at the 80% epiboly stage is higher (93%) 
than at the than at 60% epiboly stage (56%). Differences in the sizes of transplanted cell 
clusters can be most likely ruled out as a possible explanation. As shown above (Fig. 5-4 G), 
such clusters have to reach a certain size to maintenance of sox19a expression in the centre of 
the clone. However, clusters of this size were also obtained upon transplanation of dorsal cells 
at the 80% epiboly stage, while cells lost sox19a expression even in the middle of the cluster 
(Fig. 5-6 A). Also, survival rates of transplanted cells were reasonable (10/10 embryos for 
transplantation of dorsal cells into ventralised hosts; 6/9 embryos for transplantation of ventral 
cells into dorsalised hosts; Tab 5-1). Nevertheless, I have to admit that the transplantation of 
cells out of 80% epiboly embryos was a technical challenge, due the advanced gastrulation, so 
that only a few transplantions with comparably low numbers of transplanted cells were 








Figure 5-6: Heterochronic transplantations of dorsal (A,B) or ventral (C,D) ectodermal cells from 
80% epiboly stage embryos into ventralised (A,B) or dorsalised (C,D) sphere stage hosts, 
respectively  
All panels show confocal microscopy images of mosaic embryos at the 15-25 somite stage, after whole-
mount fluorescent in situ-hydrisation against sox19a (red), followed by immunhistochemistry using 
antibodies against fluorescein dextran (green) and DeltaNp63 (blue) as noted. 
(A, B) dorsal cells were surrounded by DeltaNp63 positive cells, but itself they were negative for 
DeltaNp63 as well as sox19a. (C, D) show ventral cells close to the sox19a domain, but did not stain 
either for the neural marker nor the epidermal marker. 
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for both markers 
Heterotopic     
Dorsal to Ventral 
    
 at shield stage 166 34 119 13 
 at 60%epiboly 130 19 81 30 
     
Ventral to Dorsal 
    
at shield stage 160 126 0 34  
at 60% epiboly 60 22 6 32 
     
Heterochronic      
Dorsal to alk8CA 
    
at 60% epiboly 287 119 7 128 
at 80% epiboly 40 3 0 37 
     
Ventral to tBRIa 
    
at 60% epiboly 228 138 0 90 
at 80%epiboly 36 2 3 31 
 
Table 5-2: Overview of all transplantations analysed by whole mount fluorescent stainings 
with sox19a/ otx2 and DeltaNp63 and further analysed by confocal microscopy. Shown are 
the absolute numbers of counted cells. 
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5.3. Discussion 
5.3.1. After heterotopic transplantations, both dorsal and ventral cells do not 
maintain their initial fate and can integrate into the new tissues 
The BMP gradient with its from ventral to dorsal progressively dropping BMP concentration 
most likely fulfils multiple functions during early embryonic patterning and morphogenesis. 
First, BMPs are supposed to act as a morphogen, inducing differential cell fates along the 
dorsoventral axis in a dose-dependent fashion. According to this concept, high BMP levels in 
the ventral ectoderm induce epidermal fates, intermediate levels in the lateral ectoderm levels 
cause neural crest and preplacodal specification, while lowest levels in the dorsal ectoderm 
lead to neural development (see for review; Mullins and Hammerschmidt, 2002). A second 
function is concerned with guiding the migration of cells from ventrolateral into dorsal 
regions (von der Hardt et al., 2007). Here, I addressed a possible third function, which is 
related to the known role of BMPs in stem cell biology, keeping cells in an undifferentiated 
and pluripotent status under certain conditions (Hogan, 1996; Varga and Wrana, 2005) (see 
general introduction). My working hypothesis was that the high levels of BMPs on the ventral 
side keep cells in a multipotent and undifferentiated status, whereas on the dorsal side, where 
BMP signaling is weak or absent, cells start to differentiate and become committed to their 
final fate. Interestingly, the dorsoventral BMP gradient is highly dynamic over time, and the 
BMP expression domain becomes more and more restricted to ventral-most regions of the 
gastrulating embryo, suggesting that cells might only be released from the BMP-mediated 
specification block once BMP levels have dropped below a certain threshold. To study 
differential timing of cell specification along the dorsoventral axis of zebrafish embryos, I 
carried out cell commitment studies, using heterotopic transplantations of ventral ectodermal 
cells (normally given rise to epidermis) into the dorsal ectoderm (normally giving rise to 
neural tissue), and vice versa. Similar heterotopic transplanations have been previously 
performed for the Drosophila embryo, which like vertebrate embryos is patterned along its 
dorsoventral axis under the control of the BMP-like signal Decapentaplegic (Dpp) and its 
Chordin-like inhibitor Short gastrulation (Sog). However, in line with the concept of axis 
inversion during bilaterian evolution (Arendt and Nübler-Jung, 1994; De Robertis and Sasai, 
1996), Dpp is most strongly expressed on the dorsal side of Drosophila embryos, whereas 
Sog is strongest in ventrolateral regions, where the neuroectoderm is formed. 
Correspondingly, and consistent with my working hypothesis, ventrolateral cells of the 
Drosophila embryo displayed a higher degree of commitment than cells in more dorsal 
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positions (Technau, 1987; Udolph et al., 1995). However, my own results obtained for 
zebrafish embryos were less clear. According to my working hypothesis, I would have 
expected that after transplantation into the ventral ectoderm, dorsal ectodermal cells specify 
according to their original positions, forming ectopic neuroectodermal domains within the 
epidermis. In contrast, ventral cells transplanted into the dorsal domain should be 
uncommitted and more plastic, and should acquire neural fates according to the instructions of 
their new environment, rather than becoming epidermal, the fate according to their original 
position. 
I carried out heterotopic transplantations at two subsequent developmental stages, at shield 
stage, an early gastrula stage, when the dorsoventral axis becomes morphologically visible, 
and approximately 1 hour later, at the 60% epiboly stage. For both time points, I obtained 
rather similar results: the majority of dorsal ectodermal cells lost expression of the neural 
markers sox19a and otx2 (both of which are already expressed in the neuroectoderm at shield 
stage), integrated into the epidermis and started to express DeltaNp63 (72% after 
transplantation at shield stage; 62% after transplantation at 60-70% epiboly stage). DeltaNp63 
is a direct transcriptional target gene of BMP signaling and one of the key factors towards 
epidermal commitment (Bakkers et al., 2002; Medawar et al., 2008). This indicates that at 
early gastrula stages, dorsal ectodermal cells are not committed to their neural fate as yet, but 
are still able to receive and respond to BMP signals and to acquire epidermal fates (but see 
below). In reverse, the same is true for ventral cells, which after transplantation into the dorsal 
ectoderm started to express neural marker genes (79% after transplantation at shield stage; 
39% after transplantation at 60-70% epiboly stage). There was one subtle difference in the 
behavior of dorsal and ventral cells: while at least some of the transplanted dorsal cells 
maintained neural marker gene expression in the ectopic ventral environment (20% after 
transplantation at shield stage; 15% after transplantation at 60-70% epiboly stage), not a 
single ventral cell displayed persistent DeltaNp63 expression after transplantation into the 
dorsal ectoderm. This suggests that dorsal cells might have reached a more advanced, 
although not fully committed status than ventral cells. 
Nevertheless, the differences between dorsal and ventral cells are less striking that I would 
have expected according to my working hypothesis. How do my findings correlate to previous 
data obtained for the specification status within the zebrafish neuroectoderm? Presumptive 
forebrain tissue had been shown to display persistent expression of the anterior neural marker 
genes opl and otx2 even when explanted at the shield stage (Grinblat et al., 1998; Sagerstrom 
et al., 1996). This, however, does not mean that cells were committed to the neural fate, since 
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the explants were cultured in saline, meaning that cells were not really challenged by extrinsic 
factors that could induce trans-fating. And indeed, when the same explants were treated with 
BMPs, neural marker gene expression was lost (Sagerstrom et al., 2005). Consistently, in vivo 
expression of opl within its endogeneous presumptive forebrain domain was lost when BMP-
loaded beads were implanted into the dorsal side of embryos even after the shield stage 
(Grinblat et al., 1998). This is in line with the data obtained in my transplantation 
experiments, indicating that at early gastrula stages, dorsal ectodermal cells can still respond 
to BMPs and give up neural specificity. In addition to the exposure to neural-blocking BMPs, 
a second reason for the loss of neural identity could be the loss of neural-inducing or –
maintaining factors in the new environment. Thus, in contrast to data obtained for animal caps 
from Xenopus embryos, it has been shown that the expression of neural genes in 
neuroectodermal zebrafish explants is lost when the tissue is dissociated into a single cells 
suspension (Sagerstrom et al., 2005). This could be due to diluting out autocrine pro-neural 
factors when dissociating the tissue. Likewise, dorsal ectodermal cells become at least 
transiently dissociated when transferred in a narrow capillary into the new tissue.  
In addition to losing the neural fate, transplanted dorsal cells also seem to acquire epidermal 
fates. This is at least suggested by the integration of transplanted cells into the epidermis, as 
observed in multiple mosaic embryos, and by the initiation of DeltaNp63 expression. 
DeltaNp63 is known to be required for basal keratinocyte proliferation in zebrafish embryos 
(Lee and Kimelman, 2002), and for BMP-induced commitment of embryonic stem cells to an 
epidermal fate (Medawar et al., 2008; Aberdam et al., 2007). However, although co-expressed 
with keratin genes in differentiated keratinocytes, its expression is initiated much before the 
onset of keratin expression, in zebrafish during earliest gastrula stages (Bakkers et al., 2002), 
when ventral ectodermal cells are not committed to their epidermal fate as yet. Therefore, 
DeltaNp63 cannot necessarily be regarded as a bona fide marker of differentiated 
keratinocytes. For this purpose, it would have been necessary to carry out in situ-
hybridizations for keratin genes. Nevertheless, my data show that most likely induced by 
BMP signaling (Bakkers et al., 2002), dorsal cells not only lose neural marker gene 
expression, but also initiate the expression of genes that are exclusively expressed in 
epidermal cells and their precursors.  
Interestingly, such trans-fating from neural to epidermal was not observed when dorsal cells 
were heterochronically transplanted into hyper-ventralised embryos, although also in this 
case, cells lost neural marker gene expression (see also below). Furthermore, according to a 
previous report, stable neural specification can be obtained when presumptive hindbrain tissue 
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is microsurgically transplanted into ventral regions of 80% epiboly stage embryos (Woo and 
Fraser, 1998). Sizes of transplanted cell clusters and community effects might account for 
these differences, as will be discussed in more detail below.  
But what is the exact status of transplanted cells which at mid segmentation stages lacked 
both neural and epidermal marker gene expression. They were obtained, although with 
slightly different frequencies, upon transplantation of dorsal cells into the ventral ectoderm, 
and transplantation of ventral cells into the dorsal ectoderm, and upon heterotopic and 
heterochronic transplantations. Since cells were transplanted into the animal / ectodermal half 
of hosts, it is very unlikely they that might have acquired mesodermal fates. They could have 
returned to naive, completely unspecified embryonic cells, comparable to Oct4-positive 
embryonic stem cells of the mouse, which can be obtained by BMP treatment of ES cells that 
would otherwise form neurons (Tropepe et al., 2001). Alternatively, they might have acquired 
an intermediate ectodermal fate. Ventral-most cell types are known to require sustained BMP 
signaling beyond early gastrula stages (Pyati et al., 2005). Thus, a ventral cells that is 
transplanted dorsally during early gastrula stages might have already received too much BMP 
signaling to acquire a neural fate (since BMPs are switched off in this domain before the onset 
of gastrulation), but not enough to acquire an epidermal cell (since it misses BMP signaling 
after being moved out of the tissue and onto the dorsal side). Accordingly, the would have 
received intermediate levels of BMP signaling, which according to the fate map should make 
them become  preplacodal or neural crest derivatives (Barembaum and Bronner-Fraser, 2005; 
Huang and Saint-Jeannet, 2004; Nguyen et al., 1998). Likewise, dorsal cells transplanted to 
the ventral side would be exposed to additional BMP signaling after their transplantation to 
the ventral side, preventing them from becoming or remaining neural. On the other hand, they 
would not acquire enough BMP signaling for epidermal specification, since they missed BMP 
signaling before their transplantation, when they were still on the BMP-negative dorsal side, 
again resulting in intermediate fates. Future experiments with placodal and neural crest 
markers have to test this notion. If correct, the data would be in line with a morphogenetic 
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5.3.2. After heterochronic transplantations, both dorsal and ventral cells show an 
increased tendency to lack the neural as well as the epidermal marker  
Because of technical reasons I decided to carry out heterochronic transplantations at 60% 
epiboly and, around two hours later, at 80% epiboly into late blastula (sphere) stage embryos. 
At late blastula stage the D-V axis is morphological not visible, yet. Therefore, I transplanted 
the dorsal cells into a hyper-ventralised and the ventral cells into a hyper-dorsalised host 
embryo to challenge them.  
I obtained higher ratios of sox19a positive cells in the heterochronic transplantation of 60% 
epiboly donors than in the corresponding heterotopic approach (41% after heterochronic 
transplantation from dorsal to ventral compared to 15% in the heterotopic approach; 61% 
after hetrochronic transplantation from ventral to dorsal compared to 37% in the heterotopic 
transplantation). These results are in line with my working hypothesis that dorsal cells are 
committed at an earlier timepoint and keep their initial marker expression (neural), whereas 
the ventral cells are more plastic and can adopt the new fate (neural). But these results are still 
not as striking as I expected, because many cells stayed in an unspecified state, as I already 
mentioned. 
Nearly all dorsal cells, that were positive for the neuroectodermal marker, were found in or 
close to the remaining natural sox19a domain of the ventralised host embryo. Therefore one 
cannot conclude that these cells maintained the neural fate on their own. However, this 
remaining domain is rather small in a hyper-ventralised embryo. But 41% of the cells ended 
up in this neuroectodermal region and this is a relative high ratio. Therefore I cannot rule out 
a directed migration of the heterochronically transplanted cells. Such an intrinsic “homing” 
effect has been shown for mesodermal and endodermal precursors. Transplanted marginal 
cells directly migrate from their ectopic positions towards their endogenous domain (David 
and Rosa, 2001; Aoki et al., 2002). One would have to perform timelapse analysis of the 
heterochronically transplanted cells to see if the cells directly migrate towards the 
neuroectodermal domain.   
Another result of the heterochronically transplanated dorsal cells is even more puzzling. The 
majority of dorsal cells in ectopic positions were neither positive for sox19a nor for 
DeltaNp63, even when they were surrounded by DeltaNp63 postive cells. The lack of the 
epidermal maker is contradicting my own results that I obtained after the heterotopic 
transplantation (2% DeltaNp63 positive cells and 56% marker-negative cells after the 
heterochronic transplantation; in comparison 62% of DeltaNp63 positive cells, 23% marker-
negative cells after the heterotopic transplantation). Why do the dorsal cells after the 
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heterotopic transplantation respond to BMP signaling and express DeltaNp63; and after 
heterochronic transplantation not? In both cases, they are challenged with high levels of BMP 
signaling, the cells receive even a higher level of BMP signaling after the heterochronic 
transplantation into a hyper-ventralised embryo. So, if the level BMP signaling would be the 
sole trigger for the cell fate decision, I would have expected that the ratio of DeltaNp63 
positive cells after the heterochronic transplantation is similar or even higher than the ratio 
after the heterotopic transplantation. Other effects beside a morphogenetic role of BMP seem 
to be important for cell fate specification.  
Community effects might account for the differences between the two approaches. After the 
heterotopic transplantation the cells are directly intermingled with an epithelium of cells, 
while in the heterochronic approach the cells are inserted between loosely associated cells. 
Could it be, that the close contact of heterotopically transplanted cells to epidermal precursors 
promotes the epidermal specification? It has been shown in explant studies of Xenopus, that 
the specification of the epidermis requires cell contact or close cell proximity (Jones and 
Woodland, 1986). It is speculative whether direct cell-cell contacts are required for epidemal 
specification or this is due to a community effect (Gurdon et al., 1993). To test the effect of 
cell-cell contact one would need to repeat the experiment with cells lacking the ability to form 
cell contacts, but it will be difficult to prove this idea in in vivo experiments like cell 
transplantations.  
However, the results of explantations differ between Xenopus and zebrafish. In zebrafish, 
undissociated explants initiate and maintain the expression of neural markers, but it is lost 
after dissociation of the cells or upon challenge with BMPs (Grinblat et al., 1998; Sagerstrom 
et al., 1996, 2005). So far, no report describes the exact fate of the dissociated cells in 
zebrafish. So, it is speculative whether these cells stay undifferentiated or become epidermis. 
But on the other side, and in contrast to the data from Xenopus, neural precursors seem to 
require close proximity to each other to maintain neural commitment in zebrafish (Sagerstrom 
et al., 2005). A community effect of neuroectodermal cells will be a possible explanation of 
the behaviour of heterochronically transplanted dorsal cells, as I will discuss in more detail 
below. 
I found some populations of dorsal cells with sox19a positive cells in the center of the cluster, 
but the cells at the margin of the population were unspecified. The formation of cellular 
clusters becomes evident by the analysis of the stainings, but I did not clarify whether it is an 
active migration of transplanted cells towards their siblings or this formation is due to the 
transient dissociation of the cells when they were transferred in a narrow capillary into the 
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new tissue. However, a group of dorsal cells can form its own community (population/ 
cellular cluster) in the ventralised blastula stage embryo. The transplanted cells are in direct 
contact to each other and protect themselves from signals of the ectopic environment (BMPs) 
via anatgonistic factors sectered by themselves, e.g. Fibroblast Growth Factors (FGFs). FGFs 
are antagonising BMP-signaling during early gastrulation and are involved in patterning of 
the neuroecoderm along the A-P axis (Furthauer et al., 1997; Pera et al., 2003; Rentzsch et al., 
2004). All cells within such a population will emit this anti-BMP/ pro-neural signal, but the 
effective concentration of this factor can be reached only if the population of cells achieves a 
certain size. In the center of the cluster the concentration of the pro-neural factor will become 
high enough to drive neural differentation. Also the concentration of BMPs, emitted from the 
surrounding host tissue, will be at the lowest in the center of the population (Freeman and 
Gurdon, 2002). The cells at the margin of the population, so far described as unspecified cells, 
would receive intermediate levels of BMP. Cells receiving intermediate levels of BMP 
signaling should become neural crest or preplacodal ectoderm according to the fate map and 
as I disccussed above.  
So far, I mainly focussed on the behaviour of the heterochronically transplanted dorsal cells. 
The ventral cells do not maintain their initial fate, either they do adopt the neural fate or they 
stay unspecified. The tendency to exclude the neural marker, too, and to become unspecified 
is more evident after heterochronic transplantation of ventral cells at the 80% epiboly stage. 
So, ventral cells seem to be more plastic, and they adopt new fates depending on the received 
level of BMP signaling. As I already mentioned, it is crucial to see whether the unspecified 
cells become neural crest and preplacodal ectoderm or not. If so, these results would be in line 
with my working hypothesis and with a morphogenetic role of BMP signaling integrated over 
time. 
There are differences between the heterochronic and the heterotopic transplantation of ventral 
ectodermal cells at the 60% epiboly stage (after heterotopic transplantation 53% of the cells 
are unspecified, 37% adopt the neural fate; in comparison 39% of the cells are unspecified 
and 61% adopt the neural fate after the heterochronic transplantation). Why are 
heterochronically transplanted cells more plastic than cells after heterotopic transplantation? 
A community effect, as described above, should shield the heterochronically transplanted 
cells from neural inducing factors and promote the unspecified or intermediate fates. But 
another explanation might be simplier than community effects. The heterochronically 
transplanted cells (into a hyper-dorsalised embryo) are exposed to high levels of neural-
inducing factors, and achieve the neural fates in high ratios. In the situation after the 
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heterotopic transplantation, the cells received slightly lower levels of neural inducing 
signaling, and therefore the cells either stay undifferentiated or become an intermediate fate in 
a higher frequency. If correct, ventral ectodermal cells sense even very small changes in pro- 
and anti-BMP signaling at 60% epiboly. Therefore one has to propose a morphogenetic role 
of BMP signaling as well as of anti-BMP / pro-neural factor signaling integrated over time.  
 
 
5.3.3. Outlook and further perspective 
It is not clear when ectodermal cells become committed to their specific fate during the course 
of gastrulation. There is some data pointing into the direction that the dorsal ectodermal cells 
are specified and committed at an earlier point of time than the ventral cells. But the results of 
my transplantation experiments show differences between each appoach and are inconclusive; 
and a lot of open questions remain.  
The cell fate specification of ectodermal cells, both dorsal and ventral, seem to depend on the 
level and the time of BMP signaling, proposing a morphogenetic role of BMP signaling. 
Thereby the fate of a cell depend on the achieved level of BMP signaling over time, low 
levels will promote neural fates, intermediate levels will give rise to neural crest and 
preplacodal ectoderm and high and sustained levels of BMP signaling are required for the 
ventral most fates (see also above). But the different results between heterotopic and 
heterochronic show that community effects and probably even more factors than sole BMPs 
are involved in cell fate specification along the D-V axis. Further experiments have to adress 
the role of cell contacts and community effects as well as the possible morphogenetic role of 
BMP signaling.  
The most striking question is, whether the unspecified cells achieved a fate of neural crest and 
preplacodal ectoderm, as I have speculated, or if they have acquired a completely unspecified 
fate. The new analysis of the transplanted cells with neural crest and preplacodal markers is 
absolute crucial, to test the hypothesis of a morphogene concept. 
During gastrulation the mesendoderm becomes internalised and moves anteriorly. Still, it is 
possible that the unspecified cells are of mesodermal origin, although I carried out the 
transplantations close to the animal pole and very carefully. However, the injection of lefty 
RNA in donor and host embryos would reduce the risk of mesodermal contaminations. 
Overexpression of Lefty completely abolishes mesoderm induction at blastula stage, via 
antagonising Squint signaling, without affecting the D-V patterning of the ectoderm (Thisse 
and Thisse, 1999; Chen and Schier, 2002). 
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One has to perform transplantations during the whole course of gastrulation, to nail down the 
exact timing of cellular commitment. The transplantation of dorsal cells until the end of 
gastrulation (tailbud stage, 10 hpf) will be necessary. This will technical be very challenging 
because the dorsal tissue becomes more compact and the ventral side becomes very thin. The 
injection of has2 MO, to impair the gastrulation movements without affecting D-V patterning, 
would avoid these problems (Bakkers et al., 2004). This could be done in combination with 
the lefty RNA injection, to reduce the technical source of errors to a minimum.  
As I speculated above, ventral cells sense even very small changes in pro- and anti-BMP 
signaling at 60% epiboly. If the aforementioned morphogenetic role of BMP signaling is 
correct, a fine-mapping of the plasticity of ventral cells from shield stage to the 70% epiboly 
stage might be worth to perform. 
Further one could combine loss and gain of function approaches in the transplantation 
experiments to adress the question, which factors are required for cellular commitment. So, 
one could test dorsal cells with a gain of BMP signaling in a dorsal and ventral environment, 
as well as ventral cells with a loss of BMP signaling. One could also test additional factors 
that might be involved. For example, whether gain of FGF signaling in the donor cells can 
promote the neural fate of ectopically transplanted cells or not, this will show the relevance of 
these factors.  
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6. Large-scale screen using morpholino antisense nucleotides to 
identify new genes involved in early development, pituitary or 
skin development 
6.1. Introduction 
Genetic studies of loss-of-function mutations gain insights to the function of a gene. The 
Nüsslein-Volhard and Driever labs started in the 1990s large-scale screens using ENU-
mutagenised zebrafish. The zebrafish is an ideal vertebrate model organism for large-scale 
screening. These and following forward genetic screens gave the first large collection of 
mutants for vertebrate development. The generation of mutagenised fish, the screening for 
phenotypes and positional cloning of the mutated gene is a time-expensive approach. In 
contrast the design of morpholinos and injections to obtain morphant embryos can be done in 
a little while. A further advantage of reverse genetics is that the targeted gene is already 
known. Stephen C. Ekker (University of Minnesota, Minneapolis) started an international 
consortium of zebrafish labs, funded by the NIH (USA) for screening a collection of 
morpholinos. The morpholino collection targeted either annotated full length genes or 
Expressed Sequence Tags (EST) of so far unknown function. The screen was organized and 
coordinated by the lab of Stephen C. Ekker (Pickart et al., 2006). 
As a starting point of my PhD thesis work I joined this consortium and performed a large-
scale screen using the collection of morpholino antisense oligonucleotides.  
 
6.2. Results 
Morpholinos were injected in different concentrations (0.01mM to 1.5mM); injected embryos 
were screened for the first three days of development by general morphology. To circumvent 
unspecific effects of the MOs, like small heads and eyes (SHE), brain necrosis, edema in the 
heart and the brain and retarded development, I reinjected some MOs together with p53 MO 
(Robu et al.,  2007). Further the injected embryos were checked for proper pituitary 
development, by fixation at three days post fertilisation and analysis by whole mount in situ-
hybridisations with the previously described pituitary gland markers pomc and prl  (Herzog et 
al., 2004). A second batch of injected embryos was stained for DeltaNp63 to check 
keratinocyte and skin development (Lee and Kimelman, 2002).  
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I picked genes and EST with known or annotated expression pattern (ZFIN expression pattern 
Database). Thereby I concentrated on genes expressed in the developing pituitary gland or 
epidermis. A second criteria for selection was homology to genes that are annotated in OMIM 
(Online Mendelian Inheritance in Man), a database for human disorders, and could also cause 
developmental defects in zebrafish. The morpholinos were designed by members of the 
consortium themselves. Morpholinos named with BR…. were designed by myself as 
contribution to the screened MO collection. 
In total I screened morpholinos targeting 60 different genes or ESTs. 36 out of these 60 
morpholinos caused effects in general. In the following I describe the morpholino targets and 
observed effects of injected embryos. 
 
BR0001 zgc:110343; an EST expressed in hypothalamus and epidermis. Its sequence is 
similar to natural killer cell enhancement factor (nkef), a factor of the antioxidant 
protein family that enhances natural killer cell activity (Zhang et al., 2001). 
 Embryos injected with this morpholino showed pleiotropic defects such as slight 
toxicity during the first 24 hours (17/88; 7/70), edemas along the body, small eyes, 
curved tail or reduced tail fins. A concentration of 0.1mM caused a significant 
developmental delay in an additional part of the clutch (11/70). No differences in 
skin or pituitary tests were observed compared to the uninjected control. 
 
BR0002 secretograninV (scg5) is expressed in the zebrafish pituitary gland. Secretogranins 
belong to the chromogranin-secretogranin family and are realesed from 
neuroendocrine cells as granins, which are acidic proteins co-localized with 
peptides in secretory granules (Taupenot et al., 2003) 
 Injected embryos did not show any phenotype except for small edema, no 
phenotype during the development of the pituitary gland was observed. 
 
BR0003 secretograninIII (scg3) is another member of the chromogranin-secretogranin 
family, which is also expressed in the zebrafish pituitary gland. 
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BR0004 and BR0019  n-myc downstream related family member 3b and 3a 
respectively, are expressed in the zebrafish pituitary gland, a gene function is not 
reported so far. 
 The morpholino targeting ndrg3b (BR0004) caused SHE phenotype, heart edema, 
shortened axis or curved down tail with a penetrance of 50% in a concentration of 
0.01 mM. The morpholino against ndrg3a showed similar phenotypes with a lower 
penetrance. Coinjection of both morpholinos increased the penetrance with no 
additional phenotypes. By in situ-hybridisation with pituitary gland markers the 
intensity of the staining was increased, but no additional cells were observed and 
the increased intensity occured solely in embryos with small heads. Injection of 
single or both morpholinos into transgenic pomc::GFP embryos did not show an 
increase in pomc expression, indicating that changes in intensity were staining 
artefacts. 
 
BR0005 inositol heyaphosphate kinase 2 (ihpk2) is expressed in the zebrafish pituitary gland 
and encodes an enzyme required in the production of inositol pyrophosphate and 
inositol trisphosphate (Saiardi et al., 1999).  
 The morpholino injected in a high concentration of 1mM caused edema, apart from 
that the embryos and analysis of pituitary gland markers revealed no phenotypes. 
 
BR0006 claudin h; the gene target was chosen because of its expression domain in the 
zebrafish pituitary gland. Claudin h is a tight junction molecule that belongs to 
large family of claudins (Angelow et al., 2008). 
 A few of the injected embryos generated showed strong edema during the first five 
days at a morpholino concentration of 0.1mM (5/105). The tests with pituitary 
markers did not show any change in marker expression. 
 
BR0010 claudin 7, another tight junction molecule, is expressed in the zebrafish epidermis, 
but also in several other tissues like pronephric duct, neuromasts, hatching gland 
and otic placode (Angelow et al., 2008). 
 This morpholino caused high toxicity and necrosis at a concentration of 0.05 mM, 4 
out of 80 suffered from a gastrulation arrest and less affected embryos had 
uncoordinated swimming movements. Lower concentrations just caused brain 
necrosis. No obvious changes in DeltaNp63 stainings were observed. 
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BR0007 spalt-like1, is expressed in the zebrafish brain including the pituitary gland and the 
homologue to the homeotic gene spalt (sal) in Drosophila. 
 Injected embryos showed edema at the heart and in the brain; also a small head/ 
small eyes phenotype was observed; pit1, prl and pomc markers for the pituitary 
gland was misexpressed or the intensity of expression was altered, but only in 
embryos with SHE.  Coinjection of p53 MO did prevent any phenotype. 
 
BR0008 zgc:174890, an EST encoding a predicted Zinc-finger protein, that is expressed in 
the EVL and epidermis. 
 The morpholino caused high toxicity and pleiotropic phenotypes in a concentration 
of 0.05 mM; whereas 0.01 mM caused blisters and edema at day three of 
development. 
 
BR0009 im:7142141, an EST of a predicted gene, encoding a GA-binding-protein, a 
putative transcription factor that is expressed in the epidermis. 
 In a high concentration of 1 mM the embryos became necrotic, developed edemas 
and smaller heads, the embryos did not survive until day five. Single cells were 
delaminating from the skin, but staining with DeltaNp63 did not confirm a skin 
phenotype. 
 
BR0011 cysteine-rich, angiogenic inducer, 61 (cyr61) encodes an extracellular protein, that 
promotes the adhesion of endothelial cells (Babic et al., 1998). The morpholino was 
ordered for tests of skin defects. 
 Injected embryos had an overall smaller body size and loss of tail fins together with 
kinked tail, they survived only for two days. The morpholino was toxic above 
0.01mM concentration; coinjection with p53 morpholino in the same concentration 
reduced the strength of the phenotypes as well as toxicity. Staining against 
DeltaNp63 did not show a specific loss of keratinocytes. 
 
BR0012 zgc:64101 is an unknown EST that was ordered by the lab of Stephen Ekker. 
 This morpholino caused edema along the body axis and loss of the tail tip, but had a 
low penetrance (15/76 embroys for 0.05mM; 5/60 for 0.1mM). 
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BR0013 coagulation factor II (thrombin) receptor-like1 encodes a G-Protein-coupled 
receptor, also called proteinase-activated receptor 2 (par2), was ordered in 
collaboration with Tom Carney to test for putative skin development. 
 Embryos injected with this morpholino showed no specific phenotype, but strong 
necrosis from 0.1 mM upwards. 
 
BR0014 ron protein tyrosine kinase, also called macrophage stimulating 1 receptor (c-met-
related tyrosine kinase) (mst1r) was ordered in collaboration with Tom Carney 
because of  its presumptive role in skin development (Carney et al., 2007) 
 
BR0015 nidogen2, a basement membrane protein described in mouse and human (Kohfeldt 
et al., 1998; Schymeinsky et al., 2002), It was annotated to be expressed in the 
zebrafish hypophysis. In the current annotation the expression pattern is not 
available anymore and in the new annotated sequence this morpholino is not 
targeting the 5’UTR. 
 This morpholino did not cause any effects and was obviously misdesigned. 
 
BR0016 transforming growth factor beta 1, was picked because of its expression in the 
epidermis at day one of development. It was cloned and described in oocyte 
maturation (Kohli et al., 2003), meanwhile it was also used as marker in wound 
healing of adult zebrafish (Andreasen et al., 2007). 
 The morpholino caused pleiotropic defects with a low penetrance (6/45 and 14/51); 
the embryos without pleiotropic phenotypes were screened for keratinocytes, but 
did not show a phenotype. Around day 3 all embryos died. 
 
BR0017 cellular retionoic acid binding protein 1a, is expressed in the neurohypophysis (Liu 
et al., 2005) and was picked for a collaboration with Hans-Martin Pogoda. 
 
BR0018 sb:cb649, an EST expressed in the EVL during gastrulation and later in the 
pituitary gland. It is predicted to encode a SH3 domain binding protein. 
 The morpholino caused pleiotropic defects (SHE, edemas, brain necrosis) and 
showed up to 50% (41/82, 14/81) toxicity during the first 48 hours. At  a 
concentration of 0.1mM the embryos did not move upon touching, too. No specific 
phenotype was found in the skin or pituitary test. 
Morpholino Screen 
 - 103 - 
 
BR0020 dyskerin, found to be the gene responsible for dyskeratosis congenitautaneous 
pigmentation, dystrophy of the nails, leukoplakia of the oral mucosa, continuous 
lacrimation due to atresia of the lacrimal ducts, often thrombocytopenia, anemia, 
and in most cases testicular atrophy (Knight el al., 1999; see also for an over view 
OMIM). It was choosen for test of skin defects. 
 Concentrations of 0.5mM caused toxicity and very strong necrosis during the first 
day of development. At lower concentrations of 0.2mM embryos were smaller in 
body size and had SHE phenotype, the blood circulation was absent and heart 
edema did form, the embryos showed uncoordinated swimming movements and 
survived only until day four. But no specific phenotype in the keratinocytes was 
observed. 
 
BR0021 zinc metallopeptidase STE24, This MO was designed because of its annotation in 
OMIM. Malfunctions of it can cause Mandibuloacral dysplasia, patients with this 
disorder suffer from skeletal abnormalities, cutaneous atrophy and lipodystrophy. 
 This morpholino caused no morphology or skin defects during the first five days of 
development. 
 
BR0022 zinc finger protein 750, was found in OMIM to cause the human disease seborrhea-
like dermatitis with psoriasiform elements (Birnbaum et al., 2006) and tested for 
skin phenotypes. 
 This morpholino did not cause a skin phenotype, even in a concentration of 1.5mM. 
 
BR0023 zgc:85705, an EST encoding T-Box gene 2a, picked for the screen because of its 
predicted expression in the pituitary gland, but recently shown to be involved in 
heart development (Ribeiro et al., 2007) 
 This morpholino did not show phenotypes in pituitary development or general 
morphology. The morpholino was not tested for heart defects as control for proper 
morpholino functionality. 
 
BR0024 t-box gene2b, is according to the ZFIN expression pattern database expressed in the 
epihysis, and was ordered to be checked for pituitary/neurohypophysis 
development (Fong et al., 2005; Gross and Dowling, 2005). 
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 Also this morpholino did not show any phenotype by morphology or pituitary 
markers, even when coinjected with the tbx2a MO (BR0023). 
 
BR0025 ventral anterior homeobox gene (vax), is expressed in the anterior forebrain and 
pituitary gland, before shown to be involved in the development of the optic stalk 
(Take-uchi et al., 2003). 
 This Morpholino did not cause any phenotype. 
 
BR0026 frizzled homolg8b, is expressed in the zebrafish neurohypophysis. It is a predicted 
receptor of Wnt signaling with no published function so far. 
 0.05mM concentrated morpholino did cause some SHE phenotype (6/50), but no 
change in pomc expression. 
 
BR0027 sciellin, in humans the protein is found in keratinizing tissues and functions as 
barrier protein (Champliaud et al., 2000; Champliaud et al., 1998) and was 
investigated for a potential role in zebrafish skin development. 
 Injection of high concentrations above 1mM caused edema, but with a low 
penetrance (5/49). No further skin phenotypes were observed. 
 
SP3001 plexin D1; a gene that is described in development of the vasculature and nervous 
system (Gitler et al., 2004). 
 Embryos injected with raising concentrations of morpholino (from 0.05 to 0.1mM) 
did not show any phenotype in morphology, pituitary or skin development. 
 
SP3002 TC285526, an EST for a hypothetical protein of unknown function. 
 Injection of this morpholino did not show any phenotypes in any test. 
 
SP3003 TC269498, an EST of a novel Cysteine Proteinase, most similar to CathepsinK. 
 This morpholino showed SHE phenotype, edema, and a reduced hypothalamic 
pomc expression as well as a general lethality of 50%. 
 
SP3004 prepronociceptin, encoding the precursor of the neuropeptide nociceptin, a natural 
agonist of opioid receptor in humans (Mollereau et al., 1996) 
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 Concentrations of 0,02mM led to embryos with curled up tail, reduced blood flow 
and movement defects, higher concentration caused lethality during the first 24 hpf. 
 
SP3006 TC280069, similar to BBP-like protein2, beta-amyloid peptide-binding protein 
(denoted BBP) containing a G protein-coupling module. This protein binds beta-
amyloid peptide and induces apotosis via caspase activity, as seen in the 
degeneration of neurons in Alzheimer disease (Kajkowski et al., 2001) 
 Injection of 0.05mM morpholino caused SHE in 19% (n=14/71) of injected 
embryos, also it led to a loss of hypothalamic pomc expression, which might be due 
to the small head phenotype. A concentration of 0.1mM led to general necrosis. 
 
SP3007 TC283881, an EST with similarities to Cysteine knot secreted protein DAN, a 
putative BMP-like protein. 
 Upon injection diverse phenotypes were observed like delayed gastrulation, loss of 
the tail fin or edema at the heart, but for every phenotype with a very low 
penetrance (below 5% per clutch). 
 
SP3008 renin, human Renin catalyzes the first step in the activation pathway of 
angiotensinogen, which is further required for aldosterone release, vasoconstriction 
and the increase in blood pressure. 
 Embryos injected by this morpholino developed edema from day one onwards. 
 
SP3009 TC284843, this EST is weakly similar to nerve growth factor receptor (ngfr) 
(Bothwell, 1996). 
 A concentration of 0.02mM led to high lethality during the first day after injection, 
the surviving embryos had a reduced blood flow and a ventral curvature of the body 
axis. 
 
SP3010 TC271225, an EST of an unknwon protein with calcium binding properties. 
 This morpholino did not cause any phenotypes. 
 
SP3011 stanniocalcin2, Stanniocalcins are glycoprotein hormones working as paracrine 
factor during follicular development (Luo et al., 2005) 
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 10% of injected embryos showed retardation during development, edema or shorten 
tails. 
 
SP3012 microfibril-associated glycoprotein-1 (magp1), this morpholino and the role of 
Magp1 in vascular development is described by the lab of Stephen Ekker (Chen et 
al., 2006). 
 
SP3013 TC299698; an EST with a weak similarity to WNT1 inducible signaling pathway 
protein 2 (WISP2). WISPs belong to the subfamily of connective tissue growth 
factors. They are acting downstream of wnt signaling and might play a role in 
tumor biology (Pennica et al., 1998) 
 This morpholino show pleiotropic defects with strong necrosis and a high lethality 
upon injection of 0.05mM. In lower concentration I observed a reduction in 
DeltaNp63 staining, but could not confirm this phenotype in further injections. 
 
SP3014 TC268808, is an EST of a hypothetical protein with no known similarities. 
 The injected morpholino did not cause any phenotype. 
 
SP3015 torsinA, which is an ATPase of the AAA family and has got functional properties 
of a chaperone (Konakova et al., 2001) 
 Zebrafish injected with 0.1mM morpholino responded after touching with 
uncoordinated/ spasm movements of their body. 
 
SP3017 TC281391 is an EST weakly similar to a member of the family of Epidermal 
growth factor like proteins. 
 10% of embryos injected with 0.05 mM concentrated MO showed delayed 
development at 24 hpf, but recovered after 48 hpf. 
 
SP3019 ephrinB2 (epnb2), EphrinBs are transmembrane ligands for Ephrin receptor 
tyrosine kinases, EphrinB2 is described to play a role in hematopoiesis (Sakano et 
al., 1996) 
 Injection of this MO caused no defects.  
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SP3020 TC282663, an EST for a novel protein with a weak similarity to Cystatins, a family 
of mammalian lysosomal cysteine proteinases. 
 Embryos injected with 0.1mM MO had movements defects and a shorten tail. 
 
SP3021 TC269176, EST similar to ER-Golgi intermediate compartment 53 kDa protein 
(ergic53), in humans also called Lectin. The protein functions as chaperone and is 
important for proper coagulation (Nichols et al., 1998b) 
 Injection of 0.05mM led to pleiotropic defects like SHE and heart edema and 50% 
of the injected embryos showed movement defects, higher concentration led to a 
shorten axis, too. 
 
SP3022 is targeting the gene transforming growth factor-ß typeII receptor (tgfbr2), which 
was before described in oocyte maturation (Kohli et al., 2003) 
Injection of 0.1mM or higher concentrations led to shorten axis with blocky somits, 
always in combination with brain necrosis and SHE phenotype, even upon 
coinjection of the same amount of p53 morpholino 
 
SP3023 TC288467; an EST that is weakly similar to Cytochrome P450 2K1 (Cyp2K1), a 
novel member of the large family of cytochrome P450 proteins. 
Injection of this morpholino showed no phentotype. 
 
SP3024 TC294353, an EST similar to Esophageal cancer related gene 4 protein (ECRG4-A) 
(Yue et al., 2003) 
 This morpholino caused pleiotropic defects and high lethality from concentrations 
of 0.01mM upwards. 
 
SP3026B ApolipoproteinE; which has multiple roles in lipid homeostasis, like interactions 
with lipoproteins. In zebrafish it is expressed in the YSL (Poupard et al., 2000). 
 Embryos showed no phenotypes compared to the control. 
 
SP3054b CB578, an EST similar to Neuroplastin, a member of the Ig superfamily expressed 
in human brain (Bernstein et al., 2007). 
 The morpholino was toxic in concentrations of 0.1mM and caused strong necrosis 
in lower concentrations. 
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BB0006 lipocalin-interacting membrane receptor, the protein is working as endocytic 
receptor in human cell lines (Wojnar et al., 2003) 
 This morpholino caused pleiotropic defects (SHE phenotype, shorten tail or curved 
up, edema). In a concentration of 0.1mM also loss of blood circulation, edema in 
vasculature and blood pooling. 
 
boc brother of cdon, BOC is decribed as cell surface receptors of the immunoglobulin 
(Ig)/fibronectin type III repeat family. It is involved in myogenic differentiation 
(Kang et al., 2002). 
 Embryos injected with 0.1mM morpholino were retarded after 24 hpf and showed 
pleiotropic phenotypes. Coinjection with p53 morpholino did increase the 
phenotypic strength and lethality. 
 
cndp2 carnosine dipeptidase2, human Carnosine Dipeptidase2 is a nonspecific dipeptidase 
(Teufel et al., 2003). 
 Upon injection of this morpholino no phenotype was found. 
 
elmo1 engulfement and cell motility gene 1, the C.elegans homologue ced12 is required 
for phagocytosis and cell migration functioning via Dock180 and CrkII (Gumienny 
et al., 2001) 
Upon injection of this morpholino no phenotype was found. 
 
mcts1 Malignant T-Cell Amplified Sequence1, a putative oncogene that increases cell 
proliferation by decreasing G1-Phase (Prosniak et al., 1998) 
 This morpholino caused no phenotype. 
 
npc2 niemann-pieck C Disease 2, encoding a cholesterol-binding protein involved in the 
Niemann-Pieck disease, a disorder of lipid storage affecting visceral and central 
nervous system (Naureckiene et al., 2000) 
 No phenotype was found in morphology and touch response. 
 
nxph1 neurexophilin 1, a neuropeptide-like glycoprotein bindimg to alpha neurexins 
(Missler and Sudhof, 1998) 
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Upon injection of this morpholino no phenotype was found. 
 
ppt1 palmitoyl-protein thioesterase 1, this enzyme is involved in catabolism of lipid-
modified proteins (Camp et al., 1994) 
 This morpholino caused no phenotype. 
 
rfng radical fringe is a mammalian homologue of Drosophila mel. fringe, the protein is 
modulating the activity of Notch receptor (Johnston et al., 1997). 
 No phenotype was found. 
 
6.3. Discussion 
The outcome of the screen was less efficient than of an ENU-mutangenesis in regard to the 
discovery of new gene functions. The selection of genes was just based on published 
expression data (ZFIN expression pattern database). But neither me nor the collaborating labs 
have done a confirmation of the expression pattern prior to morpholino design. Hence some 
morpholinos might target genes with wrong annotated expression pattern and could not cause 
any phenotype. Or they caused unexpected phenotypes that were overlooked. Also a further 
validation of the annotated sequences, like a 5’RACE (rapid ampification of cDNA ends), 
was not done. So morpholinos could be designed against wrong target sequences, especially 
in the case of ESTs. A more stringent validation of the targeted genes might decrease the 
number of false positives or morphants without any phenotype. 
Morpholinos are chemical substances and can cause toxic side effects. Many of the 
morpholinos I screened, showed known unspecific phenotypes, like small heads and eyes 
(SHE), brain necrosis, edema in the heart and the brain and retarded development. Although 
simultaneous knock-down of p53 function can deplete toxicity (Robu et al., 2007), real 
phenotypes might be masked by either the unspecific defects or even by the knock-down of 
p53 function. Further the efficiency of morpholinos depends on their chemical composition 
and purification. Every gene/ EST was only targeted by one morpholino. So it might be that 
an inefficient MO let me miss a phenotype. During the screen several batches showed reduced 
efficiency of newly synthesised morpholinos, even in controls with known morpholinos. 
Because of this variability in morpholino synthesis I assume that some morpholinos giving no 
phenotype were just ineffective. 
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8. Appendix 
I also contributed substantial work during the revisions of following manuscript in addition to 
my thesis work. 
 
Martina Jänicke, Björn Renisch and Matthias Hammerschmidt (2009). „Zebrafish grainyhead-
like1 is a common marker of different non-keratinocyte epidermal cell lineages, which 
segregate from each other in a Foxi3-dependent manner“ Int.J.Dev.Biol., in press 
 
My contributions are to the final manuscript are in particular: Figure1, panels (P-T); Figure 2, 
panels (C-E); Figure 4 panel (F), Supplementary Figure S2 and Supplementary Figure S6. 
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Abbreviations 
AA arachidonic acid 
Alk Activin receptor-like kinase 
A-P anterior-posterior 
ASS acetylsaliacylacid 
bp base pairs 
BSA bovine serum albumin 
Bmp bone morphogenetic protein 
CA constitutive active 
C-terminal carboxy-terminal 
C&E convergence and extension 
cDNA DNA complementairy to RNA 
D-V dorsoventral 
ddH2O double distilled water  
DMSO dimetylsulphoxide 
DNA deoxyribonucleic acid 
dNTP Desoxyribonucleotide 
dpf day(s) post fertilization 
DTT Dithiothreitol 
e.g.  example given 
ENU ethylnitrosourea  
EST expressed sequence tag 
EVL enveloping layer 
Fgf fibroblast growth factor 
g, mg, µg, ng gram, milligrams, micrograms, nanograms 
GFP green fluorescent protein 
HETE hydroxy eicosatetraenoic acid 
hpf hours post fertilization 
kb kilobase pairs 
L, mL, µL litres, millilitres, microlitres 
M, mM, µM moles, millimoles, micromoles per litre 
MO morpholino oligonucleotide 
mRNA messenger RNA 
n number 
NSAID non steroidal anti inflammatory drugs 
PBS phosphate buffered saline 
PBST phosphate buffered saline with 0.1% Tween 
PCR polymerase chain reaction 
PFA para-formaldehyde 
PG prostaglandin 
PLA2 Phospholipase A2 
PPAR peroxisome proliferator-activated receptor 
p-Smad phosphorylated Smad1/5/8 
RNA ribonucleic acid 
RT reverse transcription 
Smad Sma and Mad family member 
tBR truncated BMP receptor 
Tris Tris-(Hydroxymethyl)-amino methane 
Tween-20 polyoxyethylensorbitanmonolaurat 
rpm rotations per minute 
w/v weight per volume  
v/v volume per volume 
YSL yolk synticial layer 
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